EurekaMag PDF full texts Chapter 57,334

Wu, M.; Gu, X.; Li, X.; Li, Y.; Zhou, H.; Lu, G.; Wu, Z.; Huang, H.; Tang, L.; Zeng, J. 2016: C-Reactive Protein and Inflammatory Cytokines during Percutaneous Coronary Intervention. Journal of Vascular Research 53(1-2): 39-48

Muñoz, Jé.Luis.; Ruiz-Tovar, J.; Miranda, E.; Berrio, D.Lorena.; Moya, P.; Gutiérrez, M.; Flores, R.; Picó, C.; Pérez, A. 2016: C-Reactive Protein and Procalcitonin as Early Markers of Septic Complications after Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients Within an Enhanced Recovery After Surgery Program. Journal of the American College of Surgeons 222(5): 831-837

Giardino, A.; Spolverato, G.; Regi, P.; Frigerio, I.; Scopelliti, F.; Girelli, R.; Pawlik, Z.; Pederzoli, P.; Bassi, C.; Butturini, G. 2016: C-Reactive Protein and Procalcitonin as Predictors of Postoperative Inflammatory Complications After Pancreatic Surgery. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 20(8): 1482-1492

Ramel, A.; Geirsdottir, O.G.; Jonsson, P.V.; Thorsdottiri, I. 2015: C-Reactive Protein and Resistance Exercise in Community Dwelling Old Adults. Journal of Nutrition Health and Aging 19(7): 792-796

Mc Causland, F.R.; Claggett, B.; Burdmann, E.A.; Eckardt, K-Uwe.; Kewalramani, R.; Levey, A.S.; McMurray, J.J.V.; Parfrey, P.; Remuzzi, G.; Singh, A.K.; Solomon, S.D.; Toto, R.D.; Pfeffer, M.A. 2016: C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 68(6): 873-881

Straatman, J.; de Weerdesteijn, E.d.W.; Tuynman, J.B.; Cuesta, M.A.; van der Peet, D.L. 2016: C-Reactive Protein as a Marker for Postoperative Complications. Are there Differences in Emergency and Elective Colorectal Surgery?. Diseases of the Colon and Rectum 59(1): 35-41

Wiese, D.; Kampe, K.; Waldmann, J.; Heverhagen, A.E.; Bartsch, D.K.; Fendrich, V. 2016: C-Reactive Protein as a new Prognostic Factor for Survival in Patients with Pancreatic Neuroendocrine Neoplasia. Journal of Clinical Endocrinology and Metabolism 101(3): 937-944

Yu, M.; Dou, C.; Gu, Y.; Cheng, W. 2018: Crystallization and structure analysis of the core motif of the Pks13 acyltransferase domain from Mycobacterium tuberculosis. Peerj 6: E4728

Kinoshita, A.; Onoda, H.; Imai, N.; Nishino, H.; Tajiri, H. 2015: C-Reactive Protein as a Prognostic Marker in Patients with Hepatocellular Carcinoma. Hepato-Gastroenterology 62(140): 966-970

Neumaier, M.; Braun, K.F.; Sandmann, G.; Siebenlist, S. 2015: C-Reactive Protein in Orthopaedic Surgery. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 82(5): 327-331

Podzimek, S.; Mysak, J.; Janatova, T.; Duskova, J. 2015: C-Reactive Protein in Peripheral Blood of Patients with Chronic and Aggressive Periodontitis, Gingivitis, and Gingival Recessions. Mediators of Inflammation 2015: 564858

Aslan, V.; Akay, O.M.; Gülbaş, Z. 2003: C-Reactive Protein in the Follow-up and Estimation of Infections in Acute Leukemic Patients. Turkish Journal of Haematology: Official Journal of Turkish Society of Haematology 20(2): 75-80

Liao, S.-G.; Cheng, H.-H.; Lei, Y. 2016: C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer. Oncology Research and Treatment 39(5): 266-271

Gorska-Ciebiada, M.; Saryusz-Wolska, M.; Borkowska, A.; Ciebiada, M.; Loba, J. 2015: C-Reactive Protein, Advanced Glycation End Products, and their Receptor in Type 2 Diabetic, Elderly Patients with Mild Cognitive Impairment. Frontiers in Aging Neuroscience 7: 209

Salazar, J.; Martínez, M.ía.S.ía.; Chávez-Castillo, M.; Núñez, V.; Añez, R.; Torres, Y.; Toledo, A.; Chacín, M.; Silva, C.; Pacheco, E.; Rojas, J.; Bermúdez, V. 2014: C-Reactive Protein: An In-Depth look into Structure, Function, and Regulation. International Scholarly Research Notices 2014: 653045

Codner, E.; Merino, P.M.; Martínez, D.; Lopez, P.; Godoy, C.; Iñiguez, G.; Cassorla, F.; Perez-Bravo, F. 2016: C-Reactive protein and insulin growth factor 1 serum levels during the menstrual cycle in adolescents with Type 1 diabetes. Diabetic Medicine: a Journal of the British Diabetic Association 33(1): 70-76

Nevet, A.; Yarden-Bilavsky, H.; Ashkenazi, S.; Livni, G. 2014: C-Reactive protein levels in children with primary herpetic gingivostomatitis. Israel Medical Association Journal: Imaj 16(11): 700-702

Alkofide, H.; Huggins, G.S.; Beshansky, J.R.; Ruthazer, R.; Peter, I.; Ray, M.; Mukherjee, J.T.; Selker, H.P. 2015: C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes. Bmc Cardiovascular Disorders 15: 163

Ma, M.; Lohman, J.R.; Liu, T.; Shen, B. 2015: C-S bond cleavage by a polyketide synthase domain. Proceedings of the National Academy of Sciences of the United States of America 112(33): 10359-10364

Wang, J.; Yue, K.; Zhu, X.; Wang, K.L.; Duan, L. 2016: C-S@PANI composite with a polymer spherical network structure for high performance lithium-sulfur batteries. Physical Chemistry Chemical Physics: Pccp 18(1): 261-266

Zougman, A.; Banks, R.E. 2015: C-STrap Sample Preparation Method--In-Situ Cysteinyl Peptide Capture for Bottom-Up Proteomics Analysis in the STrap Format. Plos one 10(9): E0138775

Smith, R. 2014: C-TECC Update. Journal of Special Operations Medicine: a Peer Reviewed Journal for Sof Medical Professionals 14(1): 118-120

Blaurock, N.; Schmerler, D.; Hünniger, K.; Kurzai, O.; Ludewig, K.; Baier, M.; Brunkhorst, F.M.; Imhof, D.; Kiehntopf, M. 2016: C-Terminal Alpha-1 Antitrypsin Peptide: a new Sepsis Biomarker with Immunomodulatory Function. Mediators of Inflammation 2016: 6129437

Zhang, X.; Bilic, I.; Marek, A.; Glösmann, M.; Hess, M. 2016: C-Terminal Amino Acids 471-507 of Avian Hepatitis e Virus Capsid Protein Are Crucial for Binding to Avian and Human Cells. Plos one 11(4): E0153723

Gupta, G.; Song, J. 2016: C-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts with Human VAPB-MSP to Form a Dynamic Replication Complex. Plos one 11(1): E0147278

Liu, B.; Di, G. 2017: C-Terminal Binding Protein is Involved in Promoting to the Carcinogenesis of Human Glioma. Molecular Neurobiology 54(8): 6121-6132

Somasundaram, P.; Koudelka, T.; Linke, D.; Tholey, A. 2016: C-Terminal Charge-Reversal Derivatization and Parallel use of Multiple Proteases Facilitates Identification of Protein C-Termini by C-Terminomics. Journal of Proteome Research 15(4): 1369-1378

Suzuki, H.; Watari, A.; Hashimoto, E.; Yonemitsu, M.; Kiyono, H.; Yagi, K.; Kondoh, M.; Kunisawa, J. 2015: C-Terminal Clostridium perfringens Enterotoxin-Mediated Antigen Delivery for Nasal Pneumococcal Vaccine. Plos one 10(5): E0126352

Roberts, V.A. 2015: C-Terminal Domain of Integrase Binds between the two Active Sites. Journal of Chemical Theory and Computation 11(9): 4500-4511

Ray, G.; Schmitt, P.Tieu.; Schmitt, A.P. 2016: C-Terminal DxD-Containing Sequences within Paramyxovirus Nucleocapsid Proteins Determine Matrix Protein Compatibility and Can Direct Foreign Proteins into Budding Particles. Journal of Virology 90(7): 3650-3660

Devetzis, V.; Daryadel, A.; Roumeliotis, S.; Theodoridis, M.; Wagner, C.A.; Hettwer, S.; Huynh-Do, U.; Ploumis, P.; Arampatzis, S. 2015: C-Terminal Fragment of Agrin (CAF): a Novel Marker for Progression of Kidney Disease in Type 2 Diabetics. Plos one 10(12): E0143524

Bansal, S.; Maurya, I.Kumar.; Yadav, N.; Thota, C.Kumar.; Kumar, V.; Tikoo, K.; Chauhan, V.Singh.; Jain, R. 2016: C-Terminal Fragment, Aβ32-37, Analogues Protect Against Aβ Aggregation-Induced Toxicity. Acs Chemical Neuroscience 7(5): 615-623

Li, W.; O'Brien-Simpson, N.M.; Yao, S.; Tailhades, J.; Reynolds, E.C.; Dawson, R.M.; Otvos, L.; Hossain, M.A.; Separovic, F.; Wade, J.D. 2017: C-Terminal Modification and Multimerization Increase the Efficacy of a Proline-Rich Antimicrobial Peptide. Chemistry 23(2): 390-396

Vinogradov, A.A.; Simon, M.D.; Pentelute, B.L. 2016: C-Terminal Modification of Fully Unprotected Peptide Hydrazides via in Situ Generation of Isocyanates. Organic Letters 18(6): 1222-1225

Russell, J.A. 2015: C-Terminal Portion of Pro-Arginine-Vasopressin (Ct-Pro-Avp) as a Predictive Biomarker in Sepsis: not there Yet. Shock 44(4): 381-382

Kobayashi, Y.; Otani, T.; Ishibashi, K.; Shikanai, T.; Nishimura, Y. 2016: C-Terminal Region of Sulfite Reductase Is Important to Localize to Chloroplast Nucleoids in Land Plants. Genome Biology and Evolution 8(5): 1459-1466

Schwartz, H.C. 2015: C-Terminal Telopeptide—Science or Politics?. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 73(7): 1239

Chemuru, S.; Kodali, R.; Wetzel, R. 2016: C-Terminal Threonine Reduces Aβ43 Amyloidogenicity Compared with Aβ42. Journal of Molecular Biology 428(2 Part A): 274-291

Kleinknecht, A.; Popova, B.; Lázaro, D.F.; Pinho, R.; Valerius, O.; Outeiro, T.F.; Braus, G.H. 2016: C-Terminal Tyrosine Residue Modifications Modulate the Protective Phosphorylation of Serine 129 of α-Synuclein in a Yeast Model of Parkinson's Disease. Plos Genetics 12(6): E1006098

Xu, W.; Liu, Y.; Ye, Y.; Liu, M.; Han, L.; Song, A.; Liu, L. 2016: C-Terminal carbohydrate-binding module 9_2 fused to the N-terminus of GH11 xylanase from Aspergillus niger. Biotechnology Letters 38(10): 1739-1745

Hover, B.M.; Yokoyama, K. 2015: C-Terminal glycine-gated radical initiation by GTP 3',8-cyclase in the molybdenum cofactor biosynthesis. Journal of the American Chemical Society 137(9): 3352-3359

Murza, A.; Besserer-Offroy, Él.; Côté, J.ér.ôm.; Bérubé, P.; Longpré, J.-M.; Dumaine, R.; Lesur, O.; Auger-Messier, M.; Leduc, R.; Sarret, P.; Marsault, Ér. 2015: C-Terminal modifications of apelin-13 significantly change ligand binding, receptor signaling, and hypotensive action. Journal of Medicinal Chemistry 58(5): 2431-2440

Irfan, M.; Guler, H.I.; Ozer, A.; Sapmaz, M.T.; Belduz, A.O.; Hasan, F.; Shah, A.A. 2016: C-Terminal proline-rich sequence broadens the optimal temperature and pH ranges of recombinant xylanase from Geobacillus thermodenitrificans C5. Enzyme and Microbial Technology 91: 34-41

Bożentowicz-Wikarek, M.; Owczarek, A.; Kocełak, P.; Olszanecka-Glinianowicz, M.; Więcek, A.; Chudek, J. 2016: C-Terminal to Intact Fibroblast Growth Factor 23 Ratio in Relation to Estimated Glomerular Filtration Rate in Elderly Population. Kidney and Blood Pressure Research 41(5): 519-526

Honda, H.; Matsuzono, K.; Fushimi, S.; Sato, K.; Suzuki, S.O.; Abe, K.; Iwaki, T. 2016: C-Terminal-Deleted Prion Protein Fragment Is a Major Accumulated Component of Systemic PrP Deposits in Hereditary Prion Disease with a 2-Bp (CT) Deletion in PRNP Codon 178. Journal of Neuropathology and Experimental Neurology 75(11): 1008-1019

Hata, Y.; Matsumoto, T.; Tanaka, T.; Kondo, A. 2015: C-Terminal-oriented Immobilization of Enzymes Using Sortase A-mediated Technique. Macromolecular Bioscience 15(10): 1375-1380

Kanmert, D.; Cantlon, A.; Muratore, C.R.; Jin, M.; O'Malley, T.T.; Lee, G.; Young-Pearse, T.L.; Selkoe, D.J.; Walsh, D.M. 2015: C-Terminally Truncated Forms of Tau, but not Full-Length Tau or its C-Terminal Fragments, Are Released from Neurons Independently of Cell Death. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 35(30): 10851-10865

Kittur, F.S.; Lalgondar, M.; Hung, C.-Y.; Sane, D.C.; Xie, J. 2015: C-Terminally fused affinity Strep-tag Ii is removed by proteolysis from recombinant human erythropoietin expressed in transgenic tobacco plants. Plant Cell Reports 34(3): 507-516

Hansen, J.; Diness, F.; Meldal, M. 2016: C-Terminally modified peptides via cleavage of the HMBA linker by O-, N- or S-nucleophiles. Organic and Biomolecular Chemistry 14(12): 3238-3245

Toyonaga, K.; Torigoe, S.; Motomura, Y.; Kamichi, T.; Hayashi, J.M.; Morita, Y.S.; Noguchi, N.; Chuma, Y.; Kiyohara, H.; Matsuo, K.; Tanaka, H.; Nakagawa, Y.; Sakuma, T.; Ohmuraya, M.; Yamamoto, T.; Umemura, M.; Matsuzaki, G.; Yoshikai, Y.; Yano, I.; Miyamoto, T.; Yamasaki, S. 2016: C-Type Lectin Receptor DCAR Recognizes Mycobacterial Phosphatidyl-Inositol Mannosides to Promote a Th1 Response during Infection. Immunity 45(6): 1245-1257

Miyake, Y.; Masatsugu, O.-h.; Yamasaki, S. 2015: C-Type Lectin Receptor MCL Facilitates Mincle Expression and Signaling through Complex Formation. Journal of Immunology 194(11): 5366-5374

Wang, L.; Yin, J.; Wang, X.; Shao, M.; Duan, F.; Wu, W.; Peng, P.; Jin, J.; Tang, Y.; Ruan, Y.; Sun, Y.; Gu, J. 2016: C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Gastroenterology 150(5): 1183-1195.E16

Korostyshevskaya, I.M.; Maksimov, V.F.; Rudenko, N.S. 2015: C-Type Natriuretic Pep- Tide: What, Where and what for is This?. Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 101(5): 515-524

Legeai-Mallet, L. 2016: C-Type Natriuretic Peptide Analog as Therapy for Achondroplasia. Endocrine Development 30: 98-105

Li, T.; Cheng, H.-J.; Ohte, N.; Hasegawa, H.; Morimoto, A.; Herrington, D.M.; Little, W.C.; Li, W.; Cheng, C.P. 2016: C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure. Journal of Pharmacology and Experimental Therapeutics 357(3): 545-553

Pernomian, L.; Prado, A.F.; Silva, B.R.; Azevedo, A.; Pinheiro, L.C.; Tanus-Santos, J.é E.; Bendhack, L.M. 2016: C-Type Natriuretic Peptide Induces Anti-contractile Effect Dependent on Nitric Oxide, Oxidative Stress, and NPR-B Activation in Sepsis. Frontiers in Physiology 7: 226

Zhong, Y.; Lin, J.; Liu, X.; Hou, J.; Zhang, Y.; Zhao, X. 2015: C-Type natriuretic peptide maintains domestic cat oocytes in meiotic arrest. Reproduction Fertility and Development 2015

Sarpel, D.; Dieterich, D.T. 2016: C-WORTHY: the beginning of the rise of elbasvir and grazoprevir for the treatment of hepatitis C genotype 1 mono and HIV co-infected patients. Annals of Translational Medicine 4(Suppl 1): S12

Xu, Z.; Zhang, X.; Lau, J.; Yu, J. 2016: C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication. Expert Reviews in Molecular Medicine 18: E16

Wang, X.; Cho, S.Y.; Hu, C.S.; Chen, D.; Roboz, J.; Hoffman, R. 2015: C-X-C motif chemokine 12 influences the development of extramedullary hematopoiesis in the spleens of myelofibrosis patients. Experimental Hematology 43(2): 100-9.E1

Yun, H.-J.; Ryu, H.; Choi, Y.S.; Song, I.-C.; Jo, D.-Y.; Kim, S.; Lee, H.J. 2015: C-X-C motif receptor 7 in gastrointestinal cancer. Oncology Letters 10(3): 1227-1232

Butz, D.R.; Kim, E.K.; Song, D.H. 2015: C-Y Trilobed Flap for Improved Nipple-Areola Complex Reconstruction. Plastic and Reconstructive Surgery 136(2): 234-237

Duan, X.-H.; Li, Y.-S.; Han, X.-W.; Wang, Y.-L.; Jiao, D.-C.; Li, T.-F.; Chen, P.-F.; Fang, Y. 2016: C-arm CT-guided renal arterial embolisation followed by radiofrequency ablation for treatment of patients with unresectable renal cell carcinoma. Clinical Radiology 71(1): 79-85

Li, J.-J.; Zheng, J.-S.; Cui, S.-C.; Cui, X.-W.; Hu, C.-X.; Fang, D.; Ye, L.-C. 2015: C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma. World Journal of Gastroenterology 21(10): 3035-3040

Pedemonte, C.; Sáez, F.; Vargas, I.; González, E.; Canales, M.; Lazo, D.; Pérez, H.án. 2016: C-arm as intraoperative control in reduction of isolated zygomatic arch fractures: a randomized clinical trial. Oral and Maxillofacial Surgery 20(1): 79-83

Czerwinski, M. 2015: C-arm assisted zygoma fracture repair: a critical analysis of the first 20 cases. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 73(4): 692.E1-8

Syha, R.; Gatidis, S.; Grözinger, G.; Grosse, U.; Maurer, M.; Zender, L.; Horger, M.; Nikolaou, K.; Ketelsen, D. 2016: C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 16(1): 30

Syha, R.; Grözinger, G.; Grosse, U.; Maurer, M.; Zender, L.; Horger, M.; Nikolaou, K.; Ketelsen, D. 2015: C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 15: 22

Jaconi, M.; Pagni, F.; Vacirca, F.; Leni, D.; Corso, R.; Cortinovis, D.; Bidoli, P.; Bono, F.; Cuttin, M.S.; Valente, M.G.; Pesci, A.; Bedini, V.A.; Leone, B.E. 2015: C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool: an observational study. Medicine 94(12): E698

Jiao, D.; Xie, N.; Wu, G.; Ren, J.; Han, X. 2017: C-arm cone-beam computed tomography with stereotactic needle guidance for percutaneous adrenal biopsy: initial experience. Acta Radiologica 58(5): 617-624

Kamran, M.; Byrne, J.V. 2015: C-arm flat detector computed tomography parenchymal blood volume imaging: the nature of parenchymal blood volume parameter and the feasibility of parenchymal blood volume imaging in aneurysmal subarachnoid haemorrhage patients. Neuroradiology 57(9): 937-949

Guggenberger, R.; Ulbrich, E.J.; Dietrich, T.J.; Scholz, R.; Kaelin, P.; Köhler, C.; Elsässer, T.; Le Corroller, T.; Pfammatter, T.; Alkadhi, H.; Andreisek, G. 2017: C-arm flat-panel CT arthrography of the shoulder: Radiation dose considerations and preliminary data on diagnostic performance. European Radiology 27(2): 454-463

Pasciak, A.S.; Bourgeois, A.C.; Jones, A.K. 2014: C-arm rotation as a method for reducing peak skin dose in interventional cardiology. Open Heart 1(1): E000141

Li, N.; Timurdogan, E.; Poulton, C.V.; Byrd, M.; Magden, E.S.; Su, Z.; Purnawirman; Leake, G.; Coolbaugh, D.D.; Vermeulen, D.; Watts, M.R. 2016: C-band swept wavelength erbium-doped fiber laser with a high-Q tunable interior-ridge silicon microring cavity. Optics Express 24(20): 22741-22748

Roy, P.; Dhara, D.; Parida, P.K.; Kar, R.K.; Bhunia, A.; Jana, K.; Sinha Babu, S.P.; Misra, A.K. 2016: C-cinnamoyl glycosides as a new class of anti-filarial agents. European Journal of Medicinal Chemistry 114: 308-317

Mustafa, Z.; Jaradat, M.M.M.; Ansari, A.H.; Popović, B.Z.; Jaradat, H.M. 2016: C-class functions with new approach on coincidence point results for generalized [Formula: see text]-weakly contractions in ordered b-metric spaces. Springerplus 5(1): 802

Sukhija, H.; Krishnan, R.; Balachander, N.; Raghavendhar, K.; Ramadoss, R.; Sen, S. 2015: C-deletion in exon 4 codon 63 of p53 gene as a molecular marker for oral squamous cell carcinoma: a preliminary study. Contemporary Clinical Dentistry 6(Suppl 1): S227-S234

Mewara, A.; Gadbail, A.R.; Patil, S.; Chaudhary, M.; Chavhan, S.D. 2010: C-deletion mutation of the p53 gene at exon 4 of codon 63 in the saliva of oral squamous cell carcinoma in central India: a preliminary study. Journal of Investigative and Clinical Dentistry 1(2): 108-113

Jones, C.J.; Utada, A.; Davis, K.R.; Thongsomboon, W.; Zamorano Sanchez, D.; Banakar, V.; Cegelski, L.; Wong, G.C.L.; Yildiz, F.H. 2015: C-di-GMP Regulates Motile to Sessile Transition by Modulating MshA Pili Biogenesis and Near-Surface Motility Behavior in Vibrio cholerae. Plos Pathogens 11(10): E1005068

Schirmer, T. 2016: C-di-GMP Synthesis: Structural Aspects of Evolution, Catalysis and Regulation. Journal of Molecular Biology 428(19): 3683-3701

Xiao, Y.; Nie, H.; Liu, H.; Luo, X.; Chen, W.; Huang, Q. 2016: C-di-GMP regulates the expression of lapA and bcs operons via FleQ in Pseudomonas putida KT2440. Environmental Microbiology Reports 8(5): 659-666

Xie, C.; Yang, S.; Li, B.; Wang, H.; Shi, J.-W.; Li, G.; Niu, C. 2016: C-doped mesoporous anatase TiO2 comprising 10nm crystallites. Journal of Colloid and Interface Science 476: 1-8

Wang, Z.Q.; Sun, B.J. 2015: C-erbB-2 expression and prognosis of gastric cancer: a meta-analysis. Genetics and Molecular Research: Gmr 14(1): 1782-1787

Tigerholm, J.; Petersson, M.E.; Obreja, O.; Eberhardt, E.; Namer, B.; Weidner, C.; Lampert, A.; Carr, R.W.; Schmelz, M.; Fransén, E. 2015: C-fiber recovery cycle supernormality depends on ion concentration and ion channel permeability. Biophysical Journal 108(5): 1057-1071

Altiti, A.S.; Mootoo, D.R. 2015: C-glycosphingolipid precursors via iodocyclization of homoallyic trichloroacetimidates. Carbohydrate Research 407: 148-153

Barutcu, A.R.; Fritz, A.J.; Zaidi, S.K.; van Wijnen, A.é J.; Lian, J.B.; Stein, J.L.; Nickerson, J.A.; Imbalzano, A.N.; Stein, G.S. 2016: C-ing the Genome: a Compendium of Chromosome Conformation Capture Methods to Study Higher-Order Chromatin Organization. Journal of Cellular Physiology 231(1): 31-35

Kafshdooz, T.; Mohaddes Ardabili, S.M.; Kafshdooz, L.; Tabrizi, A.D.; Ghojazadeh, M.; Gharesouran, J.; Akbarzadeh, A. 2015: C-kit Mutations in Endometrial Cancer: Correlation with Tumor Histologic Type. Asian Pacific Journal of Cancer Prevention: Apjcp 16(17): 7449-7452

Gil da Costa, R.M. 2015: C-kit as a prognostic and therapeutic marker in canine cutaneous mast cell tumours: from laboratory to clinic. Veterinary Journal 205(1): 5-10

Staats, K.A.; Schönefeldt, S.; Van Helleputte, L.; Van Rillaer, M.; Lampi, Y.; Dooley, J.; Van Den Bosch, L.; Liston, A. 2015: C-kit is important for SOD1(G93A) mouse survival independent of mast cells. Neuroscience 301: 415-420

Tobío, A.; Alfonso, A.; Botana, L.M. 2015: C-kit mutations determine dasatinib mechanism of action in HMC-1 neoplastic mast cells: dasatinib differently regulates PKCδ translocation in HMC-1(560) and HMC-1(560,816) cell lines. Immunopharmacology and Immunotoxicology 37(4): 380-387

Liu, J.; Liu, X.; Feng, X.; Liu, J.; Lv, S.; Zhang, W.; Niu, Y. 2015: C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast. Breast Cancer Research and Treatment 149(2): 395-401

Tan, J.; Yang, S.; Shen, P.; Sun, H.; Xiao, J.; Wang, Y.; Wu, B.; Ji, F.; Yan, J.; Xue, H.; Zhou, D. 2015: C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model. Oncotarget 6(29): 27037-27048

Kazakov, A.; Meier, T.; Werner, C.; Hall, R.; Klemmer, B.; Körbel, C.; Lammert, F.; Maack, C.; Böhm, M.; Laufs, U. 2015: C-kit(+) resident cardiac stem cells improve left ventricular fibrosis in pressure overload. Stem cell research 15(3): 700-711

Fujiwara, M.; Kato, S.; Niwa, Y.; Suzuki, T.; Tsuchiya, M.; Sasazawa, Y.; Dohmae, N.; Simizu, S. 2016: C-mannosylation of R-spondin3 regulates its secretion and activity of Wnt/β-catenin signaling in cells. Febs Letters 590(16): 2639-2649

D'Amico, L.; Belisario, D.; Migliardi, G.; Grange, C.; Bussolati, B.; D'Amelio, P.; Perera, T.; Dalmasso, E.; Dalle Carbonare, L.; Godio, L.; Comoglio, P.; Trusolino, L.; Ferracini, R.; Roato, I. 2016: C-met inhibition blocks bone metastasis development induced by renal cancer stem cells. Oncotarget 7(29): 45525-45537

Lee, Y.H.; Kim, H.S.; Kim, J.S.; Yu, M.K.; Cho, S.D.; Jeon, J.G.; Yi, H.K. 2016: C-myb Regulates Autophagy for Pulp Vitality in Glucose Oxidative Stress. Journal of Dental Research 95(4): 430-438

Lin, X.; Sun, R.; Zhao, X.; Zhu, D.; Zhao, X.; Gu, Q.; Dong, X.; Zhang, D.; Zhang, Y.; Li, Y.; Sun, B. 2017: C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling. Journal of Molecular Medicine 95(1): 53-67

Xu, S.; Jiang, Y.; Wang, H.; Wang, Z.; Liu, H.; Peng, L.; Fang, Q.; Deng, T.; You, J.; Zhou, X.; Zhang, W.; Lou, J. 2015: C-peptide ameliorates renal injury in type 2 diabetic rats through protein kinase A-mediated inhibition of fibronectin synthesis. Biochemical and Biophysical Research Communications 458(3): 674-680

Bhargava, R.; Mitsides, N.; Saif, I.; MacDowall, P.; Woywodt, A. 2009: C-peptide and combined kidney-pancreas transplantation. Ndt Plus 2(6): 489-492

Brunskill, N.J. 2017: C-peptide and diabetic kidney disease. Journal of Internal Medicine 281(1): 41-51

Liu, Y.; Chen, C.; Summers, S.; Medawala, W.; Spence, D.M. 2015: C-peptide and zinc delivery to erythrocytes requires the presence of albumin: implications in diabetes explored with a 3D-printed fluidic device. Integrative Biology: Quantitative Biosciences from Nano to Macro 7(5): 534-543

Luppi, P.; Drain, P. 2017: C-peptide antioxidant adaptive pathways in β cells and diabetes. Journal of Internal Medicine 281(1): 7-24

Shaw, J.A.; Shetty, P.; Burns, K.D.; Fergusson, D.; Knoll, G.A. 2015: C-peptide as a Therapy for Kidney Disease: a Systematic Review and Meta-Analysis. Plos one 10(5): E0127439

Cabrera de León, A.; Oliva García, J.é G.; Marcelino Rodríguez, I.; Almeida González, D.; Alemán Sánchez, J.é J.; Brito Díaz, B.; Domínguez Coello, S.; Bertomeu Martínez, V.; Aguirre Jaime, A.; Rodríguez Pérez, M.ía.d.C. 2015: C-peptide as a risk factor of coronary artery disease in the general population. Diabetes and Vascular Disease Research 12(3): 199-207

Landreh, M.; Jörnvall, H. 2015: C-peptide evolution: generation from few structural restrictions of bioactivities not necessarily functional. Febs Letters 589(4): 415-418

Nishimura, T.; Meguro, S.; Sekioka, R.; Tanaka, K.; Saisho, Y.; Irie, J.; Tanaka, M.; Kawai, T.; Itoh, H. 2015: C-peptide immunoreactivity index is associated with improvement of HbA1c: 2-Year follow-up of sitagliptin use in patients with type 2 diabetes. Diabetes Research and Clinical Practice 108(3): 441-447

Beliakin, S.A.; Serebrennikov, V.N.; Shklovskiĭ, B.L.; Patsenko, M.B. 2014: C-peptide level as an early diagnostic marker of metabolic syndrome and predictor of cardiovascular disease in patients with diabetes mellitus type 2. Voenno-Meditsinskii Zhurnal 335(10): 46-49

Gregg, B.; Connor, C.G.; Cheng, P.; Ruedy, K.J.; Beck, R.W.; Kollman, C.; Schatz, D.; Cengiz, E.; Tamborlane, W.V.; Klingensmith, G.J.; Lee, J.M. 2016: C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatric Diabetes 17(4): 274-280

Garcia-Serrano, S.; Gutiérrez-Repiso, C.; Gonzalo, M.; Garcia-Arnes, J.; Valdes, S.; Soriguer, F.; Perez-Valero, V.; Alaminos-Castillo, M.A.; Francisco Cobos-Bravo, J.; Moreno-Ruiz, F.J.; Rodriguez-Cañete, A.; Rodríguez-Pacheco, F.; Garcia-Escobar, E.; García-Fuentes, E. 2015: C-peptide modifies leptin and visfatin secretion in human adipose tissue. Obesity 23(8): 1607-1615

Bhatt, M.P.; Lee, Y.-J.; Jung, S.-H.; Kim, Y.H.; Hwang, J.Y.; Han, E.-T.; Park, W.S.; Hong, S.-H.; Kim, Y.-M.; Ha, K.-S. 2016: C-peptide protects against hyperglycemic memory and vascular endothelial cell apoptosis. Journal of Endocrinology 231(1): 97-108

Wahren, J.; Larsson, C. 2015: C-peptide: new findings and therapeutic possibilities. Diabetes Research and Clinical Practice 107(3): 309-319

Huda, M.S.B.; Hitman, G.A. 2015: C-peptide: should we be testing this routinely in the Type 1 diabetes clinic?. Diabetic Medicine: a Journal of the British Diabetic Association 32(10): 1259-1260

Young, I.-C.; Chuang, S.-T.; Hsu, C.-H.; Sun, Y.-J.; Lin, F.-H. 2016: C-phycocyanin alleviates osteoarthritic injury in chondrocytes stimulated with H2O2 and compressive stress. International Journal of Biological Macromolecules 93(Part A): 852-859

Fernández-Rojas, B.; Rodríguez-Rangel, D.Sarai.; Granados-Castro, L.Fernando.; Negrette-Guzmán, M.; León-Contreras, J.Carlos.; Hernández-Pando, R.; Molina-Jijón, E.; Reyes, Jé.L.; Zazueta, C.; Pedraza-Chaverri, Jé. 2015: C-phycocyanin prevents cisplatin-induced mitochondrial dysfunction and oxidative stress. Molecular and Cellular Biochemistry 406(1-2): 183-197

Li, Y.-J.; Han, Z.; Ge, L.; Zhou, C.-J.; Zhao, Y.-F.; Wang, D.-H.; Ren, J.; Niu, X.-X.; Liang, C.-G. 2016: C-phycocyanin protects against low fertility by inhibiting reactive oxygen species in aging mice. Oncotarget 7(14): 17393-17409

Ingle, A.; Varghese, T. 2014: C-plane Reconstructions from Sheaf Acquisition for Ultrasound Electrode Vibration Elastography. Proceedings. IEEE Ultrasonics Symposium 2014: 1826-1829

Shiraishi, J. 2016: C-programing for Image Processing: Introduction of the Experience-based E-learning. Nihon Hoshasen Gijutsu Gakkai zasshi 72(10): 1049-1051

AlGhamdi, K.M. 2016: C-punch excision: a novel technique. International Journal of Dermatology 55(10): 1154-1156

Liu, Y.; Geng, P.-L.; Yan, F.-Q.; Chen, T.; Wang, W.; Tang, X.-D.; Zheng, J.-C.; Wu, W.-P.; Wang, Z.-F. 2015: C-reactive Protein -717A>G and -286C>T>A Gene Polymorphism and Ischemic Stroke. Chinese Medical Journal 128(12): 1666-1670

Lee, J.H.; Yeom, H.; Kim, H.C.; Suh, I.; Kim, M.K.; Shin, M.-H.; Shin, D.H.; Koh, S.-B.; Ahn, S.V.; Lee, T.-Y.; Ryu, S.Y.; Song, J.-S.; Choe, H.-S.; Lee, Y.-H.; Choi, B.Y. 2016: C-reactive Protein Concentration Is Associated with a Higher Risk of Mortality in a Rural Korean Population. Journal of Preventive Medicine and Public Health 49(5): 275-287

Tian, Y.F.; Zhou, Y.P.; Zhong, C.K.; Buren, B.; Xu, T.; Li, H.M.; Zhang, M.Z.; Wang, A.L.; Zhang, Y.H. 2016: C-reactive Protein Level, Apolipoprotein B-to-apolipoprotein A-1 Ratio, and Risks of Ischemic Stroke and Coronary Heart Disease among Inner Mongolians in China. Biomedical and Environmental Sciences: Bes 29(7): 467-474

Bhattacharjee, R.; Kheirandish-Gozal, L.; Kaditis, A.G.; Verhulst, S.L.; Gozal, D. 2016: C-reactive Protein as a Potential Biomarker of Residual Obstructive Sleep Apnea Following Adenotonsillectomy in Children. Sleep 39(2): 283-291

Edagawa, E.; Matsuda, Y.; Gyobu, K.; Lee, S.; Kishida, S.; Fujiwara, Y.; Hashiba, R.; Osugi, H.; Suehiro, S. 2015: C-reactive Protein is a Useful Marker for Early Prediction of Anastomotic Leakage after Esophageal Reconstruction. Osaka City Medical Journal 61(1): 53-61

Cobo, G.; Qureshi, A.R.; Lindholm, B.; Stenvinkel, P. 2016: C-reactive Protein: Repeated Measurements will Improve Dialysis Patient Care. Seminars in Dialysis 29(1): 7-14

Galili, N.; Marionneaux, S.; Lascher, S.; Mazumder, A.; Vesole, D.; Mumtaz, M.; Mehdi, M.; Jagannath, S.; Raza, A. 2016: C-reactive protein (CRP) associated with higher risk patients with myelodysplastic syndromes (MDS). Journal of Clinical Oncology 26(15_Suppl): 18009-18009

Ticinesi, A.; Lauretani, F.; Nouvenne, A.; Porro, E.; Fanelli, G.; Maggio, M.; Meschi, T. 2017: C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection. European Journal of Internal Medicine 37: 7-12

Tenforde, M.W.; Gupte, N.; Dowdy, D.W.; Asmuth, D.M.; Balagopal, A.; Pollard, R.B.; Sugandhavesa, P.; Lama, J.R.; Pillay, S.; Cardoso, S.W.; Pawar, J.; Santos, B.; Riviere, C.; Mwelase, N.; Kanyama, C.; Kumwenda, J.; Hakim, J.G.; Kumarasamy, N.; Bollinger, R.; Semba, R.D.; Campbell, T.B.; Gupta, A. 2015: C-reactive protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settings. Plos one 10(2): E0117424

Kaur, R.; Matharoo, K.; Sharma, R.; Bhanwer, A.J.S. 2013: C-reactive protein + 1059 G>C polymorphism in type 2 diabetes and coronary artery disease patients. Meta Gene 1: 82-92

Dargél, A.A.; Godin, O.; Kapczinski, F.áv.; Kupfer, D.J.; Leboyer, M. 2015: C-reactive protein alterations in bipolar disorder: a meta-analysis. Journal of Clinical Psychiatry 76(2): 142-150

Ogita, M.; Miyauchi, K. 2016: C-reactive protein and cardiovascular disease. Journal of Cardiology 68(2): 179

Saito, I.; Maruyama, K.; Eguchi, E. 2014: C-reactive protein and cardiovascular disease in East asians: a systematic review. Clinical Medicine Insights. Cardiology 8(Suppl 3): 35-42

Soheilian, R.; Jabbarpour Bonyadi, M.Hossein.; Moein, H.; Babanejad, M.; Ramezani, A.; Yaseri, M.; Soheilian, M. 2017: C-reactive protein and complement factor H polymorphism interaction in advanced exudative age-related macular degeneration. International Ophthalmology 37(5): 1161-1168

Yang, X.-F.; Deng, Y.; Gu, H.; Lim, A.; Snellingen, T.; Liu, X.-P.; Wang, N.-L.; Domalpally, A.; Danis, R.; Liu, N.-P. 2016: C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus. International Journal of Ophthalmology 9(1): 111-118

Bleda, S.; de Haro, J.; Varela, C.; Acin, F. 2015: C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factor. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 22(2): 233-239

Uhrikova, I.; Rauserova-Lexmaulova, L.; Rehakova, K.; Scheer, P.; Doubek, J. 2015: C-reactive protein and high mobility group box 1 in dogs with gastric dilatation and volvulus. Journal of Veterinary Emergency and Critical Care 25(4): 488-494

Wu, Y.; Potempa, L.A.; El Kebir, D.; Filep, J.án.G. 2015: C-reactive protein and inflammation: conformational changes affect function. Biological Chemistry 396(11): 1181-1197

Abdel-Razik, A.; Eldars, W.; Elhelaly, R.; Elzehery, R. 2016: C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites. Journal of Gastroenterology and Hepatology 31(11): 1868-1873

Xu, T.; Ke, K. 2015: C-reactive protein and ischemic stroke risk in general population: a dose-response meta-analysis of prospective studies. International Journal of Cardiology 190: 264-267

Mohaupt, M.G. 2015: C-reactive protein and its role in preeclampsia. Hypertension 65(2): 285-286

Ruf, A.E.; Villamil, F.G. 2015: C-reactive protein and model for end-stage liver disease score: have we found the fifth element?. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 21(6): 713-715

Zawadzki, M.; Czarnecki, R.; Rzaca, M.; Obuszko, Z.; Velchuru, V.Ramana.; Witkiewicz, W. 2016: C-reactive protein and procalcitonin predict anastomotic leaks following colorectal cancer resections - a prospective study. Wideochirurgia i Inne Techniki Maloinwazyjne 10(4): 567-573

Kwon, C.H.; Kang, J.G.; Lee, H.J.; Kim, N.H.; Sung, J.-W.; Cheong, E.; Sung, K.-C. 2017: C-reactive protein and risk of atrial fibrillation in East Asians. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 19(10): 1643-1649

Salim, A.; Tai, E.S.; Tan, V.Y.; Welsh, A.H.; Liew, R.; Naidoo, N.; Wu, Y.; Yuan, J.-M.; Koh, W.P.; van Dam, R.M. 2016: C-reactive protein and serum creatinine, but not haemoglobin A1c, are independent predictors of coronary heart disease risk in non-diabetic Chinese. European Journal of Preventive Cardiology 23(12): 1339-1349

Bertsch, T.; Triebel, J.; Bollheimer, C.; Christ, M.; Sieber, C.; Fassbender, K.; Heppner, H.J.ür. 2015: C-reactive protein and the acute phase reaction in geriatric patients. Zeitschrift für Gerontologie und Geriatrie 48(7): 595-600

Gans, S.L.; Atema, J.J.; Stoker, J.; Toorenvliet, B.R.; Laurell, H.; Boermeester, M.A. 2015: C-reactive protein and white blood cell count as triage test between urgent and nonurgent conditions in 2961 patients with acute abdominal pain. Medicine 94(9): E569

Tind, S.; Lassen, A.T.; Zimmerman-Nielsen, E.; Qvist, N. 2015: C-reactive protein and white blood cell count do not improve clinical decision-making in acute appendicitis. Danish Medical Journal 62(12): A5167

Mańkowska-Wierzbicka, D.; Karczewski, J.; Poniedziałek, B.; Grzymisławska, M.łg.; Staszewski, R.ł; Królczyk, A.; Dobrowolska, A.; Grzymisławski, M. 2016: C-reactive protein as a diagnostic and prognostic factor in inflammatory bowel diseases. Postepy Higieny i Medycyny Doswiadczalnej 70: 1124-1130

Fond, G.; Brunel, L.; Boyer, L. 2017: C-reactive protein as a differential biomarker of bipolar II depression versus major depressive disorder. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 18(1): 71-72

Chang, H.Hua.; Chen, P.See. 2017: C-reactive protein as a differential biomarker of bipolar versus unipolar depression: Response. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 18(1): 73-74

Fang, S.; Wang, Y.; Sui, D.; Liu, H.; Ross, M.I.; Gershenwald, J.E.; Cormier, J.N.; Royal, R.E.; Lucci, A.; Schacherer, C.W.; Gardner, J.M.; Reveille, J.D.; Bassett, R.L.; Wang, L.-E.; Wei, Q.; Amos, C.I.; Lee, J.E. 2015: C-reactive protein as a marker of melanoma progression. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(12): 1389-1396

Fan, Y.; Li, S.; Li, X.-L.; Zhu, C.-G.; Guo, Y.-L.; Wu, N.-Q.; Qing, P.; Gao, Y.; Dong, Q.; Liu, G.; Li, J.-J. 2016: C-reactive protein as a predictor for poor collateral circulation in patients with chronic stable coronary heart disease. Annals of Medicine 48(1-2): 83-88

Westhorpe, C.L.V.; Schneider, H.G.; Dunne, M.; Middleton, T.; Sundararajan, V.; Spelman, T.; Carter, V.; Crowe, S.M.; Dart, A.; Mijch, A.; Kotsanas, D.; Woolley, I. 2014: C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals. Sexual Health 11(6): 580-582

Lagrand, W.K.; Nijmeijer, R.; Niessen, H.W.M.; Visser, C.A.; Hermens, W.Th.; Hack, C.E. 2002: C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 10(4): 189-197

Lee, J.Y.; Lee, J.-H.; Kim, D.K.; Yim, J.-J.; Yoo, C.-G.; Chung, H.S.; Kim, Y.W.; Han, S.K.; Lee, C.-H. 2014: C-reactive protein as a prognostic factor for mortality in pneumonia patients with liver cirrhosis. Hepato-Gastroenterology 61(133): 1331-1338

Hobusch, G.M.; Bodner, F.; Walzer, S.; Marculescu, R.; Funovics, P.T.; Sulzbacher, I.; Windhager, R.; Panotopoulos, J. 2016: C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study. World Journal of Surgical Oncology 14: 111

Lee, H.H.; Park, J.M.; Lee, S.-W.; Kang, S.H.; Lim, C.-H.; Cho, Y.K.; Lee, B.-I.; Lee, I.S.; Kim, S.W.; Choi, M.-G. 2015: C-reactive protein as a prognostic indicator for rebleeding in patients with nonvariceal upper gastrointestinal bleeding. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 47(5): 378-383

Van der Bom, J.G.; Cramer, M.J.M. 2003: C-reactive protein as a prognostic tool in cardiovascular practices: should CRP testing be ordered along with lipid profiles?. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 11(6): 265-267

Numbenjapon, N.; Chamnanwanakij, S.; Sangaroon, P.; Simasathien, S.; Watanaveeradej, V. 2015: C-reactive protein as a single useful parameter for discontinuation of antibiotic treatment in Thai neonates with clinical sepsis. Journal of the Medical Association of Thailand 98(4): 352-357

Erritzøe, L.W.; Gögenur, I.; Alamili, M. 2015: C-reactive protein as a tool in the diagnosis of anastomotic leak after colorectal surgery. Ugeskrift for Laeger 177(42): V12140749

Sabour, H.; Latifi, S.; Soltani, Z.; Shakeri, H.; Norouzi Javidan, A.; Ghodsi, S-Mohammad.; Hadian, M.Reza.; Emami Razavi, S-Hassan. 2017: C-reactive protein as an available biomarker determining mental component of health-related quality of life among individuals with spinal cord injury. Journal of Spinal Cord Medicine 40(3): 329-337

Semple, J.W. 2015: C-reactive protein boosts antibody-mediated platelet destruction. Blood 125(11): 1690-1691

Yılmaz, I.; Ozkok, A.; Kostek, O.; Kolukısa, A.; Duran, I.; Odabaş, A.R.ız.; Kemal Işman, F.; Işbilen Başok, B. 2016: C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients. Renal Failure 38(1): 89-95

Kim, E.Y.; Yim, H.W.; Park, C.H.; Song, K.Y. 2017: C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer. Surgical Endoscopy 31(1): 445-454

Chen, J.; Gu, Z.; Wu, M.; Yang, Y.; Zhang, J.; Ou, J.; Zuo, Z.; Wang, J.; Chen, Y. 2016: C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways. Stem Cell Research and Therapy 7(1): 114

Fernandes, B.S.; Steiner, J.; Molendijk, M.L.; Dodd, S.; Nardin, P.; Gonçalves, C.-A.; Jacka, F.; Köhler, C.A.; Karmakar, C.; Carvalho, A.é F.; Berk, M. 2016: C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. LANCET. Psychiatry 3(12): 1147-1156

Tian, J.; Liu, X.; Liu, D. 2016: C-reactive protein correlates to functional score systems of patients in general surgical intensive care unit. Journal of Biological Regulators and Homeostatic Agents 30(1): 147-153

Zhang, L.; Liu, S.-H.; Wright, T.T.; Shen, Z.-Y.; Li, H.-Y.; Zhu, W.; Potempa, L.A.; Ji, S.-R.; Szalai, A.J.; Wu, Y. 2015: C-reactive protein directly suppresses Th1 cell differentiation and alleviates experimental autoimmune encephalomyelitis. Journal of Immunology 194(11): 5243-5252

Kapur, R.; Heitink-Pollé, K.M.J.; Porcelijn, L.; Bentlage, A.E.H.; Bruin, M.C.A.; Visser, R.; Roos, D.; Schasfoort, R.B.M.; de Haas, M.; van der Schoot, C.E.; Vidarsson, G. 2015: C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia. Blood 125(11): 1793-1802

Xu, P.-c.; Lin, S.; Yang, X.-w.; Gu, D.-M.; Yan, T.-k.; Wei, L.; Wang, B.-l. 2015: C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis. Bmc Immunology 16: 10

Kapur, R.; Kim, M.; Shanmugabhavananthan, S.; Liu, J.; Li, Y.; Semple, J.W. 2015: C-reactive protein enhances murine antibody-mediated transfusion-related acute lung injury. Blood 126(25): 2747-2751

Salgia, G.; Kulkarni, D.G.; Shetty, L. 2015: C-reactive protein estimation: a quantitative analysis for three nonsteroidal anti-inflammatory drugs: a randomized control trial. Indian Journal of Dental Research: Official Publication of Indian Society for Dental Research 26(1): 43-47

Pegues, M.A.; McWilliams, I.L.; Szalai, A.J. 2016: C-reactive protein exacerbates renal ischemia-reperfusion injury: are myeloid-derived suppressor cells to blame?. American Journal of Physiology. Renal Physiology 311(1): F176-F181

Garrido, M.; Dezerega, A.; Bordagaray, Mía.José.; Reyes, M.; Vernal, R.; Melgar-Rodríguez, S.; Ciuchi, Pía.; Paredes, R.; García-Sesnich, J.; Ahumada-Montalva, P.; Hernández, M. 2015: C-reactive protein expression is up-regulated in apical lesions of endodontic origin in association with interleukin-6. Journal of Endodontics 41(4): 464-469

Chen, Z.; Yu, D.; Xu, Z.-W.; Li, S.-S.; Li, X.-F.; Li, J.; Yang, X. 2015: C-reactive protein gene polymorphisms and gene-environment interactions in ischaemic stroke. Neurological Research 37(11): 979-984

Ahmed, S.K.; Mahmood, N.; Malalla, Z.H.; Alsobyani, F.M.; Al-Kiyumi, I.S.; Almawi, W.Y. 2015: C-reactive protein gene variants associated with recurrent pregnancy loss independent of CRP serum levels: a case-control study. Gene 569(1): 136-140

Peng, D.; Wang, J.; Zhang, R.; Tang, S.; Jiang, F.; Chen, M.; Yan, J.; Sun, X.; Wang, T.; Wang, S.; Bao, Y.; Hu, C.; Jia, W. 2015: C-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Bmc Endocrine Disorders 15: 8

Beliaev, A.M.; Marshall, R.J.; Booth, M. 2015: C-reactive protein has a better discriminative power than white cell count in the diagnosis of acute cholecystitis. Journal of Surgical Research 198(1): 66-72

Wium-Andersen, M.K.; Wium-Andersen, I.K. 2016: C-reactive protein in bipolar disorder. LANCET. Psychiatry 3(12): 1096-1098

Pelkonen, T.; Albino, A.; Roine, I.; Bernardino, L.; Peltola, H. 2015: C-reactive protein in children with malaria in Luanda, Angola: a prospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene 109(8): 535-537

Kostić, Z.; Slavković, D.; Mijusković, Z.; Panisić, M.; Ignjatović, M. 2016: C-reactive protein in drainage fluid as a predictor of anastomotic leakage after elective colorectal resection. Vojnosanitetski Pregled 73(3): 228-233

Gallego, M.; Pomares, X.; Capilla, S.; Marcos, M.A.; Suárez, D.; Monsó, E.; Montón, C.ón. 2016: C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity. International Journal of Chronic Obstructive Pulmonary Disease 11: 2633-2640

Ferreiro, L.; Valdés, L. 2016: C-reactive protein in pleural fluid. Does it help predict complicated parapneumonic effusions?. Revista Clinica Espanola 216(7): 370-371

Panduranga, P.; Riyami, A.A.; Sulaiman, K.J.; Mukhaini, M. 2010: C-reactive protein in unstable angina: clinical and angiographic correlation. Heart Asia 2(1): 140-144

Huang, J.; Baum, Y.; Alemozaffar, M.; Ogan, K.; Harris, W.; Kucuk, O.; Master, V.A. 2015: C-reactive protein in urologic cancers. Molecular Aspects of Medicine 45: 28-36

Mei, Z.; Li, H.; Serdula, M.K.; Flores-Ayala, R.C.; Wang, L.; Liu, J.-M.; Grummer-Strawn, L.M. 2016: C-reactive protein increases with gestational age during pregnancy among Chinese women. American Journal of Human Biology: the Official Journal of the Human Biology Council 28(4): 574-579

Kudo, S.; Saito, H.; Motoyama, S.; Sasaki, T.; Imai, K.; Konno, H.; Takashima, S.; Atari, M.; Sato, Y.; Minamiya, Y. 2015: C-reactive protein inhibits expression of N-cadherin and ZEB-1 in murine colon adenocarcinoma. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(9): 7035-7043

Liu, Y.; Liu, C.; Jiang, C.; Wang, S.; Yang, Q.; Jiang, D.; Yuan, G. 2016: C-reactive protein inhibits high-molecular-weight adiponectin expression in 3T3-L1 adipocytes via PI3K/Akt pathway. Biochemical and Biophysical Research Communications 472(1): 19-25

She, S.; Xiang, Y.; Yang, M.; Ding, X.; Liu, X.; Ma, L.; Liu, Q.; Liu, B.; Lu, Z.; Li, S.; Liu, Y.; Ran, X.; Xu, X.; Hu, H.; Hu, P.; Zhang, D.; Ren, H.; Yang, Y. 2015: C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. International Journal of Oncology 47(2): 543-554

Poskus, E.; Karnusevicius, I.; Andreikaite, G.; Mikalauskas, S.; Poskus, T.; Strupas, K. 2015: C-reactive protein is a predictor of complications after elective laparoscopic colorectal surgery: five-year experience. Wideochirurgia i Inne Techniki Maloinwazyjne 10(3): 418-422

Gordon, A.C.; Cross, A.J.; Foo, E.W.; Roberts, R.H. 2018: C-reactive protein is a useful negative predictor of anastomotic leak in oesophago-gastric resection. ANZ Journal of Surgery 88(3): 223-227

Kim, B-Gun.; Lee, Y-Kyun.; Park, H-Pyoung.; Sohn, H-Min.; Oh, A-Young.; Jeon, Y-Tae.; Koo, K-Hoi. 2016: C-reactive protein is an independent predictor for 1-year mortality in elderly patients undergoing hip fracture surgery: A retrospective analysis. Medicine 95(43): E5152

Dhamoon, M.S.; Cheung, Y-Kuen.; Moon, Y.P.; Wright, C.B.; Willey, J.Z.; Sacco, R.; Elkind, M.Sv. 2016: C-reactive protein is associated with disability independently of vascular events: the Northern Manhattan Study. Age and Ageing (): -

Dongway, A.C.; Faggad, A.S.; Zaki, H.Y.; Abdalla, B.E. 2015: C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Diabetes Metabolic Syndrome and Obesity: Targets and Therapy 8: 427-435

Weinstein, G.; Lutski, M.; Goldbourt, U.; Tanne, D. 2017: C-reactive protein is related to future cognitive impairment and decline in elderly individuals with cardiovascular disease. Archives of Gerontology and Geriatrics 69: 31-37

Fujii, T.; Sutoh, T.; Kigure, W.; Morita, H.; Katoh, T.; Yajima, R.; Tsutsumi, S.; Asao, T.; Kuwano, H. 2015: C-reactive protein level as a possible predictor for early postoperative ileus following elective surgery for colorectal cancer. Hepato-Gastroenterology 62(138): 283-285

Iwasa, R.; Yamada, A.; Sono, K.; Furukawa, R.; Takeuchi, K.; Suzuki, Y. 2015: C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study. Bmc Gastroenterology 15: 103

Shah, M.; Paulson, D. 2016: C-reactive protein level partially mediates the relationship between moderate alcohol use and frailty: the Health and Retirement Study. Age and Ageing 45(6): 874-878

Paraskevas, K.I.; Mikhailidis, D.P.; Shearman, C.P. 2016: C-reactive protein levels and aortic aneurysmal disease progression after endovascular repair: the jury is still out. International Journal of Cardiology 203: 1141

Schulz, S.; Lüdike, H.; Lierath, M.; Schlitt, A.; Werdan, K.; Hofmann, B.; Gläser, C.; Schaller, H.-G.ün.; Reichert, S. 2016: C-reactive protein levels and genetic variants of CRP as prognostic markers for combined cardiovascular endpoint (cardiovascular death, death from stroke, myocardial infarction, and stroke/TIA). Cytokine 88: 71-76

Thanakun, S.; Pornprasertsuk-Damrongsri, S.; Izumi, Y. 2017: C-reactive protein levels and the association of carotid artery calcification with tooth loss. Oral Diseases 23(1): 69-77

Mitaki, S.; Nagai, A.; Oguro, H.; Yamaguchi, S. 2016: C-reactive protein levels are associated with cerebral small vessel-related lesions. Acta Neurologica Scandinavica 133(1): 68-74

Kitterer, D.; Segerer, S.; Steurer, W.; Dippon, J.; Geissler, A.; Ulmer, C.; Braun, N.; Alscher, M.D.; Latus, J. 2015: C-reactive protein levels in combination with abdominal CT scans is a useful tool to predict the macroscopic appearance in late-stage EPS patients prior to surgery. International Journal of Nephrology and Renovascular Disease 8: 83-90

Tarhan, H.; Ekin, R.G.; Can, E.; Cakmak, O.; Yavascan, O.; Mutlubas Ozsan, F.; Helvaci, M.; Zorlu, F. 2016: C-reactive protein levels in girls with lower urinary tract symptoms. Journal of Pediatric Urology 12(2): 105.E1-4

Silva, D.R.; Gazzana, M.B.; Knorst, M.M. 2015: C-reactive protein levels in stable COPD patients: a case-control study. International Journal of Chronic Obstructive Pulmonary Disease 10: 1719-1725

Cardoso, F.S.; Ricardo, L.; Gondar, P.; Deus, Jão.R.; Horta, D. 2015: C-reactive protein may influence decisively the prescription of prophylactic antibiotics in acute pancreatitis: a population-based cohort study. Pancreas 44(3): 404-408

Beliaev, A.M.; Booth, M. 2015: C-reactive protein measurement is not associated with an improved management of acute cholecystitis: a plié for a change. Journal of Surgical Research 198(1): 93-98

Shishido, Y.; Fujitani, K.; Yamamoto, K.; Hirao, M.; Tsujinaka, T.; Sekimoto, M. 2016: C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 19(1): 293-301

Yang, J.; Fan, C.; Pan, L.; Xie, M.; He, Q.; Li, D.; Wang, S. 2015: C-reactive protein plays a marginal role in cognitive decline: a systematic review and meta-analysis. International Journal of Geriatric Psychiatry 30(2): 156-165

Minnaard, M.C.; van de Pol, A.C.; Hopstaken, R.M.; van Delft, S.; Broekhuizen, B.D.L.; Verheij, T.J.M.; de Wit, N.J. 2016: C-reactive protein point-of-care testing and associated antibiotic prescribing. Family Practice 33(4): 408-413

Van den Bruel, A.; Jones, C.; Thompson, M.; Mant, D. 2016: C-reactive protein point-of-care testing in acutely ill children: a mixed methods study in primary care. Archives of Disease in Childhood 101(4): 382-385

Claushuis, T.A.M.; de Vries, M.K.; van der Weijden, M.A.C.; Visman, I.M.; Nurmohamed, M.T.; Twisk, J.W.R.; Van der Horst-Bruinsma, I.E.; Crusius, J.B.A. 2015: C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis. Clinical and Experimental Rheumatology 33(2): 159-165

De Haro, J.; Bleda, S.; Acin, F. 2016: C-reactive protein predicts aortic aneurysmal disease progression after endovascular repair. International Journal of Cardiology 202: 701-706

Patel, A.; Szydlo, R.M.; Auner, H.W.; Kanfer, E.J.; MacDonald, D.H.; Milojkovic, D.; Altaf, S.; Innes, A.; Gabriel, I.; Rahemtulla, A.; Chaidos, A.; Karadimitris, A.; Olavarria, E.; Apperley, J.F.; Pavlů, J.ří 2018: C-reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early- and long-term mortality. British Journal of Haematology 180(6): 889-892

Lai, W.; Tang, Y.; Huang, X.R.; Ming-Kuen Tang, P.; Xu, A.; Szalai, A.J.; Lou, T.-Q.; Lan, H.Y. 2016: C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin e. Kidney International 90(3): 610-626

Gang, T.B.; Hanley, G.A.; Agrawal, A. 2015: C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms. Infection and Immunity 83(5): 1845-1852

Korhonen, K.V.M.; Savolainen-Peltonen, H.M.; Mikkola, T.S.; Tiitinen, A.E.; Unkila-Kallio, L.S. 2016: C-reactive protein response is higher in early than in late ovarian hyperstimulation syndrome. European Journal of Obstetrics Gynecology and Reproductive Biology 207: 162-168

Sutliffe, J.T.; Wilson, L.D.; de Heer, H.D.; Foster, R.L.; Carnot, M.J. 2015: C-reactive protein response to a vegan lifestyle intervention. Complementary Therapies in Medicine 23(1): 32-37

McDade, T.W.; Borja, J.B.; Kuzawa, C.W.; Perez, T.L.L.; Adair, L.S. 2015: C-reactive protein response to influenza vaccination as a model of mild inflammatory stimulation in the Philippines. Vaccine 33(17): 2004-2008

Farshchian, M.; Ansar, A.; Sobhan, M.; Hoseinpoor, V. 2016: C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B. Anais Brasileiros de Dermatologia 91(5): 580-583

Sato, A.; Oe, K.; Yamanaka, H.; Yokoyama, I.; Ebina, K. 2014: C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo. European Journal of Pharmacology 745: 46-51

Ortega-Deballon, P.; Facy, O.; Rat, P. 2016: C-reactive protein to rule out infections after major abdominal surgery. International Journal of Colorectal Disease 31(3): 779-780

Mendy, J.; Togun, T.; Owolabi, O.; Donkor, S.; Ota, M.O.C.; Sutherland, J.S. 2016: C-reactive protein, Neopterin and Beta2 microglobulin levels pre and post TB treatment in the Gambia. Bmc Infectious Diseases 16: 115

Kawada, T. 2015: C-reactive protein, depressive symptoms and incident diabetes mellitus with special emphasis on physical activity. Journal of Psychosomatic Research 78(4): 407

Zhu, Y.; Liu, Z.; Wang, Y.; Wang, Z.; Shi, J.; Xie, X.; Jin, L.; Chu, X.; Wang, X. 2016: C-reactive protein, frailty and overnight hospital admission in elderly individuals: a population-based study. Archives of Gerontology and Geriatrics 64: 1-5

Saco, Y.; Martínez-Lobo, F.; Cortey, M.; Pato, R.; Peña, R.; Segalés, J.; Prieto, C.; Bassols, A. 2016: C-reactive protein, haptoglobin and Pig-Major acute phase protein profiles of pigs infected experimentally by different isolates of porcine reproductive and respiratory syndrome virus. Veterinary Microbiology 183: 9-15

Vrsalovic, M.; Zeljkovic, I.; Presecki, A.Vrsalovic.; Pintaric, H.; Kruslin, B. 2015: C-reactive protein, not cardiac troponin T, improves risk prediction in hypertensives with type A aortic dissection. Blood Pressure 24(4): 212-216

Horvei, L.D.; Grimnes, G.; Hindberg, K.; Mathiesen, E.B.; Njølstad, I.; Wilsgaard, T.; Brox, J.; Braekkan, S.K.; Hansen, J.-B. 2016: C-reactive protein, obesity, and the risk of arterial and venous thrombosis. Journal of Thrombosis and Haemostasis: Jth 14(8): 1561-1571

Agostinis Sobrinho, C.Aparecido.; Moreira, C.Marisa.Maia.; Mota, J.Augusto.Pinto.da.Silva.; Santos, R.Marina.Roberto. 2015: C-reactive protein, physical activity and cardiorespiratory fitness in Portuguese adolescents: a cross-sectional study. Cadernos de Saude Publica 31(9): 1907-1915

Meinarde, L.; Hillman, M.; Rizzotti, A.; Basquiera, A.Lisa.; Tabares, A.; Cuestas, E. 2016: C-reactive protein, platelets, and patent ductus arteriosus. Platelets 27(8): 821-823

Vrsalović, M.; Vučur, K.; Car, B.; Krčmar, T.; Vrsalović Presečki, A. 2015: C-reactive protein, renal function, and cardiovascular outcome in patients with symptomatic peripheral artery disease and preserved left ventricular systolic function. Croatian Medical Journal 56(4): 351-356

Park, H.-C.; Kim, M.-Y.; Kim, C.-H. 2016: C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma. Journal of the Korean Association of Oral and Maxillofacial Surgeons 42(5): 243-250

Chang, H.H.; Wang, T.-Y.; Lee, I.H.; Lee, S.-Y.; Chen, K.C.; Huang, S.-Y.; Yang, Y.K.; Lu, R.-B.; Chen, P.S. 2017: C-reactive protein: a differential biomarker for major depressive disorder and bipolar Ii disorder. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 18(1): 63-70

Segman, R.H.; Stein, M.B. 2015: C-reactive protein: a stress diathesis marker at the crossroads of maladaptive behavioral and cardiometabolic sequelae. American Journal of Psychiatry 172(4): 307-309

Fehily, S.R.; Forlano, R.; Fitzgerald, P.B. 2016: C-reactive protein: an early critical sign of clozapine-related myocarditis. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists 24(2): 181-184

Christensen, M.B.; Eriksen, T.; Kjelgaard-Hansen, M. 2015: C-reactive protein: quantitative marker of surgical trauma and post-surgical complications in dogs: a systematic review. Acta Veterinaria Scandinavica 57: 71

Hatano, M.; Yamashita, K.; Mizuno, M.; Ito, O.; Ishihara, K. 2015: C-selective and diastereoselective alkyl addition to β,γ-alkynyl-α-imino esters with zinc(II)ate complexes. Angewandte Chemie 54(9): 2707-2711

Shemesh, A.; Levin, A.; Katzenell, V.; Itzhak, J.Ben.; Levinson, O.; Avraham, Z.; Solomonov, M. 2017: C-shaped canals-prevalence and root canal configuration by cone beam computed tomography evaluation in first and second mandibular molars-a cross-sectional study. Clinical Oral Investigations 21(6): 2039-2044

Ozcan, G.; Sekerci, A.Ercan.; Kocoglu, F. 2016: C-shaped mandibular primary first molar diagnosed with cone beam computed tomography: A novel case report and literature review of primary molars' root canal systems. Journal of the Indian Society of Pedodontics and Preventive Dentistry 34(4): 397-404

Chu, M.W.; Soleimani, T.; Evans, T.A.; Fernandez, S.I.; Spera, L.; Klene, C.; Zarzaur, B.L.; Tholpady, S.S. 2016: C-spine injury and mandibular fractures: lifesaver broken in two spots. Journal of Surgical Research 206(2): 386-390

Flörkemeier, T. 2014: C-stem prostheses - migration behavior of the shaft in the cement mantle. Zeitschrift für Orthopadie und Unfallchirurgie 152(6): 544

Ji, Q.-Q.; Fang, Z.-P.; Ye, Q.; Ruan, Z.-R.; Zhou, X.-L.; Wang, E.-D. 2016: C-terminal Domain of Leucyl-tRNA Synthetase from Pathogenic Candida albicans Recognizes both tRNASer and tRNALeu. Journal of Biological Chemistry 291(7): 3613-3625

Lorenzón, E.N.; Santos-Filho, N.A.; Ramos, M.A.S.; Bauab, T.M.; Camargo, I.L.B.C.; Cilli, E.M. 2016: C-terminal Lysine-Linked Magainin 2 with Increased Activity Against Multidrug-Resistant Bacteria. Protein and Peptide Letters 23(8): 738-747

Spring, A.M.; Brusich, D.J.; Frank, C.A. 2016: C-terminal Src Kinase Gates Homeostatic Synaptic Plasticity and Regulates Fasciclin Ii Expression at the Drosophila Neuromuscular Junction. Plos Genetics 12(2): E1005886

Senda, Y.; Murata-Kamiya, N.; Hatakeyama, M. 2016: C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility. Cancer Science 107(7): 972-980

Ohtomo, H.; Akashi, S.; Moriwaki, Y.; Okuwaki, M.; Osakabe, A.; Nagata, K.; Kurumizaka, H.; Nishimura, Y. 2016: C-terminal acidic domain of histone chaperone human NAP1 is an efficient binding assistant for histone H2A-H2B, but not H3-H4. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 21(3): 252-263

Drey, M.; Behnes, M.; Kob, R.; Lepiorz, D.; Hettwer, S.; Bollheimer, C.; Sieber, C.C.; Bertsch, T.; Hoffmann, U. 2015: C-terminal agrin fragment (CAF) reflects renal function in patients suffering from severe sepsis or septic shock. Clinical Laboratory 61(1-2): 69-76

Emery, A.C.; Alvarez, R.A.; Abboud, P.; Xu, W.; Westover, C.D.; Eiden, M.V.; Eiden, L.E. 2016: C-terminal amidation of PACAP-38 and PACAP-27 is dispensable for biological activity at the PAC1 receptor. Peptides 79: 39-48

Stankiewicz, T.R.; Gray, J.J.; Winter, A.N.; Linseman, D.A. 2014: C-terminal binding proteins: central players in development and disease. Biomolecular Concepts 5(6): 489-511

Elhage, R.; Cheraï, M.; Levacher, B.; Darrasse-Jeze, G.; Baillou, C.; Zhao, X.; Khatib, A.-M.; Piaggio, E.; Klatzmann, D. 2015: C-terminal cleavage of human Foxp3 at a proprotein convertase motif abrogates its suppressive function. Scandinavian Journal of Immunology 81(4): 229-239

Zhang, B.; Yang, G.; Chen, Y.; Zhao, Y.; Gao, P.; Liu, B.; Wang, H.; Zheng, Z.-L. 2016: C-terminal domain (CTD) phosphatase links Rho GTPase signaling to Pol Ii CTD phosphorylation in Arabidopsis and yeast. Proceedings of the National Academy of Sciences of the United States of America 113(50): E8197-E8206

Gopal, G.J.; Pal, J.; Kumar, A.; Mukhopadhyay, G. 2015: C-terminal domain of CagX is responsible for its interaction with CagT protein of Helicobacter pylori type IV secretion system. Biochemical and Biophysical Research Communications 456(1): 98-103

Brown, M.A.; Foreman, K.; Harriss, J.; Das, C.; Zhu, L.; Edwards, M.; Shaaban, S.; Tucker, H. 2015: C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis. Oncotarget 6(6): 4005-4019

Gong, J.; Lai, Y.; Li, X.; Wang, M.; Leitz, J.; Hu, Y.; Zhang, Y.; Choi, U.B.; Cipriano, D.; Pfuetzner, R.A.; Südhof, T.C.; Yang, X.; Brunger, A.T.; Diao, J. 2016: C-terminal domain of mammalian complexin-1 localizes to highly curved membranes. Proceedings of the National Academy of Sciences of the United States of America 113(47): E7590-E7599

Santiago-Frangos, A.; Kavita, K.; Schu, D.J.; Gottesman, S.; Woodson, S.A. 2016: C-terminal domain of the RNA chaperone Hfq drives sRNA competition and release of target RNA. Proceedings of the National Academy of Sciences of the United States of America 113(41): E6089-E6096

Somrit, M.; Watthammawut, A.; Chotwiwatthanakun, C.; Ounjai, P.; Suntimanawong, W.; Weerachatyanukul, W. 2017: C-terminal domain on the outer surface of the Macrobrachium rosenbergii nodavirus capsid is required for Sf9 cell binding and internalization. Virus Research 227: 41-48

Huang, J.; Wu, C.; Liu, D.; Yang, X.; Wu, R.; Zhang, J.; Ma, C.; He, H. 2017: C-terminal domains of bacterial proteases: structure, function and the biotechnological applications. Journal of Applied Microbiology 122(1): 12-22

Chinpongpanich, A.; Phean-O-Pas, S.; Thongchuang, M.; Qu, L.-J.; Buaboocha, T. 2015: C-terminal extension of calmodulin-like 3 protein from Oryza sativa L.: interaction with a high mobility group target protein. Acta Biochimica et Biophysica Sinica 47(11): 880-889

Zhou, S.-L.; Yang, C.; Wu, M. 2016: C-terminal fibroblast growth factor 23: a real culprit for the progressive development of acute burn?. Burns: Journal of the International Society for Burn Injuries 42(6): 1365-1366

Wang, Y.; McAlpine, S.R. 2015: C-terminal heat shock protein 90 modulators produce desirable oncogenic properties. Organic and Biomolecular Chemistry 13(16): 4627-4631

Crum, M.A.; Park, J.M.; Sewell, B.T.; Benedik, M.J. 2015: C-terminal hybrid mutant of Bacillus pumilus cyanide dihydratase dramatically enhances thermal stability and pH tolerance by reinforcing oligomerization. Journal of Applied Microbiology 118(4): 881-889

Eiamtanasate, S.; Juricek, M.; Yap, Y.-K. 2007: C-terminal hydrophobic region leads PRSV P3 protein to endoplasmic reticulum. Virus Genes 35(3): 875-876

Huang, S.; Green, B.; Thompson, M.; Chen, R.; Thomaston, J.; DeGrado, W.F.; Howard, K.P. 2015: C-terminal juxtamembrane region of full-length M2 protein forms a membrane surface associated amphipathic helix. Protein Science: a Publication of the Protein Society 24(3): 426-429

Wanka, L.; Babilon, S.; Burkert, K.; Mörl, K.; Gurevich, V.V.; Beck-Sickinger, A.G. 2017: C-terminal motif of human neuropeptide Y4 receptor determines internalization and arrestin recruitment. Cellular Signalling 29: 233-239

De Vos, A.; Jacobs, D.; Struyfs, H.; Fransen, E.; Andersson, K.; Portelius, E.; Andreasson, U.; De Surgeloose, D.; Hernalsteen, D.ël.; Sleegers, K.; Robberecht, C.; Van Broeckhoven, C.; Zetterberg, H.; Blennow, K.; Engelborghs, S.; Vanmechelen, E. 2015: C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease. Alzheimer's and Dementia: the Journal of the Alzheimer's Association 11(12): 1461-1469

Hishinuma, S.; Nozawa, H.; Akatsu, C.; Shoji, M. 2016: C-terminal of human histamine H1 receptors regulates their agonist-induced clathrin-mediated internalization and G-protein signaling. Journal of Neurochemistry 139(4): 552-565

Peng, Z.; McLuckey, S.A. 2015: C-terminal peptide extension via gas-phase ion/ion reactions. International Journal of Mass Spectrometry 391: 17-23

Otsuka, R.; Harada, N.; Aoki, S.; Shirai, K.; Nishitsuji, K.; Nozaki, A.; Hatakeyama, A.; Shono, M.; Mizusawa, N.; Yoshimoto, K.; Nakaya, Y.; Kitahata, H.; Sakaue, H. 2016: C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells. Cell Stress and Chaperones 21(1): 29-40

Singh, G.K.; Karade, S.S.; Ranjan, R.; Ahamad, N.; Ahmed, S. 2017: C-terminal region of Mad2 plays an important role during mitotic spindle checkpoint in fission yeast Schizosaccharomyces pombe. Molecular Biology Reports 44(1): 89-96

McGovern, S.; Baconnais, S.; Roblin, P.; Nicolas, P.; Drevet, P.; Simonson, H.él.ïs.; Piétrement, O.; Charbonnier, J.-B.; Le Cam, E.; Noirot, P.; Lecointe, F.ço. 2016: C-terminal region of bacterial Ku controls DNA bridging, DNA threading and recruitment of DNA ligase D for double strand breaks repair. Nucleic Acids Research 44(10): 4785-4806

Beard, N.A.; Dulhunty, A.F. 2015: C-terminal residues of skeletal muscle calsequestrin are essential for calcium binding and for skeletal ryanodine receptor inhibition. Skeletal Muscle 5: 6

Dehghani, M.; Lasko, P. 2016: C-terminal residues specific to Vasa among DEAD-box helicases are required for its functions in piRNA biogenesis and embryonic patterning. Development Genes and Evolution 226(6): 401-412

Sawashita, J.; Zhang, B.; Hasegawa, K.; Mori, M.; Naiki, H.; Kametani, F.; Higuchi, K. 2015: C-terminal sequence of amyloid-resistant type F apolipoprotein A-Ii inhibits amyloid fibril formation of apolipoprotein A-Ii in mice. Proceedings of the National Academy of Sciences of the United States of America 112(8): E836-E845

Maity, A.; Sinha, S.; Ganguly, D.; Ghosh Dastidar, S. 2016: C-terminal tail insertion of Bcl-xL in membrane occurs via partial unfolding and refolding cycle associating microsolvation. Physical Chemistry Chemical Physics: Pccp 18(34): 24095-24105

Bennett, D.T.; Reece, T.B.; Foley, L.S.; Sjoberg, A.; Meng, X.; Fullerton, D.A.; Weyant, M.J. 2015: C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3. Journal of Thoracic and Cardiovascular Surgery 149(1): 369-375

Azevedo, A.W.; Doan, T.; Moaven, H.; Sokal, I.; Baameur, F.; Vishnivetskiy, S.A.; Homan, K.T.; Tesmer, J.J.G.; Gurevich, V.V.; Chen, J.; Rieke, F. 2015: C-terminal threonines and serines play distinct roles in the desensitization of rhodopsin, a G protein-coupled receptor. Elife 4

Ng, K.-Y.; Chai, S.; Tong, M.; Guan, X.-Y.; Lin, C.-H.; Ching, Y.-P.; Xie, D.; Cheng, A.S.-L.; Ma, S. 2016: C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties. Oncotarget 7(17): 24005-24017

Schlesier, R.é; Bernd Klösgen, R. 2015: C-terminal truncation of a Tat passenger protein affects its membrane translocation by interfering with receptor binding. Biological Chemistry 396(4): 349-357

Motomiya, Y.; Higashimoto, Y.; Uji, Y.; Suenaga, G.; Ando, Y. 2015: C-terminal unfolding of an amyloidogenic β2-microglobulin fragment: ΔN6β2-microglobulin. Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis 22(1): 54-60

Hinkel, R.; Ball, H.L.; DiMaio, J.M.; Shrivastava, S.; Thatcher, J.E.; Singh, A.N.; Sun, X.; Faskerti, G.; Olson, E.N.; Kupatt, C.; Bock-Marquette, I. 2015: C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair. Journal of Molecular and Cellular Cardiology 87: 113-125

Quetier, I.; Brezillon, N.; Revaud, J.; Ahodantin, J.; DaSilva, L.; Soussan, P.; Kremsdorf, D. 2015: C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis. Journal of General Virology 96(Part 3): 614-625

Kim, S.; Sung, H.J.; Lee, J.W.; Kim, Y.H.; Oh, Y.-S.; Yoon, K.-A.; Heo, K.; Suh, P.-G. 2017: C-terminally mutated tubby protein accumulates in aggresomes. Bmb Reports 50(1): 37-42

Azoitei, A.; Merseburger, A.S.; Godau, B.; Hoda, M.R.; Schmid, E.; Cronauer, M.V. 2017: C-terminally truncated constitutively active androgen receptor variants and their biologic and clinical significance in castration-resistant prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 166: 38-44

Vidhyasagar, V.; He, Y.; Guo, M.; Ding, H.; Talwar, T.; Nguyen, V.; Nwosu, J.; Katselis, G.; Wu, Y. 2016: C-termini are essential and distinct for nucleic acid binding of human NABP1 and NABP2. Biochimica et Biophysica Acta 1860(2): 371-383

Liu, Q.; Cheng, Z.; Luo, L.; Yang, Y.; Zhang, Z.; Ma, H.; Chen, T.; Huang, X.; Lin, S.-Y.; Jin, M.; Li, Q.; Li, X. 2016: C-terminus of MUC16 activates Wnt signaling pathway through its interaction with β-catenin to promote tumorigenesis and metastasis. Oncotarget 7(24): 36800-36813

Zhang, N.; Pati, D. 2015: C-terminus of Sororin interacts with SA2 and regulates sister chromatid cohesion. Cell Cycle 14(6): 820-826

Els-Heindl, S.; Bellmann-Sickert, K.; Beck-Sickinger, A.G. 2016: C-terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism. Biopolymers 106(1): 101-108

Chalat, M.; Moleschi, K.; Molday, R.S. 2017: C-terminus of the P4-ATPase ATP8A2 functions in protein folding and regulation of phospholipid flippase activity. Molecular Biology of the Cell 28(3): 452-462

Behler-Janbeck, F.; Takano, T.; Maus, R.; Stolper, J.; Jonigk, D.; Tort Tarrés, M.; Fuehner, T.; Prasse, A.; Welte, T.; Timmer, M.S.M.; Stocker, B.L.; Nakanishi, Y.; Miyamoto, T.; Yamasaki, S.; Maus, U.A. 2016: C-type Lectin Mincle Recognizes Glucosyl-diacylglycerol of Streptococcus pneumoniae and Plays a Protective Role in Pneumococcal Pneumonia. Plos Pathogens 12(12): E1006038

Lundberg, K.; Rydnert, F.; Broos, S.; Andersson, M.; Greiff, L.; Lindstedt, M. 2016: C-type Lectin Receptor Expression on Human Basophils and Effects of Allergen-Specific Immunotherapy. Scandinavian Journal of Immunology 84(3): 150-157

Huang, X.; Feng, J.-L.; Jin, M.; Ren, Q.; Wang, W. 2016: C-type lectin (MrCTL) from the giant freshwater prawn Macrobrachium rosenbergii participates in innate immunity. Fish and Shellfish Immunology 58: 136-144

Oğuz, A.Kemal.; Yılmaz, S.; Akar, N.; Özdağ, H.; Gürler, A.; Ateş, Aşkın.; Oygür, Çağdaş.Şahap.; Kılıçoğlu, S.Serin.; Demirtaş, S. 2015: C-type lectin domain family 12, member A: A common denominator in Behçet's syndrome and acute gouty arthritis. Medical Hypotheses 85(2): 186-191

Manne, B.K.; Badolia, R.; Dangelmaier, C.A.; Kunapuli, S.P. 2015: C-type lectin like receptor 2 (CLEC-2) signals independently of lipid raft microdomains in platelets. Biochemical Pharmacology 93(2): 163-170

Goyal, S.; Klassert, T.E.; Slevogt, H. 2016: C-type lectin receptors in tuberculosis: what we know. Medical Microbiology and Immunology 205(6): 513-535

Takahashi, S.; Watanabe, K.; Watanabe, Y.; Fujioka, D.; Nakamura, T.; Nakamura, K.; Obata, J.-e.; Kugiyama, K. 2015: C-type lectin-like domain and fibronectin-like type Ii domain of phospholipase A(2) receptor 1 modulate binding and migratory responses to collagen. Febs Letters 589(7): 829-835

Wiersma, V.R.; de Bruyn, M.; Shi, C.; Gooden, M.J.M.; Wouters, M.C.A.; Samplonius, D.F.; Hendriks, D.; Nijman, H.W.; Wei, Y.; Zhou, J.; Helfrich, W.; Bremer, E. 2015: C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity. Mabs 7(2): 321-330

Dambuza, I.M.; Brown, G.D. 2015: C-type lectins in immunity: recent developments. Current Opinion in Immunology 32: 21-27

Yan, H.; Yang, C.; Yao, J.; Li, H.; Xu, Z.; Wang, J. 2016: C-type lysozyme gene haplotypes in Rhode Island Red layer chickens are associated with hatchability and survival. Animal Genetics 47(5): 628-629

Kimura, T.; Nojiri, T.; Hino, J.; Hosoda, H.; Miura, K.; Shintani, Y.; Inoue, M.; Zenitani, M.; Takabatake, H.; Miyazato, M.; Okumura, M.; Kangawa, K. 2016: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice. Respiratory Research 17: 19

Lippert, S.; Iversen, P.; Brasso, K.; Goetze, J.P. 2015: C-type natriuretic peptide and its precursor: potential markers in human prostate cancer. Biomarkers in Medicine 9(4): 319-326

Buttgereit, J.; Shanks, J.; Li, D.; Hao, G.; Athwal, A.; Langenickel, T.H.; Wright, H.; da Costa Goncalves, A.C.; Monti, J.; Plehm, R.; Popova, E.; Qadri, F.; Lapidus, I.; Ryan, B.; Özcelik, C.; Paterson, D.J.; Bader, M.; Herring, N. 2016: C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function. Cardiovascular Research 112(3): 637-644

Kimura, T.; Nojiri, T.; Hosoda, H.; Ishikane, S.; Shintani, Y.; Inoue, M.; Miyazato, M.; Okumura, M.; Kangawa, K. 2015: C-type natriuretic peptide attenuates lipopolysaccharide-induced acute lung injury in mice. Journal of Surgical Research 194(2): 631-637

Yang, L.; Wei, Q.; Li, W.; Ge, J.; Zhao, X.; Ma, B. 2016: C-type natriuretic peptide improved vitrified-warmed mouse cumulus oocyte complexes developmental competence. Cryobiology 72(2): 161-164

Zenitani, M.; Nojiri, T.; Uehara, S.; Miura, K.; Hosoda, H.; Kimura, T.; Nakahata, K.; Miyazato, M.; Okuyama, H.; Kangawa, K. 2016: C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells. Cancer Medicine 5(5): 795-805

Del Ry, S.; Cabiati, M.; Bianchi, V.; Caponi, L.; Maltinti, M.; Caselli, C.; Kozakova, M.; Palombo, C.; Morizzo, C.; Marchetti, S.; Randazzo, E.; Clerico, A.; Federico, G. 2016: C-type natriuretic peptide is closely associated to obesity in Caucasian adolescents. Clinica Chimica Acta; International Journal of Clinical Chemistry 460: 172-177

Chen, G.; Song, X.; Yin, Y.; Xia, S.; Liu, Q.; You, G.; Zhao, L.; Zhou, H. 2017: C-type natriuretic peptide prevents kidney injury and attenuates oxidative and inflammatory responses in hemorrhagic shock. Amino Acids 49(2): 347-354

Ueda, Y.; Yasoda, A.; Yamashita, Y.; Kanai, Y.; Hirota, K.; Yamauchi, I.; Kondo, E.; Sakane, Y.; Yamanaka, S.; Nakao, K.; Fujii, T.; Inagaki, N. 2016: C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation. Bone 92: 157-167

Peake, N.J.; Bader, D.L.; Vessillier, S.; Ramachandran, M.; Salter, D.M.; Hobbs, A.J.; Chowdhury, T.T. 2015: C-type natriuretic peptide signalling drives homeostatic effects in human chondrocytes. Biochemical and Biophysical Research Communications 465(4): 784-789

Kalland, L.-E.; Norberg, S.T.; Kyrklund, J.; Hull, S.; Eriksson, S.G.; Norby, T.; Mohn, C.E.; Knee, C.S. 2016: C-type related order in the defective fluorites La2Ce2O7 and Nd2Ce2O7 studied by neutron scattering and ab initio MD simulations. Physical Chemistry Chemical Physics: Pccp 18(34): 24070-24080

Fauci, A.S.; Koop, C.Everett. 2014: C. Everett Koop, 14 October 1916 - 25 February 2013. Proceedings of the American Philosophical Society 158(4): 455-460

Patel, S.R.; Duckett, P.; Canning, D.A.; Caldamone, A.A.; Koop, C.Everett. 2017: C. Everett Koop: Pioneer in Pediatric Surgery, US Surgeon General, and Early Contributor to Pediatric Urology. Urology 105: 149-152

Kovary, Z.; Jung, C.G. 2015: C. G. Jung's Dream of Siegfried: A Psychobiographical Study. Psychoanalytic Review 102(4): 461-481

Penn, C.L. 2015: C. Lowry Barnes, MD. one Physician's Work to Advance Orthopaedic Care in Arkansas. Journal of the Arkansas Medical Society 112(7): 102-103

Talley, C.Richard.; Talley, C.Richard. 2014: C. Richard Talley's contributions to the pharmacy literature and to ASHP. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 71(24): 2123-2127

Zellmer, W.A.; Talley, C.Richard. 2014: C. Richard Talley, thank you. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists 71(24): 2121-2122

Lincourt, J.M.; Olczak, P.V. 1974: C. S. Peirce and H. S. Sullivan on the Human Self †. Psychiatry 37(1): 78-87

Wang, J.; Qi, L.; Mei, L.; Wu, Z.; Wang, H. 2016: C. butyricum lipoteichoic acid inhibits the inflammatory response and apoptosis in HT-29 cells induced by S. aureus lipoteichoic acid. International Journal of Biological Macromolecules 88: 81-87

Anonymous 2007: C. difficile in infant gut associated with eczema and wheezing. Nursing Standard 1987) 21(43): 16-17

Gillen, S. 2014: C. difficile report prompts review of infection control in Scotland's NHS. Nursing Standard: 1987) 29(14): 11

Amini, R.; Goupil, E.én.; Labella, S.; Zetka, M.; Maddox, A.S.; Labbé, J.-C.; Chartier, N.T. 2015: C. elegans Anillin proteins regulate intercellular bridge stability and germline syncytial organization. Journal of Cell Biology 209(3): 467

Chrisman, S.D.; Waite, C.B.; Scoville, A.G.; Carnell, L. 2016: C. elegans Demonstrates Distinct Behaviors within a Fixed and Uniform Electric Field. Plos one 11(3): E0151320

Vuong-Brender, T.T.K.; Yang, X.; Labouesse, M. 2016: C. elegans Embryonic Morphogenesis. Current Topics in Developmental Biology 116: 597-616

Leung, A.; Hua, K.; Ramachandran, P.; Hingwing, K.; Wu, M.; Koh, P.Luan.; Hawkins, N. 2016: C. elegans HAM-1 functions in the nucleus to regulate asymmetric neuroblast division. Developmental Biology 410(1): 56-69

Zheng, S.; Chin-Sang, I.D. 2016: C. elegans Methods to Study PTEN. Methods in Molecular Biology 1388: 307-321

Yochem, J.; Lažetić, V.; Bell, L.; Chen, L.; Fay, D. 2015: C. elegans NIMA-related kinases NEKL-2 and NEKL-3 are required for the completion of molting. Developmental Biology 398(2): 255-266

Tu, H.; Pinan-Lucarré, B.ér.èr.; Ji, T.; Jospin, M.; Bessereau, J.-L. 2015: C. elegans Punctin Clusters GABA(A) Receptors via Neuroligin Binding and UNC-40/DCC Recruitment. Neuron 86(6): 1407-1419

Vidal, B.; Santella, A.; Serrano-Saiz, E.; Bao, Z.; Chuang, C.-F.; Hobert, O. 2015: C. elegans SoxB genes are dispensable for embryonic neurogenesis but required for terminal differentiation of specific neuron types. Development 142(14): 2464-2477

Yokawa, K.; Baluška, Fšek. 2015: C. elegans and Arabidopsis thaliana show similar behavior: ROS induce escape tropisms both in illuminated nematodes and roots. Plant Signaling and Behavior 10(11): E1073870

Kanteti, R.; Dhanasingh, I.; El-Hashani, E.; Riehm, J.J.; Stricker, T.; Nagy, S.; Zaborin, A.; Zaborina, O.; Biron, D.; Alverdy, J.C.; Im, H.Kyung.; Siddiqui, S.; Padilla, P.A.; Salgia, R. 2016: C. elegans and mutants with chronic nicotine exposure as a novel model of cancer phenotype. Cancer Biology and Therapy 17(1): 91-103

Maglioni, S.; Ventura, N. 2016: C. elegans as a model organism for human mitochondrial associated disorders. Mitochondrion 30: 117-125

Liu, J.; Chin-Sang, I.D. 2015: C. elegans as a model to study PTEN's regulation and function. Methods 77-78: 180-190

Gonzalez-Moragas, L.; Roig, A.; Laromaine, A. 2015: C. elegans as a tool for in vivo nanoparticle assessment. Advances in Colloid and Interface Science 219: 10-26

Hirani, N.; Westenberg, M.; Seed, P.T.; Petalcorin, M.I.R.; Dolphin, C.T. 2016: C. elegans flavin-containing monooxygenase-4 is essential for osmoregulation in hypotonic stress. Biology Open 5(5): 668

Anderson, E.N.; Corkins, M.E.; Li, J.-C.; Singh, K.; Parsons, S.é; Tucey, T.M.; Sorkaç, A.; Huang, H.; Dimitriadi, M.; Sinclair, D.A.; Hart, A.C. 2016: C. elegans lifespan extension by osmotic stress requires FUdR, base excision repair, FOXO, and sirtuins. Mechanisms of Ageing and Development 154: 30-42

Skandari, R.; Le Bihan, N.; Manton, J.H. 2015: C. elegans locomotion analysis using algorithmic information theory. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2015: 6485-6488

Zhen, M.; Samuel, A.D.T. 2015: C. elegans locomotion: small circuits, complex functions. Current Opinion in Neurobiology 33: 117-126

Fazeli, G.; Trinkwalder, M.; Irmisch, L.; Wehman, A.M. 2016: C. elegans midbodies are released, phagocytosed and undergo LC3-dependent degradation independent of macroautophagy. Journal of Cell Science 129(20): 3721-3731

Shen, Y.; Ng, L.F.; Low, N.P.W.; Hagen, T.; Gruber, J.; Inoue, T. 2016: C. elegans miro-1 Mutation Reduces the Amount of Mitochondria and Extends Life Span. Plos one 11(4): E0153233

Frézal, L.; Félix, M.-A. 2015: C. elegans outside the Petri dish. Elife 4

Maglioni, S.; Arsalan, N.; Ventura, N. 2016: C. elegans screening strategies to identify pro-longevity interventions. Mechanisms of Ageing and Development 157: 60-69

Jedrusik-Bode, M. 2014: C. elegans sirtuin SIR-2.4 and its mammalian homolog SIRT6 in stress response. Worm 3: E29102

Assadollahi, V.; Gholami, M.; Zendedel, A. 2015: C. zeylanicum aqueous extract induced apoptosis in the human myelocytic leukemia cell line (THP-1). Bratislavske Lekarske Listy 116(2): 132-135

Kvistad, C.Elnan.; Thomassen, L. 2015: C.E. Kvistad & L. Thomassen reply. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 135(12-13): 1106

Kvistad, C.Elnan. 2015: C.E. Kvistad replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 135(12-13): 1106

Mazlan, S.N.H.S.; Ali, M.S.M.; Rahman, R.N.Z.R.A.; Sabri, S.; Jonet, M.A.; Leow, T.C. 2018: Crystallization and structure elucidation of GDSL esterase of Photobacterium sp. J15. International Journal of Biological Macromolecules 119: 1188-1194

Markham, D. 2015: C.S. Greene continues his biased accusations. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology 120(6): 777

Bause, G.S. 2015: C.T. Jackson's Sealed 13 November 1846 Letter to J.B.A.L.L. Élie de Beaumont: Translated (1847), Back-Translated (1861), and Accurately Transcribed for the First Time (2014). Journal of Anesthesia History 1(1): 9-13

Konert, J.; Aiken, C.E. 2016: C. E. Alken (1909-1986) and the Alken-Prize. Der Urologe. Ausg. A 55(6): 825-828

Jurėnas, D.; Van Melderen, L.; Garcia-Pino, A. 2018: Crystallization and X-ray analysis of all of the players in the autoregulation of the ataRT toxin-antitoxin system. Acta Crystallographica. Section F Structural Biology Communications 74(Part 7): 391-401

Sheng, J.; Zhou, S.; Yang, Z.; Zhang, X. 2018: Crystallization Behavior of Poly(ethylene oxide) in Vertically Aligned Carbon Nanotube Array. Langmuir: the Acs Journal of Surfaces and Colloids 34(12): 3678-3685

Witham, E.; Comunian, C.; Ratanpal, H.; Skora, S.; Zimmer, M.; Srinivasan, S. 2016: C. elegans Body Cavity Neurons Are Homeostatic Sensors that Integrate Fluctuations in Oxygen Availability and Internal Nutrient Reserves. Cell Reports 14(7): 1641-1654

McQuary, P.R.; Liao, C.-Y.; Chang, J.T.; Kumsta, C.; She, X.; Davis, A.; Chu, C.-C.; Gelino, S.; Gomez-Amaro, R.L.; Petrascheck, M.; Brill, L.M.; Ladiges, W.C.; Kennedy, B.K.; Hansen, M. 2016: C. elegans S6K Mutants Require a Creatine-Kinase-like Effector for Lifespan Extension. Cell Reports 14(9): 2059-2067

Nath, R.D.; Chow, E.S.; Wang, H.; Schwarz, E.M.; Sternberg, P.W. 2016: C. elegans Stress-Induced Sleep Emerges from the Collective Action of Multiple Neuropeptides. Current Biology: Cb 26(18): 2446-2455

Dennis, P.P.; Tripp, V.; Lui, L.; Lowe, T.; Randau, L. 2015: C/D box sRNA-guided 2'-O-methylation patterns of archaeal rRNA molecules. Bmc Genomics 16: 632

Martens-Uzunova, E.S.; Hoogstrate, Y.; Kalsbeek, A.; Pigmans, B.; Vredenbregt-van den Berg, M.; Dits, N.; Nielsen, S.ør.J.; Baker, A.; Visakorpi, T.; Bangma, C.; Jenster, G. 2015: C/D-box snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer. Oncotarget 6(19): 17430-17444

Liu, S.-H.; Wu, C.-T.; Huang, K.-H.; Wang, C.-C.; Guan, S.-S.; Chen, L.-P.; Chiang, C.-K. 2016: C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease. Oncotarget 7(16): 21900-21912

Noh, M.R.; Kim, J.I.; Han, S.J.; Lee, T.-J.; Park, K.M. 2015: C/EBP homologous protein (CHOP) gene deficiency attenuates renal ischemia/reperfusion injury in mice. Biochimica et Biophysica Acta 1852(9): 1895-1901

Park, S.-H.; Yu, M.; Kim, J.; Moon, Y. 2017: C/EBP homologous protein promotes NSAID-activated gene 1-linked pro-inflammatory signals and enterocyte invasion by enteropathogenic Escherichia coli. Microbes and Infection 19(2): 110-121

Cao, S.; Yan, B.; Lu, Y.; Zhang, G.; Li, J.; Guo, W.; Zhao, Y.; Zhang, S. 2015: C/EBP homologous protein-mediated endoplasmic reticulum stress-related renal apoptosis is involved in rats with brain death. Transplantation Proceedings 47(2): 354-358

Bai, Y.; Wei, Y.; Wu, L.; Wei, J.; Wang, X.; Bai, Y. 2016: C/EBP β Mediates Endoplasmic Reticulum Stress Regulated Inflammatory Response and Extracellular Matrix Degradation in LPS-Stimulated Human Periodontal Ligament Cells. International Journal of Molecular Sciences 17(3): 385

Zhou, A.-X.; Wang, X.; Lin, C.S.; Han, J.; Yong, J.; Nadolski, M.J.; Borén, J.; Kaufman, R.J.; Tabas, I. 2015: C/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates their Proliferation in Aortic Explants and Atherosclerotic Lesions. Circulation Research 116(11): 1736-1743

van der Krieken, S.E.; Popeijus, H.E.; Konings, M.; Dullens, S.P.J.; Mensink, R.P.; Plat, J. 2017: C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation. Journal of cellular biochemistry 118(4): 754-763

Van Oevelen, C.; Collombet, S.; Vicent, G.; Hoogenkamp, M.; Lepoivre, C.; Badeaux, A.; Bussmann, L.; Sardina, J.L.; Thieffry, D.; Beato, M.; Shi, Y.; Bonifer, C.; Graf, T. 2015: C/EBPα Activates Pre-existing and de Novo Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and Myelopoiesis. Stem Cell Reports 5(2): 232-247

Huan, H.; Wen, X.; Chen, X.; Wu, L.; Liu, W.; Habib, N.A.; Bie, P.; Xia, F. 2016: C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT. Plos one 11(4): E0153117

Kasakura, K.; Takahashi, K.; Itoh, T.; Hosono, A.; Nunomura, S.; Ra, C.; Momose, Y.; Itoh, K.; Nishiyama, C.; Kaminogawa, S. 2014: C/EBPα controls mast cell function. Febs Letters 588(24): 4645-4653

Costa, D.B.; Stephenson, P.; Kocher, O.; Tenen, D.G.; Feins, R.H.; Keller, S.M.; Schiller, J.H.; Johnson, D.H.; Halmos, B. 2016: C/EBPα expression by immunohistochemistry lacks prognostic or predictive significance in primary resected non-small cell lung cancer. Journal of Clinical Oncology 24(18_Suppl): 7202-7202

Adoligbe, C.; Huangfu, Y.F.; Zan, L.S.; Wang, H. 2015: C/EBPα gene as a genetic marker for beef quality improvement. Genetics and Molecular Research: Gmr 14(3): 9370-9383

Friedman, A.D. 2015: C/EBPα in normal and malignant myelopoiesis. International Journal of Hematology 101(4): 330-341

Zhang, J.; Ma, Y.; Wang, S.; Chen, F.; Gu, Y. 2015: C/EBPα inhibits proliferation of breast cancer cells via a novel pathway of miR-134/CREB. International Journal of Clinical and Experimental Pathology 8(11): 14472-14478

Liu, G.-f.; Lu, J.-y.; Zhang, Y.-j.; Zhang, L.-x.; Lu, G.-d.; Xie, Z.-j.; Cheng, M.-b.; Shen, Y.-f.; Zhang, Y. 2016: C/EBPα negatively regulates SIRT7 expression via recruiting HDAC3 to the upstream-promoter of hepatocellular carcinoma cells. Biochimica et Biophysica Acta 1859(2): 348-354

Hall, J.R.; Bereman, M.S.; Nepomuceno, A.I.; Thompson, E.A.; Muddiman, D.C.; Smart, R.C. 2014: C/EBPα regulates CRL4(Cdt2)-mediated degradation of p21 in response to UVB-induced DNA damage to control the G1/S checkpoint. Cell Cycle 13(22): 3602-3610

Cavanaugh, E.J.; DiMario, J.X. 2016: C/EBPα represses slow myosin heavy chain 2 gene expression in developing avian myotubes. Biochimica et Biophysica Acta 1860(11 Part A): 2355-2362

Shi, D.-B.; Wang, Y.-W.; Xing, A.-Y.; Gao, J.-W.; Zhang, H.; Guo, X.-Y.; Gao, P. 2015: C/EBPα-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer. Cancer Letters 369(2): 376-385

Hughes, J.M.; Legnini, I.; Salvatori, B.; Masciarelli, S.; Marchioni, M.; Fazi, F.; Morlando, M.; Bozzoni, I.; Fatica, A. 2015: C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget 6(21): 18534-18544

Sayeed, S.K.; Zhao, J.; Sathyanarayana, B.K.; Golla, J.P.; Vinson, C. 2015: C/EBPβ (CEBPB) protein binding to the C/EBP|CRE DNA 8-mer TTGC|GTCA is inhibited by 5hmC and enhanced by 5mC, 5fC, and 5caC in the CG dinucleotide. Biochimica et Biophysica Acta 1849(6): 583-589

Hansberg-Pastor, V.; Piña-Medina, A.G.; González-Arenas, A.; Camacho-Arroyo, I. 2015: C/EBPβ Isoforms Expression in the Rat Brain during the Estrous Cycle. International Journal of Endocrinology 2015: 674915

Xia, P.; Zhang, R.; Ge, G. 2015: C/EBPβ Mediates TNF-α-Induced Cancer Cell Migration by Inducing MMP Expression Dependent on p38 MAPK. Journal of Cellular Biochemistry 116(12): 2766-2777

Simpson-Abelson, M.R.; Childs, E.E.; Ferreira, M.C.; Bishu, S.; Conti, H.R.; Gaffen, S.L. 2015: C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins. Plos one 10(8): E0136538

Pulido-Salgado, M.; Vidal-Taboada, J.M.; Saura, J. 2015: C/EBPβ and C/EBPδ transcription factors: Basic biology and roles in the CNS. Progress in Neurobiology 132: 1-33

Oller, J.; Alfranca, Aántzazu.; Méndez-Barbero, N.; Villahoz, S.; Lozano-Vidal, N.; Martín-Alonso, M.; Arroyo, A.G.; Escolano, A.; Armesilla, A.Luis.; Campanero, M.R.; Redondo, J.Miguel. 2015: C/EBPβ and Nuclear Factor of Activated T Cells Differentially Regulate Adamts-1 Induction by Stimuli Associated with Vascular Remodeling. Molecular and Cellular Biology 35(19): 3409-3422

Rahman, S.M.; Baquero, K.C.; Choudhury, M.; Janssen, R.C.; de la Houssaye, B.A.; Sun, M.; Miyazaki-Anzai, S.; Wang, S.; Moustaid-Moussa, N.; Miyazaki, M.; Friedman, J.E. 2016: C/EBPβ in bone marrow is essential for diet induced inflammation, cholesterol balance, and atherosclerosis. Atherosclerosis 250: 172-179

Nerlich, A.; Ruangkiattikul, N.; Laarmann, K.; Janze, N.; Dittrich-Breiholz, O.; Kracht, M.; Goethe, R. 2015: C/EBPβ is a transcriptional key regulator of IL-36α in murine macrophages. Biochimica et Biophysica Acta 1849(8): 966-978

Redondo-Angulo, I.; Mas-Stachurska, A.; Sitges, M.; Giralt, M.; Villarroya, F.; Planavila, A. 2016: C/EBPβ is required in pregnancy-induced cardiac hypertrophy. International Journal of Cardiology 202: 819-828

Xie, F.; Li, X.; Wei, C.; Liang, G.; Dang, Y.; Shan, Z. 2015: C/EBPβ promotes NF-κB-mediated invasion and migration of human renal carcinoma 786-O cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31(11): 1483-1487

Regalo, G.; Förster, S.; Resende, C.; Bauer, B.; Fleige, B.; Kemmner, W.; Schlag, P.M.; Meyer, T.F.; Machado, J.é C.; Leutz, A. 2016: C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation. Journal of Molecular Medicine 94(12): 1385-1395

Barakat, D.J.; Mendonca, J.; Barberi, T.; Zhang, J.; Kachhap, S.K.; Paz-Priel, I.; Friedman, A.D. 2016: C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion. Cancer Letters 375(1): 152-161

Huber, Ré.; Panterodt, T.; Welz, B.; Christmann, M.; Friesenhagen, J.; Westphal, A.; Pietsch, D.; Brand, K. 2015: C/EBPβ-LAP*/LAP Expression Is Mediated by RSK/eIF4B-Dependent Signalling and Boosted by Increased Protein Stability in Models of Monocytic Differentiation. Plos one 10(12): E0144338

Huggins, C.J.; Mayekar, M.K.; Martin, N.; Saylor, K.L.; Gonit, M.; Jailwala, P.; Kasoji, M.; Haines, D.C.; Quiñones, O.A.; Johnson, P.F. 2015: C/EBPγ Is a Critical Regulator of Cellular Stress Response Networks through Heterodimerization with ATF4. Molecular and Cellular Biology 36(5): 693-713

De Menezes, A.B.; Prendergast-Miller, M.T.; Poonpatana, P.; Farrell, M.; Bissett, A.; Macdonald, L.M.; Toscas, P.; Richardson, A.E.; Thrall, P.H. 2015: C/N ratio drives soil actinobacterial cellobiohydrolase gene diversity. Applied and Environmental Microbiology 81(9): 3016-3028

Harris, S.P.; Belknap, B.; Van Sciver, R.E.; White, H.D.; Galkin, V.E. 2016: C0 and C1 N-terminal Ig domains of myosin binding protein C exert different effects on thin filament activation. Proceedings of the National Academy of Sciences of the United States of America 113(6): 1558-1563

Leibfried, M.; Kovary, A. 2017: C1 Esterase Inhibitor (Berinert) for ACE Inhibitor-Induced Angioedema: Two Case Reports. Journal of Pharmacy Practice 30(6): 668-671

Campbell, J.C.; Li, Y.; van Amersfoort, E.; Relan, A.; Dubick, M.; Sheppard, F.; Pusateri, A.; Niemeyer, D.; Tsokos, G.C.; Dalle Lucca, J.J. 2016: C1 Inhibitor Limits Organ Injury and Prolongs Survival in Swine Subjected to Battlefield Simulated Injury. Shock 46(3 Suppl 1: 177-188

Ghannam, A.; Sellier, P.; Fain, O.; Martin, L.; Ponard, D.; Drouet, C. 2016: C1 Inhibitor as a glycoprotein: the influence of polysaccharides on its function and autoantibody target. Molecular Immunology 71: 161-165

Viglietti, D.; Gosset, C.; Loupy, A.; Deville, L.; Verine, J.; Zeevi, A.; Glotz, D.; Lefaucheur, C. 2016: C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 16(5): 1596-1603

Martinez-Thompson, J.M.; Garza, I.; Cutrer, F.M.; Robertson, C.E. 2017: C1 Myelitis Presenting with Neuralgic Otalgia. Headache 57(1): 126-127

Zenga, F.; Marengo, N.; Pacca, P.; Pecorari, G.; Ducati, A. 2015: C1 anterior arch preservation in transnasal odontoidectomy using three-dimensional endoscope: A case report. Surgical Neurology International 6: 192

Fries, C.A.; Villamaria, C.Y.; Spencer, J.R.; Rasmussen, T.E.; Davis, M.R. 2017: C1 esterase inhibitor ameliorates ischemia reperfusion injury in a swine musculocutaneous flap model. Microsurgery 37(2): 142-147

Mead, L.B.; Millhouse, P.W.; Krystal, J.; Vaccaro, A.R. 2016: C1 fractures: a review of diagnoses, management options, and outcomes. Current Reviews in Musculoskeletal Medicine 9(3): 255-262

Longhurst, H.J.; Tarzi, M.D.; Ashworth, F.; Bethune, C.; Cale, C.; Dempster, J.; Gompels, M.; Jolles, S.; Seneviratne, S.; Symons, C.; Price, A.; Edgar, D. 2015: C1 inhibitor deficiency: 2014 United Kingdom consensus document. Clinical and Experimental Immunology 180(3): 475-483

Ghannam, A.; Sellier, P.; Defendi, F.; Favier, B.; Charignon, D.; López-Lera, A.; López-Trascasa, M.; Ponard, D.; Drouet, C. 2015: C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay. Allergy 70(9): 1103-1111

Helling, H.; Pindur, G.; Stephan, B. 2016: C1 inhibitor in sepsis and clinical outcome. American Journal of Emergency Medicine 34(6): 1179-1180

Fu, J.; Guo, F.; Chen, C.; Yu, X.; Hu, K.; Li, M. 2016: C1 inhibitor-mediated myocardial protection from chronic intermittent hypoxia-induced injury. Experimental and Therapeutic Medicine 12(4): 2208-2214

Wada, K.; Tamaki, R.; Yui, M.; Numaguchi, D.; Murata, Y. 2017: C1 lateral mass screw insertion caudally from C2 nerve root - An alternate method for insertion of C1 screws: A technical note and preliminary clinical results. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 22(2): 213-217

Nagoshi, N.; Suda, K.; Morita, T.; Matsumoto, S.; Iimoto, S.; Yasui, K.; Komatsu, M.; Kobayashi, Y.; Minami, A.; Toyama, Y.; Matsumoto, M.; Nakamura, M. 2014: C1 posterior arch screw as an auxiliary anchor in posterior reconstruction for atlantoaxial dislocation associated with type II odontoid fracture: a case report and review of the literature. Springerplus 3: 672

Srivastava, S.; Mishra, S.; Surolia, A.; Panda, D. 2016: C1, a highly potent novel curcumin derivative, binds to tubulin, disrupts microtubule network and induces apoptosis. Bioscience Reports 36(2)

Kharosekar, H.; Valsangkar, S.; Velho, V. 2015: C1-2 ganglioneuroma in a patient with neurofibromatosis type-1. Neurology India 63(5): 794-796

Wan, M.; Lou, H.; Liu, L. 2015: C1-Benzyl and benzoyl isoquinoline synthesis through direct oxidative cross-dehydrogenative coupling with methyl arenes. Chemical Communications 51(73): 13953-13956

Ruf, M.; Drumm, J.; Pitzen, T.; Merk, H.R. 2016: C1-C2 Instrumentation According to Harms/Goel in Case of Vertebral Artery below the Arch of C1: A Case Report. Journal of Neurological Surgery. Part A Central European Neurosurgery 77(6): 543-547

Mandolesi, S.; Marceca, G.; d'Alessandro, A.; Desogus, A.; Ciccone, M.M.; Zito, A.; Manconi, E.; Niglio, T.; Mandolesi, D.; d'Alessandro, A.; Fedele, F. 2015: C1-C2 X-Ray assessment of misalignment parameters in patients with Chronic Cerebra-spinal Venous Insufficiency and Multiple Sclerosis versus patients with other pathologies. Annali Italiani di Chirurgia 86(4): 293-300

Falatko, S.Reed.; Kelkar, P.; Setty, P.; Tong, D.; Soo, T.Mun. 2015: C1-C2 cryptic cerebrospinal fluid leak directly identified by pressurized radionuclide cisternography: Case report and review of the literature. Surgical Neurology International 6: 126

Chowdhury, F.H.; Haque, M.R. 2014: C1-C3 Lateral Mass Screw-Rod Fixation and Fusion for C2 Pathologies and Hangman's Fractures. Asian Spine Journal 8(6): 735-746

Morioke, S.; Shu, M. 2014: C1-Inh. Arerugi 63(9): 1271-1272

Li, Y.; Zhao, L.; Yang, L. 2015: C1-almost periodic solutions of BAM neural networks with time-varying delays on time scales. Thescientificworldjournal 2015: 727329

Qi, L.; Li, M.; Zhang, S.; Si, H.; Xue, J. 2015: C1-c2 pedicle screw fixation for treatment of old odontoid fractures. Orthopedics 38(2): 94-100

Dürre, P.; Eikmanns, B.J. 2015: C1-carbon sources for chemical and fuel production by microbial gas fermentation. Current Opinion in Biotechnology 35: 63-72

Yu, S.K.H.; Callum, J.; Alam, A. 2016: C1-esterase inhibitor for short-term prophylaxis in a patient with hereditary angioedema with normal C1 inhibitor function. Journal of Clinical Anesthesia 35: 488-491

Landsem, A.; Fure, H.; Mollnes, T.E.; Nielsen, E.W.; Brekke, O.L. 2016: C1-inhibitor efficiently delays clot development in normal human whole blood and inhibits Escherichia coli-induced coagulation measured by thromboelastometry. Thrombosis Research 143: 63-70

Madsen, D.E.; Sidelmann, J.J.; Biltoft, D.; Gram, J.ør.; Hansen, S. 2015: C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema. Biochimica et Biophysica Acta 1850(6): 1336-1342

D.M.rtino, D.; Zullino, S.; Casati, D.; Grimaldi, A.S.; Mastroianni, C.; Principato, G.; Rosti, E.; Garbin, M.; Ferrazzi, E. 2016: C1. Maternal hemodynamic profile in hypertensive disorders of pregnancy (HDP) and intrauterine growth restriction. Journal of Maternal-Fetal and Neonatal Medicine 29(Sup 2): 11-11

Ioffe, I.N.; Yang, S.; Wang, S.; Kemnitz, E.; Sidorov, L.N.; Troyanov, S.I. 2015: C100 is Converted into C94 Cl22 by Three Chlorination-Promoted C2 Losses under Formation and Elimination of Cage Heptagons. Chemistry 21(13): 4904-4907

Desmurs, M.; Foti, M.; Raemy, E.; Vaz, F.éd.ér.M.; Martinou, J.-C.; Bairoch, A.; Lane, L. 2015: C11orf83, a mitochondrial cardiolipin-binding protein involved in bc1 complex assembly and supercomplex stabilization. Molecular and Cellular Biology 35(7): 1139-1156

Nambirajan, A.; Malgulwar, P.Benny.; Sharma, M.C.; Singh, A.; Pathak, P.; Satyarthee, G.Dutta.; Garg, A. 2016: C11orf95-RELA fusion present in a primary intracranial extra-axial ependymoma: Report of a case with literature review. Neuropathology: Official Journal of the Japanese Society of Neuropathology 36(5): 490-495

Werbrouck, J.; Lambrecht, C.; Goossens, A. 2015: C12-15 alkyl benzoate: a new cosmetic allergen?. Contact Dermatitis 73(4): 249-250

Lewis, J.B.; Isheim, D.; Floss, C.; Seidman, D.N. 2015: C12/C13-ratio determination in nanodiamonds by atom-probe tomography. Ultramicroscopy 159 Pt 2: 248-254

Chhikara, S.; Sazawal, S.; Mishra, P.; Chaubey, R.; Mahapatra, M.; Saxena, R. 2015: C1236T polymorphism in MDR1 gene correlates with therapeutic response to imatinib mesylate in Indian patients with chronic myeloid leukaemia. National Medical Journal of India 28(6): 272-275

Jiang, Y-Ping.; Liu, Y-Feng.; Guo, Q-Lan.; Shi, J-Gong. 2015: C14-polyacetylenol glycosides from the roots of Codonopsis pilosula. Journal of Asian Natural Products Research 17(12): 1166-1179

Zhang, W.; Ou, J.; Lei, F.; Hou, T.; Wu, S.; Niu, C.; Xu, L.; Zhang, Y. 2016: C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(1): 369-379

Tiirats, A.; Viltrop, T.; Nõukas, M.; Reimann, E.; Salumets, A.; Kõks, S. 2016: C14orf132 gene is possibly related to extremely low birth weight. Bmc Genetics 17(1): 132

Chen, M.; Ye, Y.; Zou, B.; Guo, S.; Zhou, F.; Lu, K.; Liu, J.; Xu, Z.; Han, H.; Liu, Z.; Li, Y.; Yao, K.; Liu, C.; Qin, Z. 2016: C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation. Journal of Translational Medicine 14: 55

Cheang, T.-y.; Zhou, H.-Y.; Chen, W.; Zhang, B.; Liu, L.; Yang, J.; Wang, S.; Li, H. 2016: C14orf166 overexpression correlates with tumor progression and poor prognosis of breast cancer. Journal of Translational Medicine 14: 54

Liu, C.; Yu, Y.; Yin, G.; Zhang, J.; Wen, W.; Ruan, X.; Li, D.; Zhang, S.; Cai, W.; Gao, M.; Chen, L. 2017: C14orf93 (RTFC) is identified as a novel susceptibility gene for familial nonmedullary thyroid cancer. Biochemical and Biophysical Research Communications 482(4): 590-596

Zhang, Z.; Xue, N.; Bian, C.; Yan, R.; Jin, L.; Chen, X.; Yu, X. 2016: C15-methoxyphenylated 18-deoxy-herbimycin a analogues, their in vitro anticancer activity and heat shock protein 90 binding affinity. Bioorganic and Medicinal Chemistry Letters 26(17): 4287-4291

Canales-Flores, R.A.; Prieto-García, F. 2016: C15039. Activation Methods of Carbonaceous Materials Obtained from Agricultural Waste. A Review. Chemistry and Biodiversity 2016

Yang, Y.; Wang, Z.; Wu, J.; Chen, Y. 2016: C15043. Chemical Constituents of Plants from the Genus Phlegmariurus. Chemistry and Biodiversity 2016

Lopes, L.Gobira.; Tavares, G.Lopes.; Thomaz, L.Dias.; Sabino, Jé.Ricardo.; Borges, K.Bastos.; Vieira, P.Cezar.; Veiga, T.André.Moura.; de Souza Borges, W. 2016: C15049. Taraxerol 4-Methoxybenzoate, an in vitro Inhibitor of Photosynthesis Isolated from Pavonia multiflora A. St-Hil. (Malvaceae). Chemistry and Biodiversity 2016

Chen, L-Jun.; Zhang, Y.; Chen, Y-Gao. 2016: C15065. Chemical Constituents of Plants from the Genus Ixora. Chemistry and Biodiversity 2016

Ouattara, Z.A.; Boti, J.Brice.; Ahibo, C.Antoine.; Bekro, Y-Alain.; Casanova, J.; Tomi, Félix.; Bighelli, A. 2016: C15066. Composition and chemical variability of Ivoirian Polyalthia oliveri leaf oil. Chemistry and Biodiversity 2016

Brunel, M.; Vitrac, C.; Costa, J.; Mzali, F.; Vitrac, X.; Muselli, A. 2016: C15078. Essential oil composition of Phagnalon sordidum (L.) from Corsica, chemical variability and antimicrobial activity. Chemistry and Biodiversity 2016

Ghorbanpour, M.; Hatami, M.; Kariman, K.; Dahaji, P.Abbaszadeh. 2016: C15082. Phytochemical Variations and Enhanced Efficiency of Antioxidant and Antimicrobial Ingredients in Salvia officinalis as Inoculated with Different Rhizobacteria. Chemistry and Biodiversity 2016

El Ayeb-Zakhama, A.; Sakka-Rouis, L.; Bergaoui, A.; Flamini, G.; Jannet, H.Ben.; Harzallah-Skhiri, F. 2016: C15083. Chemical Composition and Allelopathic Potential of Essential Oils from Tipuana tipu (Benth.) Kuntze Cultivated in Tunisia. Chemistry and Biodiversity 2016

Satyal, P.; Crouch, R.A.; Monzote, L.; Cos, P.; Awadh Ali, N.A.; Alhaj, M.A.; Setzer, W.N. 2016: C15271. The Chemical Diversity of Lantana camara: Analyses of Essential Oil Samples from Cuba, Nepal, and Yemen. Chemistry and Biodiversity 2016

Wentrup, C.; Becker, Jürgen.; Diehl, M. 2015: C15H10 and C15H12 Thermal Chemistry: Phenanthrylcarbene Isomers and Phenylindenes by Falling Solid Flash Vacuum Pyrolysis of Tetrazoles. Journal of Organic Chemistry 80(14): 7144-7149

Hla, T.; Kolesnick, R. 2014: C16:0-ceramide signals insulin resistance. Cell Metabolism 20(5): 703-705

Li, W.; Chen, X.; Wong, Y.-L.E.; Hung, Y.-L.W.; Wang, Z.; Deng, L.; Dominic Chan, T.-W. 2016: C18-attached membrane funnel-based spray ionization mass spectrometry for quantification of anti-diabetic drug from human plasma. Analytica Chimica Acta 933: 97-102

Wang, F.; Yue, Z.; Xie, P.; Zhang, L.; Li, Z.; Song, B.; Tang, Z.; Song, X. 2016: C19-Norditerpenoid Alkaloids from Aconitum szechenyianum and their Effects on LPS-Activated NO Production. Molecules 21(9)

Gagliardi, M.; Annesi, G.; Lesca, G.; Broussolle, E.; Iannello, G.; Vaiti, V.; Gambardella, A.; Quattrone, A. 2015: C19orf12 gene mutations in patients with neurodegeneration with brain iron accumulation. Parkinsonism and Related Disorders 21(7): 813-816

Jackson, R.A.; Wu, J.Shumei.; Chen, E.Sin. 2016: C1D family proteins in coordinating RNA processing, chromosome condensation and DNA damage response. Cell Division 11: 2

Baudiß, K.; de Paula Vieira, R.; Cicko, S.; Ayata, K.; Hossfeld, M.; Ehrat, N.; Gómez-Muñoz, A.; Eltzschig, H.K.; Idzko, M. 2016: C1P Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Preventing NF-κB Activation in Neutrophils. Journal of Immunology 196(5): 2319-2326

Arreola-Guerra, Jé.M.; Castelán, N.; de Santiago, Aán.; Arvizu, A.; Gonzalez-Tableros, N.; López, M.; Salcedo, I.; Vilatobá, M.; Granados, J.; Morales-Buenrostro, L.E.; Alberú, J. 2016: C1Q Assay Results in Complement-Dependent Cytotoxicity Crossmatch Negative Renal Transplant Candidates with Donor-Specific Antibodies: High Specificity but Low Sensitivity When Predicting Flow Crossmatch. Journal of Transplantation 2016: 2106028

Wang, Y.; Yue, D.; Xiao, M.; Qi, C.; Chen, Y.; Sun, D.; Zhang, N.; Chen, R. 2015: C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis. Journal of Proteome Research 14(2): 804-813

Yell, M.; Muth, B.L.; Kaufman, D.B.; Djamali, A.; Ellis, T.M. 2015: C1q Binding Activity of de Novo Donor-specific HLA Antibodies in Renal Transplant Recipients with and Without Antibody-mediated Rejection. Transplantation 99(6): 1151-1155

Benoit, M.E.; Clarke, E.V.; Tenner, A.J. 2013: C1q Binding to and Uptake of Apoptotic Lymphocytes by Human Monocyte-derived Macrophages. Bio-protocol 3(17)

Shah, D.; Romero, F.; Zhu, Y.; Duong, M.; Sun, J.; Walsh, K.; Summer, R. 2015: C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury. Journal of Biological Chemistry 290(49): 29642-29651

Carlucci, F.; Ishaque, A.; Ling, G.S.; Szajna, M.; Sandison, A.; Donatien, P.; Cook, H.T.; Botto, M. 2016: C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus. Journal of Immunology 196(4): 1488-1494

Galešić, Kšimir.; Horvatić, I.; Batinić, D.; Milošević, D.; Saraga, M.; Durdov, M.Glavina.; Ljubanović, D.Galešić. 2015: C1q Nephropathy: Case Reports and Literature Review. Lijecnicki Vjesnik 137(9-10): 283-287

Devasahayam, J.; Erode-Singaravelu, G.; Bhat, Z.; Oliver, T.; Chandran, A.; Zeng, X.; Dakshinesh, P.; Pillai, U. 2015: C1q Nephropathy: the Unique Underrecognized Pathological Entity. Analytical Cellular Pathology 2015: 490413

Son, M.; Porat, A.; He, M.; Suurmond, J.; Santiago-Schwarz, F.; Andersson, U.; Coleman, T.R.; Volpe, B.T.; Tracey, K.J.; Al-Abed, Y.; Diamond, B. 2016: C1q and HMGB1 reciprocally regulate human macrophage polarization. Blood 128(18): 2218-2228

Duan, L.; Liu, Z.; Wang, L.; Ma, B.; Fan, Y.; Xu, Y.; Guo, F. 2016: C1q and tumor necrosis factor related protein 4 (CTRP4) suppresses caspase-1/IL-1β inflammatory pathway in trophoblasts of rat models with preeclampsia. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32(11): 1441-1445

Chen, N.-N.; He, J.-R.; Li, W.-D.; Kuang, Y.-S.; Yuan, M.-Y.; Liu, X.-D.; Zhang, H.-Z.; Hu, S.-P.; Xia, H.-M.; Qiu, X. 2016: C1q and tumor necrosis factor-related protein 3 is present in human cord blood and is associated with fetal growth. Clinica Chimica Acta; International Journal of Clinical Chemistry 453: 67-70

Ghebrehiwet, B.; Hosszu, K.H.; Peerschke, E.I.B. 2017: C1q as an autocrine and paracrine regulator of cellular functions. Molecular Immunology 84: 26-33

Gupta, R.; Sharma, A.; Agarwal, S.K.; Dinda, A.K. 2015: C1q nephropathy and isolated CD59 deficiency manifesting as necrotizing crescentic glomerulonephritis: A rare association of two diseases. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 26(6): 1274-1278

Kanodia, K.V.; Vanikar, A.V.; Patel, R.D.; Suthar, K.S.; Patel, H.V.; Gumber, M.A.; Shah, P.R.; Trivedi, H.L. 2015: C1q nephropathy in India: a single-center study. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 26(2): 398-403

Maliakkal, J.G.; Liapis, H.; White, A.J.; Ahn, S.-Y. 2014: C1q nephropathy in the setting of granulomatosis with polyangiitis treated with tacrolimus. Clinical Kidney Journal 7(5): 499-500

Muorah, M.; Sinha, M.D.; Horsfield, C.; O'Donnell, P.J. 2009: C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?. Ndt Plus 2(4): 285-291

Silverman, S.M.; Kim, B.-J.; Howell, G.R.; Miller, J.; John, S.W.M.; Wordinger, R.J.; Clark, A.F. 2016: C1q propagates microglial activation and neurodegeneration in the visual axis following retinal ischemia/reperfusion injury. Molecular Neurodegeneration 11: 24

Cai, Y.; Teo, B.H.D.; Yeo, J.G.; Lu, J. 2015: C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins. Journal of Biological Chemistry 290(37): 22570-22580

Mosaad, Y.M.; Hammad, A.; Fawzy, Z.; El-Refaaey, A.; Tawhid, Z.; Hammad, E.M.; Youssef, L.F.; ElAttar, E.A.A.; Radwan, D.F.; Fawzy, I.M. 2015: C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis. Clinical and Experimental Immunology 182(1): 23-34

Yang, W.-M.; Min, K.-H.; Lee, W. 2015: C1q tumor necrosis factor α-related protein isoform 5 attenuates palmitate-induced DNA fragmentation in myocytes through an AMPK-dependent mechanism. Data in Brief 5: 770-774

Wang, L.; Liu, Z.; Duan, L.; Ma, B.; Sun, Z. 2015: C1q tumor necrosis factor-related protein 6 (CTRP6) inhibits the proliferation and migration of ovarian cancer cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31(12): 1664-1668

Beurskens, F.J.; van Schaarenburg, R.A.; Trouw, L.A. 2015: C1q, antibodies and anti-C1q autoantibodies. Molecular Immunology 68(1): 6-13

Appari, M.; Breitbart, A.; Brandes, F.; Szaroszyk, M.; Froese, N.; Korf-Klingebiel, M.; Mohammadi, M.M.; Grund, A.; Scharf, G.M.; Wang, H.; Zwadlo, C.; Fraccarollo, D.; Schrameck, U.; Nemer, M.; Wong, G.W.; Katus, H.A.; Wollert, K.C.; Müller, O.J.; Bauersachs, J.; Heineke, J. 2017: C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. Circulation Research 120(1): 66-77

Yuan, Y.; Lau, W.B.; Su, H.; Sun, Y.; Yi, W.; Du, Y.; Christopher, T.; Lopez, B.; Wang, Y.; Ma, X.-L. 2015: C1q-TNF-related protein-9, a novel cardioprotetcive cardiokine, requires proteolytic cleavage to generate a biologically active globular domain isoform. American Journal of Physiology. Endocrinology and Metabolism 308(10): E891-E898

Jackman, R.P.; Lee, J.-H.; Pei, R.; Bolgiano, D.; Lebedeva, M.; Slichter, S.J.; Norris, P.J. 2016: C1q-binding anti-HLA antibodies do not predict platelet transfusion failure in Trial to Reduce Alloimmunization to Platelets study participants. Transfusion 56(6): 1442-1450

Hajeer, A.H. 2016: C1q-binding anti-HLA antibody assay: a test dilemma. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 27(3): 457-459

McGonigal, R.; Cunningham, M.E.; Yao, D.; Barrie, J.A.; Sankaranarayanan, S.; Fewou, S.N.; Furukawa, K.; Yednock, T.A.; Willison, H.J. 2016: C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy. Acta Neuropathologica Communications 4: 23

Jung, T.W.; Hong, H.C.; Hwang, H.-J.; Yoo, H.J.; Baik, S.H.; Choi, K.M. 2015: C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress. Molecular and Cellular Endocrinology 417: 131-140

Bai, S.; Cheng, L.; Yang, Y.; Fan, C.; Zhao, D.; Qin, Z.; Feng, X.; Zhao, L.; Ma, J.; Wang, X.; Yang, J.; Xu, X.; Yi, D.; Yi, W. 2016: C1q/TNF-Related Protein 9 Protects Diabetic Rat Heart against Ischemia Reperfusion Injury: Role of Endoplasmic Reticulum Stress. Oxidative Medicine and Cellular Longevity 2016: 1902025

Wolf, R.M.; Steele, K.E.; Peterson, L.A.; Zeng, X.; Jaffe, A.E.; Schweitzer, M.A.; Magnuson, T.H.; Wong, G.W. 2016: C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated with Obesity and Decrease Following Weight Loss Surgery. Journal of Clinical Endocrinology and Metabolism 101(5): 2211-2217

Wang, X.Q.; Liu, Z.H.; Xue, L.; Lu, L.; Gao, J.; Shen, Y.; Yang, K.; Chen, Q.J.; Zhang, R.Y.; Shen, W.F. 2016: C1q/TNF-related protein 1 links macrophage lipid metabolism to inflammation and atherosclerosis. Atherosclerosis 250: 38-45

Van Hinsbergh, V.W.M.; Eringa, E.C. 2016: C1q/TNF-related protein 1: a novel link between visceral fat and athero-inflammation. European Heart Journal 37(22): 1772-1774

Nishimoto, H.; Yamamoto, A.; Furukawa, S.; Wakisaka, S.; Maeda, T. 2017: C1q/TNF-related protein 3 expression and effects on adipocyte differentiation of 3T3-L1 cells. Cell Biology International 41(2): 197-203

Yuasa, D.; Ohashi, K.; Shibata, R.; Mizutani, N.; Kataoka, Y.; Kambara, T.; Uemura, Y.; Matsuo, K.; Kanemura, N.; Hayakawa, S.; Hiramatsu-Ito, M.; Ito, M.; Ogawa, H.; Murate, T.; Murohara, T.; Ouchi, N. 2016: C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 30(3): 1065-1075

Lu, L.; Zhang, R.Y.; Wang, X.Q.; Liu, Z.H.; Shen, Y.; Ding, F.H.; Meng, H.; Wang, L.J.; Yan, X.X.; Yang, K.; Wang, H.B.; Pu, L.J.; Zhang, Q.; Chen, Q.J.; De Caterina, R.; Shen, W.F. 2016: C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis. European Heart Journal 37(22): 1762-1771

Huang, Y.; Wan, G.; Tao, J. 2017: C1q/TNF-related protein-3 exerts the chondroprotective effects in IL-1β-treated SW1353 cells by regulating the FGFR1 signaling. Biomedicine and PharmacoTherapy 85: 41-46

Jung, C.H.; Lee, M.J.; Kang, Y.M.; Lee, Y.L.; Seol, S.M.; Yoon, H.K.; Kang, S.-W.; Lee, W.J.; Park, J.-Y. 2016: C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells. Molecular and Cellular Endocrinology 419: 235-243

Kambara, T.; Shibata, R.; Ohashi, K.; Matsuo, K.; Hiramatsu-Ito, M.; Enomoto, T.; Yuasa, D.; Ito, M.; Hayakawa, S.; Ogawa, H.; Aprahamian, T.; Walsh, K.; Murohara, T.; Ouchi, N. 2015: C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism. Molecular and Cellular Biology 35(12): 2173-2185

Wang, S.; Zhou, Y.; Yang, B.; Li, L.; Yu, S.; Chen, Y.; Zhu, J.; Zhao, Y. 2016: C1q/Tumor Necrosis Factor-Related Protein-3 Attenuates Brain Injury after Intracerebral Hemorrhage via AMPK-Dependent Pathway in Rat. Frontiers in Cellular Neuroscience 10: 237

Li, R.; Yang, X.; Yu, Y.; Zhou, M.; Tian, X.; Feng, S.; Wang, H. 2016: C1q/tumor necrosis factor related protein 6 (CTRP6) is involved in gentamicin-induced acute kidney injury in rats. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 32(11): 1458-1461

Yang, B.; Wang, S.; Yu, S.; Chen, Y.; Li, L.; Zhang, H.; Zhao, Y. 2017: C1q/tumor necrosis factor-related protein 3 inhibits oxidative stress during intracerebral hemorrhage via PKA signaling. Brain Research 1657: 176-184

Lei, H.; Wu, D.; Wang, J.-Y.; Li, L.; Zhang, C.-L.; Feng, H.; Fu, F.-Y.; Wu, L.-L. 2015: C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Basic Research in Cardiology 110(4): 35

Fan, H.; Zhang, M.; Li, S.; Wu, J. 2016: WITHDRAWN: C1qTNF related protein 4 (CTRP4) promotes pancreatic ductal adenocarcinoma cell proliferation and migration via activation of EGFR-PI3K-NF-κB pathway. Oncology research 2016

Liu, F.; Tan, A.; Yang, R.; Xue, Y.; Zhang, M.; Chen, L.; Xiao, L.; Yang, X.; Yu, Y. 2017: C1ql1/Ctrp14 and C1ql4/Ctrp11 promote angiogenesis of endothelial cells through activation of ERK1/2 signal pathway. Molecular and Cellular Biochemistry 424(1-2): 57-67

Liger, F.ço.; Bouhours, P.; Ganem-Elbaz, C.; Jolivalt, C.; Pellet-Rostaing, S.ép.; Popowycz, F.; Paris, J.-M.; Lemaire, M. 2016: C2 Arylated Benzo[b]thiophene Derivatives as Staphylococcus aureus NorA Efflux Pump Inhibitors. Chemmedchem 11(3): 320-330

Motiei-Langroudi, R.; Sadeghian, H. 2016: C2 Body Fracture: Report of Cases Managed Conservatively by Philadelphia Collar. Asian Spine Journal 10(5): 920-924

Plazier, M.; Ost, J.; Stassijns, G.ët.; De Ridder, D.; Vanneste, S. 2015: C2 Nerve Field Stimulation for the Treatment of Fibromyalgia: a Prospective, Double-blind, Randomized, Controlled Cross-over Study. Brain Stimulation 8(4): 751-757

Ajayi, O.; Moisi, M.; Chapman, J.; Oskouian, R.J.; Tubbs, R.S. 2016: C2 Pedicle Screw Placement: a Novel Teaching Aid. Cureus 8(6): E630

Pearson, A.M.; Martin, B.I.; Lindsey, M.; Mirza, S.K. 2016: C2 Vertebral Fractures in the Medicare Population: Incidence, Outcomes, and Costs. Journal of Bone and Joint Surgery. American Volume 98(6): 449-456

Saetia, K.; Phankhongsab, A. 2015: C2 anatomy for translaminar screw placement based on computerized tomographic measurements. Asian Spine Journal 9(2): 205-209

Wang, Z.; Wang, X.; Wu, H.; Chen, Z.; Yuan, Q.; Jian, F. 2016: C2 dumbbell-shaped peripheral nerve sheath tumors: Surgical management and relationship with venous structures. Clinical Neurology and Neurosurgery 151: 96-101

Goel, A. 2015: C2 ganglion resection for lateral mass fixation techniques. Journal of Craniovertebral Junction and Spine 6(1): 10-11

Zou, W.; Cremer, D. 2016: C2 in a Box: Determining its Intrinsic Bond Strength for the X(1)Σg(+) Ground State. Chemistry 22(12): 4087-4099

Huang, D.-g.; Hao, D.-j.; Li, G.-l.; Guo, H.; Zhang, Y.-c.; He, B.-r. 2014: C2 nerve dysfunction associated with C1 lateral mass screw fixation. Orthopaedic Surgery 6(4): 269-273

Fujiwara, Y.; Izumi, B.; Fujiwara, M.; Nakanishi, K.; Tanaka, N.; Adachi, N.; Manabe, H. 2017: C2 spondylotic radiculopathy: the nerve root impingement mechanism investigated by para-sagittal CT/MRI, dynamic rotational CT, intraoperative microscopic findings, and treated by microscopic posterior foraminotomy. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 26(4): 1073-1081

Finn, M.A.; MacDonald, J.D. 2016: C2-3 Anterior Cervical Fusion: Technical Report. Clinical Spine Surgery (): -

Goel, A. 2016: C2-3 Fusion, C3-4 Cord Compression and C1-2 Posterior Facetal Instability: An Evaluation of Treatment Strategy Based on Four Surgically Treated Cases. Asian Spine Journal 10(3): 430-435

Crisenza, G.E.M.; Dauncey, E.M.; Bower, J.F. 2016: C2-Alkenylation of N-heteroaromatic compounds via Brønsted acid catalysis. Organic and Biomolecular Chemistry 14(24): 5820-5825

Fallon, B.J.; Derat, E.; Amatore, M.; Aubert, C.; Chemla, F.; Ferreira, F.; Perez-Luna, A.; Petit, M. 2016: C2-Alkylation and Alkenylation of Indoles Catalyzed by a Low-Valent Cobalt Complex in the Absence of Reductant. Organic Letters 18(9): 2292-2295

Finn, M.A.; MacDonald, J.D. 2016: C2-C3 Anterior Cervical Fusion: Technical Report. Clinical Spine Surgery 29(10): E536-E541

Speciale, G.; Farren-Dai, M.; Shidmoossavee, F.S.; Williams, S.J.; Bennet, A.J. 2016: C2-Oxyanion Neighboring Group Participation: Transition State Structure for the Hydroxide-Promoted Hydrolysis of 4-Nitrophenyl α-d-Mannopyranoside. Journal of the American Chemical Society 138(42): 14012-14019

Maragani, R.; Gautam, P.; Mobin, S.M.; Misra, R. 2016: C2-Symmetric ferrocenyl bisthiazoles: synthesis, photophysical, electrochemical and DFT studies. Dalton Transactions 45(11): 4802-4809

Jiang, S.; Wang, Q.; Feng, M.; Li, J.; Guan, Z.; An, D.; Dong, M.; Peng, Y.; Kuerban, K.; Ye, L. 2017: C2-ceramide enhances sorafenib-induced caspase-dependent apoptosis via PI3K/AKT/mTOR and Erk signaling pathways in HCC cells. Applied Microbiology and Biotechnology 101(4): 1535-1546

Rodriguez, L.; Gonzalez-Guzman, M.; Diaz, M.; Rodrigues, A.; Izquierdo-Garcia, A.C.; Peirats-Llobet, M.; Fernandez, M.A.; Antoni, R.; Fernandez, D.; Marquez, J.A.; Mulet, J.M.; Albert, A.; Rodriguez, P.L. 2014: C2-domain abscisic acid-related proteins mediate the interaction of PYR/PYL/RCAR abscisic acid receptors with the plasma membrane and regulate abscisic acid sensitivity in Arabidopsis. Plant Cell 26(12): 4802-4820

Pinheiro, P.S.; Houy, S.éb.; Sørensen, J.B. 2016: C2-domain containing calcium sensors in neuroendocrine secretion. Journal of Neurochemistry 139(6): 943-958

Vylíčilová, H.; Husičková, A.; Spíchal, L.áš; Srovnal, J.; Doležal, K.; Plíhal, O.ře.; Plíhalová, L. 2016: C2-substituted aromatic cytokinin sugar conjugates delay the onset of senescence by maintaining the activity of the photosynthetic apparatus. Phytochemistry 122: 22-33

Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2016: C2. Maternal cardiac deceleration capacity: a novel insight into maternal autonomic function. Journal of Maternal-Fetal and Neonatal Medicine 29(Sup 2): 12-12

Yin, Z.-Q.; Yu, S.-L.; Wei, Y.-J.; Ma, L.; Wu, Z.-F.; Wang, L.; Zhang, Q.-W.; Zhao, M.; Ye, W.-C.; Che, C.-T.; Zhang, J. 2016: C21 steroidal glycosides from Cynanchum stauntonii induce apoptosis in HepG2 cells. Steroids 106: 55-61

Zhao, D.; Feng, B.; Chen, S.; Chen, G.; Li, Z.; Lu, X.; Sang, X.; An, X.; Wang, H.; Pei, Y. 2016: C21 steroidal glycosides from the roots of Cynanchum paniculatum. Fitoterapia 113: 51-57

Zhang, M.; Rao, L.-L.; Xiang, C.; Li, B.-C.; Li, P. 2015: C21 steroidal glycosides from the roots of Cynanchum saccatum. Steroids 101: 28-36

Boucher, E.; Provost, P.R.; Tremblay, Y. 2015: C21-steroids inactivation and glucocorticoid synthesis in the developing lung. Journal of Steroid Biochemistry and Molecular Biology 147: 70-80

Khan, A.O.; Eisenberger, T.; Nagel-Wolfrum, K.; Wolfrum, U.; Bolz, H.J. 2015: C21orf2 is mutated in recessive early-onset retinal dystrophy with macular staphyloma and encodes a protein that localises to the photoreceptor primary cilium. British Journal of Ophthalmology 99(12): 1725-1731

Karnati, S.; Palaniswamy, S.; Alam, M.R.; Oruqaj, G.; Stamme, C.; Baumgart-Vogt, E. 2016: C22-bronchial and T7-alveolar epithelial cell lines of the immortomouse are excellent murine cell culture model systems to study pulmonary peroxisome biology and metabolism. Histochemistry and Cell Biology 145(3): 287-304

Li, Q.; Zhu, Y.; Hou, L.; Wang, J.; Hu, G.; Fang, X.; Hu, Y.; Tao, T.; Wei, X.; Tang, H.; Huang, B.; Hu, W. 2016: C23 promotes tumorigenesis via suppressing p53 activity. Oncotarget 7(36): 58274-58285

Yang, Y.; Yang, C.; Zhang, J. 2015: C23 protein meditates bone morphogenetic protein-2-mediated EMT via up-regulation of Erk1/2 and Akt in gastric cancer. Medical Oncology 32(3): 76

Cai, M.; Miao, J.; Song, X.; Lin, D.; Bi, Y.; Chen, L.; Liu, X.; Tyler, B.M. 2016: C239S Mutation in the β-Tubulin of Phytophthora sojae Confers Resistance to Zoxamide. Frontiers in Microbiology 7: 762

Van de Beek, M.-C.; Dijkstra, I.M.E.; van Lenthe, H.; Ofman, R.; Goldhaber-Pasillas, D.; Schauer, N.; Schackmann, M.; Engelen-Lee, J.-Y.; Vaz, F.éd.ér.M.; Kulik, W.; Wanders, R.J.A.; Engelen, M.; Kemp, S. 2016: C26:0-Carnitine Is a new Biomarker for X-Linked Adrenoleukodystrophy in Mice and man. Plos one 11(4): E0154597

Duan, C.; Wang, M.; Zhang, Y.; Wei, X.; Huang, Y.; Zhang, H.; Cheng, L.; Gai, Z. 2016: C282Y and H63D Polymorphisms in Hemochromatosis Gene and Risk of Parkinson's Disease: a Meta-Analysis. American Journal of Alzheimer's Disease and other Dementias 31(3): 201-207

Chu, W.; Wei, W.; Yu, S.; Han, H.; Shi, X.; Sun, W.; Gao, Y.; Zhang, L.; Chen, J. 2016: C2C12 myotubes inhibit the proliferation and differentiation of 3T3-L1 preadipocytes by reducing the expression of glucocorticoid receptor gene. Biochemical and Biophysical Research Communications 472(1): 68-74

Song, C.; Jiao, J.; Lin, Q.; Liu, H.; He, Y. 2016: C2H2 adsorption in three isostructural metal-organic frameworks: boosting C2H2 uptake by rational arrangement of nitrogen sites. Dalton Transactions 45(11): 4563-4569

Pei, J.; Grishin, N.V. 2015: C2H2 zinc finger proteins of the SP/KLF, Wilms tumor, EGR, Huckebein, and Klumpfuss families in metazoans and beyond. Gene 573(1): 91-99

Amino, S.; Arguelles, E.; Agerico Diño, W.; Okada, M.; Kasai, H. 2016: C2H4 adsorption on Cu(210), revisited: bonding nature and coverage effects. Physical Chemistry Chemical Physics: Pccp 18(34): 23621-23627

Abudayyeh, O.O.; Gootenberg, J.S.; Konermann, S.; Joung, J.; Slaymaker, I.M.; Cox, D.B.T.; Shmakov, S.; Makarova, K.S.; Semenova, E.; Minakhin, L.; Severinov, K.; Regev, A.; Lander, E.S.; Koonin, E.V.; Zhang, F. 2016: C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353(6299): Aaf5573

Jumde, V.R.; Eisink, N.N.H.M.; Witte, M.D.; Minnaard, A.J. 2016: C3 Epimerization of Glucose, via Regioselective Oxidation and Reduction. Journal of Organic Chemistry 81(22): 11439-11443

Riedl, M.; Thorner, P.; Licht, C. 2017: C3 Glomerulopathy. Pediatric Nephrology 32(1): 43-57

Al-Ghaithi, B.; Chanchlani, R.; Riedl, M.; Thorner, P.; Licht, C. 2016: C3 Glomerulopathy and post-infectious glomerulonephritis define a disease spectrum. Pediatric Nephrology 31(11): 2079-2086

Nsaiba, M.J.; Lapointe, M.; Mabrouk, H.; Douki, W.; Gaha, L.; Pérusse, L.; Bouchard, C.; Jrad, B.B.H.; Cianflone, K. 2015: C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients. Neurochemical Research 40(5): 906-914

Feng, H.; Wang, J.; Guo, P.; Xu, J.; Feng, J. 2015: C3 Vertebral Metastases From Tongue Adenoid Cystic Carcinoma: A Rare Case Report. Medicine 94(27): E1135

Vijayasarathy, S.; Prasad, P.; Fremlin, L.J.; Ratnayake, R.; Salim, A.A.; Khalil, Z.; Capon, R.J. 2016: C3 and 2D C3 Marfey's Methods for Amino Acid Analysis in Natural Products. Journal of Natural Products 79(2): 421-427

Lauterbach, M.; Billakurthi, K.; Kadereit, G.; Ludwig, M.; Westhoff, P.; Gowik, U. 2017: C3 cotyledons are followed by C4 leaves: intra-individual transcriptome analysis of Salsola soda (Chenopodiaceae). Journal of Experimental Botany 68(2): 161-176

Kalm, M.; Andreasson, U.; Björk-Eriksson, T.; Zetterberg, H.; Pekny, M.; Blennow, K.; Pekna, M.; Blomgren, K. 2016: C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning. Oncotarget 7(15): 19382-19394

von Elsner, L.; Hagemann, S.; Just, I.; Rohrbeck, A. 2016: C3 exoenzyme impairs cell proliferation and apoptosis by altering the activity of transcription factors. Naunyn-Schmiedeberg's Archives of Pharmacology 389(9): 1021-1031

Jung, Y.; Kim, I. 2015: C3 functionalization of indolizines via In(iii)-catalyzed three-component reaction. Organic and Biomolecular Chemistry 13(45): 10986-10994

Alexander, M.P.; Fervenza, F.C.; De Vriese, A.S.; Smith, R.J.H.; Nasr, S.H.; Cornell, L.D.; Herrera Hernandez, L.P.; Zhang, Y.; Sethi, S. 2016: C3 glomerulonephritis and autoimmune disease: more than a fortuitous association?. Journal of Nephrology 29(2): 203-209

Sethi, S.; Smith, R.J.H.; Dillon, J.J.; Fervenza, F.C. 2015: C3 glomerulonephritis associated with complement factor B mutation. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 65(3): 520-521

Yin, G.; Cheng, Z.; Zeng, C-Hong.; Liu, Z-Hong. 2016: C3 glomerulonephritis in multiple myeloma: A case report and literature review. Medicine 95(37): E4843

Ito, N.; Ohashi, R.; Nagata, M. 2017: C3 glomerulopathy and current dilemmas. Clinical and Experimental Nephrology 21(4): 541-551

Huzmeli, C.; Candan, F.; Seker, A.; Yildiz, E.; Terzi, H.; Kayatas, M. 2016: C3 mesangial proliferative glomerulonephritis initially presenting with atypical hemolytic uremic syndrome: a case report. Journal of Medical Case Reports 10: 206

Leibig, N.; Boyle, V.; Kraus, D.; Stark, G.B.; Penna, V. 2015: C3 toxin and poly-DL-lactide-ε-caprolactone conduits in the critically damaged peripheral nervous system: a combined therapeutic approach. Annals of Plastic Surgery 74(3): 350-353

Gutekunst, C.-A.; Tung, J.K.; McDougal, M.E.; Gross, R.E. 2016: C3 transferase gene therapy for continuous conditional RhoA inhibition. Neuroscience 339: 308-318

Kim, H.J.; LeVieux, J.; Yeh, Y.-C.; Liu, H.-W. 2016: C3'-Deoxygenation of Paromamine Catalyzed by a Radical S-Adenosylmethionine Enzyme: Characterization of the Enzyme AprD4 and its Reductase Partner AprD3. Angewandte Chemie 55(11): 3724-3728

Khoshravesh, R.; Stinson, C.R.; Stata, M.; Busch, F.A.; Sage, R.F.; Ludwig, M.; Sage, T.L. 2016: C3-C4 intermediacy in grasses: organelle enrichment and distribution, glycine decarboxylase expression, and the rise of C2 photosynthesis. Journal of Experimental Botany 67(10): 3065-3078

Li, L.-L.; Wang, H.-R.; Zhou, Z.-Y.; Luo, J.; Wang, X.-L.; Xiao, X.-Q.; Zhou, Y.-B.; Zeng, Y. 2016: C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination. Plos one 11(2): E0149748

Davis, S.A.; Della Ripa, L.A.; Hu, L.; Cioffi, A.G.; Pogorelov, T.V.; Rienstra, C.M.; Burke, M.D. 2015: C3-OH of Amphotericin B Plays an Important Role in Ion Conductance. Journal of the American Chemical Society 137(48): 15102-15104

Pfiffner, P.B.; Pinyol, I.; Natter, M.D.; Mandl, K.D. 2016: C3-PRO: Connecting ResearchKit to the Health System Using i2b2 and FHIR. Plos one 11(3): E0152722

Konishi, A.; Nakaoka, K.; Maruyama, H.; Nakajima, H.; Eguchi, T.; Baba, A.; Yasuda, M. 2017: C3 -Symmetric Boron Lewis Acid with a Cage-Shape for Chiral Molecular Recognition and Asymmetric Catalysis. Chemistry 23(6): 1273-1277

Rohrbeck, A.; Stahl, F.; Höltje, M.; Hettwer, T.; Lindner, P.; Hagemann, S.; Pich, A.; Haastert-Talini, K. 2015: C3-induced release of neurotrophic factors from Schwann cells - potential mechanism behind its regeneration promoting activity. Neurochemistry International 90: 232-245

McStay, N.; Molphy, Z.; Coughlan, A.; Cafolla, A.; McKee, V.; Gathergood, N.; Kellett, A. 2017: C 3-symmetric opioid scaffolds are pH-responsive DNA condensation agents. Nucleic Acids Research 45(2): 527-540

Alfonso, C.; Feliz, M.; Safont, V.S.; Llusar, R. 2016: C3-symmetry Mo3S4 aminophosphino clusters combining three sources of stereogenicity: stereocontrol directed by hydrogen bond interactions and ligand configuration. Dalton Transactions 45(18): 7829-7835

Foo, L.; McEniery, C.; Wilkinson, I.; Lees, C. 2016: C3. Cardiovascular changes from pre-pregnancy to early pregnancy in relation to viability of pregnancy. Journal of Maternal-Fetal and Neonatal Medicine 29(Sup 2): 13-13

Wang, L.; Xu, F.; Wang, G.; Wang, X.; Liang, A.; Huang, H.; Sun, F. 2016: C30F12.4 influences oogenesis, fat metabolism, and lifespan in C. elegans. Protein and Cell 7(10): 714-721

Calderón-Cruz, B.; Rodríguez-Galván, K.; Manzo-Francisco, L.A.; Vargas-Alarcón, G.; Fragoso, J.é M.; Peña-Duque, M.A.; Reyes-Gómez, C.A.; Martínez-Ríos, M.A.; De la Peña-Díaz, A. 2015: C3435T polymorphism of the ABCB1 gene is associated with poor clopidogrel responsiveness in a Mexican population undergoing percutaneous coronary intervention. Thrombosis Research 136(5): 894-898

Bodlenner, A.; Liu, W.; Hirsch, G.; Schaeffer, P.; Blumenberg, M.; Lendt, R.; Tritsch, D.; Michaelis, W.; Rohmer, M. 2015: C35 Hopanoid Side Chain Biosynthesis: Reduction of Ribosylhopane into Bacteriohopanetetrol by a Cell-Free System Derived from Methylobacterium organophilum. Chembiochem: a European Journal of Chemical Biology 16(12): 1764-1770

Dong, X.; Huang, Y.; Kong, L.; Li, J.; Kou, J.; Yin, L.; Yang, J. 2015: C35 is overexpressed in colorectal cancer and is associated tumor invasion and metastasis. Bioscience Trends 9(2): 117-121

Kerboua, K.Eddine.; Haiba, F.; Batouche, D. 2017: C3:CH50 ratio as a proposed composite marker for eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary results. Journal of Immunoassay and Immunochemistry 38(2): 178-189

Sasi Kumar, K.; Ramadhas, A.; Nayak, S.C.; Kaniyappan, S.; Dayma, K.; Radha, V. 2015: C3G (RapGEF1), a regulator of actin dynamics promotes survival and myogenic differentiation of mouse mesenchymal cells. Biochimica et Biophysica Acta 1853(10 Part A): 2629-2639

Priego, N.; Arechederra, M.ía.; Sequera, C.; Bragado, P.; Vázquez-Carballo, A.; Gutiérrez-Uzquiza, Ál.; Martín-Granado, V.íc.; Ventura, J.J.é; Kazanietz, M.G.; Guerrero, C.; Porras, A. 2016: C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms. Oncotarget 7(29): 45060-45078

Shah, B.; Lutter, D.; Bochenek, M.L.; Kato, K.; Tsytsyura, Y.; Glyvuk, N.; Sakakibara, A.; Klingauf, J.ür.; Adams, R.H.; Püschel, A.W. 2016: C3G/Rapgef1 Is Required in Multipolar Neurons for the Transition to a Bipolar Morphology during Cortical Development. Plos one 11(4): E0154174

Konstantoulas, C.J.; Indik, S. 2015: C3H strain of mouse mammary tumour virus, like GR strain, infects human mammary epithelial cells, albeit less efficiently than murine mammary epithelial cells. Journal of General Virology 96(Part 3): 650-662

Uddin, M.Hafiz.; Li, S.; Jin, Y.; Choi, M-Ho.; Jang, J.June.; Hong, S-Tae. 2016: C3H/He Mice as an Incompatible Cholangiocarcinoma Model by Clonorchis sinensis, Dicyclanil and N-Nitrosodimethylamine. Korean Journal of Parasitology 54(3): 281-289

Zhang, Y.; Guo, X.; Qian, Z.; Liu, Z.; Gao, Y.; Zhou, L.; Li, H.; Han, Y. 2015: C3H10 T1/2 cells over-expressing CCR7 have intensive immunosuppressive effect. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31(7): 873-878

Yang, M.; Liu, J.; Zhang, X.; Qiao, S.; Huang, H.; Liu, Y.; Kang, Z. 2015: C3N4-sensitized TiO2 nanotube arrays with enhanced visible-light photoelectrochemical performance. Physical Chemistry Chemical Physics: Pccp 17(27): 17887-17893

Long, Q.; Cao, X.; Bian, A.; Li, Y. 2016: C3a Increases VEGF and Decreases PEDF mRNA Levels in Human Retinal Pigment Epithelial Cells. Biomed Research International 2016: 6958752

Li, L.; Chen, L.; Zang, J.; Tang, X.; Liu, Y.; Zhang, J.; Bai, L.; Yin, Q.; Lu, Y.; Cheng, J.; Fu, P.; Liu, F. 2015: C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease. Metabolism, Clinical and Experimental 64(5): 597-610

Wu, S.-Y.; Fan, J.; Hong, D.; Zhou, Q.; Zheng, D.; Wu, D.; Li, Z.; Chen, R.-H.; Zhao, Y.; Pan, J.; Qi, X.; Chen, C.-S.; Hu, S.-Y. 2015: C3aR1 gene overexpressed at initial stage of acute myeloid leukemia-M2 predicting short-term survival. Leukemia and Lymphoma 56(7): 2200-2202

Roumenina, L.T. 2015: C3dg-CR3 interaction in erythrophagocytosis. Blood 126(7): 828-829

Krska, D.; Ravulapalli, R.; Fieldhouse, R.J.; Lugo, M.R.; Merrill, A.R. 2015: C3larvin toxin, an ADP-ribosyltransferase from Paenibacillus larvae. Journal of Biological Chemistry 290(3): 1639-1653

Heybeli, C. 2016: C4 Deposition in Glomerular Disease. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 68(5): 817

Sethi, S.; Quint, P.S.; O'Seaghdha, C.M.; Fervenza, F.C.; Bijol, V.; Dorman, A.; Dasari, S.; Smith, R.J.H.; Kurtin, P.J.; Rennke, H.G. 2016: C4 Glomerulopathy: a Disease Entity Associated With C4d Deposition. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 67(6): 949-953

Covshoff, S.; Szecowka, M.; Hughes, T.E.; Smith-Unna, R.; Kelly, S.; Bailey, K.J.; Sage, T.L.; Pachebat, J.A.; Leegood, R.; Hibberd, J.M. 2016: C4 Photosynthesis in the Rice Paddy: Insights from the Noxious Weed Echinochloa glabrescens. Plant Physiology 170(1): 57-73

Sage, R.F.; de Melo Peixoto, M.; Friesen, P.; Deen, B. 2015: C4 bioenergy crops for cool climates, with special emphasis on perennial C4 grasses. Journal of Experimental Botany 66(14): 4195-4212

Kapadia, N.; Harding, W.W. 2015: C4 phenyl aporphines with selective h5-HT(2B) receptor affinity. Bioorganic and Medicinal Chemistry Letters 25(17): 3451-3454

Heckmann, D. 2016: C4 photosynthesis evolution: the conditional Mt. Fuji. Current Opinion in Plant Biology 31: 149-154

Sugden, A.M. 2016: C4 plants in the heat of the city. Science 354(6314): 844

Unden, G.; Kleefeld, A. 2004: C4-Dicarboxylate Degradation in Aerobic and Anaerobic Growth. Ecosal Plus 1(1)

Unden, G.; Strecker, A.; Kleefeld, A.; Kim, O.B. 2016: C4-Dicarboxylate Utilization in Aerobic and Anaerobic Growth. Ecosal Plus 7(1)

Zhang, T.; Ge, C.; Deng, L.; Tan, T.; Wang, F. 2015: C4-dicarboxylic acid production by overexpressing the reductive TCA pathway. Fems Microbiology Letters 362(9)

Ghi, T.; Franchi, L.; Fieni, S.; Dall'Asta, A.; Gaibazzi, N.; Siniscalchi, C.; Pedrazzi, G.; Sciatti, E.; Bonadei, I.; Vizzardi, E.; Montaguti, E.; Degli Esposti, D.; Borghi, C.; Orabona, R.; Prefumo, F.; Frusca, T. 2016: C4. Maternal cardiac changes during uncomplicated twin pregnancy: does the chorionicity matter?. Journal of Maternal-Fetal and Neonatal Medicine 29(Sup 2): 14-14

Liu, J.-F.; Mao, L.; Bu, L.-L.; Ma, S.-R.; Huang, C.-F.; Zhang, W.-F.; Sun, Z.-J. 2015: C4.4A as a biomarker of head and neck squamous cell carcinoma and correlated with epithelial mesenchymal transition. American Journal of Cancer Research 5(12): 3505-3515

Barnum, S.R. 2015: C4a: An Anaphylatoxin in Name only. Journal of Innate Immunity 7(4): 333-339

Morita, N.; Yamai, I.; Takahashi, K.; Kusumoto, Y.; Shibata, T.; Kobayashi, T.; Nonaka, M.I.; Ichimonji, I.; Takagi, H.; Miyake, K.; Takamura, S.A. 2017: C4b binding protein negatively regulates TLR1/2 response. Innate Immunity 23(1): 11-19

Dikhoff, M.J.; ter Weeme, M.; Vonk, A.B.A.; Kupreishvili, K.; Blom, A.M.; Krijnen, P.A.J.; Stooker, W.; Niessen, H.W.M. 2015: C4b-Binding Protein Deposition is Induced in Diseased Aortic Heart Valves, Coinciding with C3d. Journal of Heart Valve Disease 24(4): 451-456

Sjölander, J.; Byman, E.; Kulak, K.; Nilsson, S.C.; Zhang, E.; Krus, U.; Westermark, G.T.; Storm, P.; King, B.C.; Renström, E.; Blom, A.M. 2016: C4b-binding Protein Protects β-Cells from Islet Amyloid Polypeptide-induced Cytotoxicity. Journal of Biological Chemistry 291(41): 21644-21655

Ermert, D.; Blom, A.M. 2016: C4b-binding protein: the good, the bad and the deadly. Novel functions of an old friend. Immunology Letters 169: 82-92

Vuohelainen, V.; Paavonen, T.; Hamalainen, M.; Moilanen, E.; Mennander, A.A. 2015: C4d Deposition Reveals Myocardial Infarction After Cardiac Arrest--Experimental Study. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 24(3): 393-399

Cook, H.T. 2015: C4d Staining in the Diagnosis of C3 Glomerulopathy. Journal of the American Society of Nephrology: Jasn 26(11): 2609-2611

Sethi, S.; Nasr, S.H.; De Vriese, A.S.; Fervenza, F.C. 2015: C4d as a Diagnostic Tool in Proliferative GN. Journal of the American Society of Nephrology: Jasn 26(11): 2852-2859

Sethi, S.; Hernandez, L.H.; Alexander, M.P.; Fervenza, F.C. 2016: C4d as a marker for masked immune deposits. Kidney International 90(1): 223-224

Jin, J.; Li, Y.W.; He, Q. 2015: C4d deposition is associated with immune cells infiltrating in kidney allograft glomerulitis and peritubular capillaritis. Renal Failure 37(5): 791-797

Lee, C.; Park, J.H.; Suh, J.H.; Kim, H.W.; Moon, K.C. 2014: C4d immunoreactivity of intraoperative zero-hour biopsy in renal allograft. Transplantation Proceedings 46(10): 3367-3370

Luk, A.; Alba, A.C.; Butany, J.; Tinckam, K.; Delgado, D.; Ross, H.J. 2015: C4d immunostaining is an independent predictor of cardiac allograft vasculopathy and death in heart transplant recipients. Transplant International: Official Journal of the European Society for Organ Transplantation 28(7): 857-863

Fuss, A.; Hope, C.M.; Deayton, S.; Bennett, G.D.; Holdsworth, R.; Carroll, R.P.; Coates, P.T.H. 2015: C4d-negative antibody-mediated rejection with high anti-angiotensin Ii type i receptor antibodies in absence of donor-specific antibodies. Nephrology 20(7): 467-473

Epstein, N.E.; Hollingsworth, R. 2015: C5 Nerve root palsies following cervical spine surgery: a review. Surgical Neurology International 6(Suppl 4): S154-S163

Mendes, E.A.; Desoti, V.ân.C.; Silva, S.d.O.; Ueda-Nakamura, T.ân.; Dias Filho, B.P.; Yamada-Ogatta, S.F.; Sarragiotto, M.H.; Nakamura, C.V. 2016: C5 induces different cell death pathways in promastigotes of Leishmania amazonensis. Chemico-Biological Interactions 256: 16-24

Kurakawa, T.; Miyamoto, H.; Kaneyama, S.; Sumi, M.; Uno, K. 2016: C5 nerve palsy after posterior reconstruction surgery: predictive risk factors of the incidence and critical range of correction for kyphosis. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 25(7): 2060-2067

Basaran, R.; Kaner, T. 2016: C5 nerve root palsy following decompression of cervical spine with anterior versus posterior types of procedures in patients with cervical myelopathy. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 25(7): 2050-2059

Klement, M.R.; Kleeman, L.T.; Blizzard, D.J.; Gallizzi, M.A.; Eure, M.; Brown, C.R. 2016: C5 palsy after cervical laminectomy and fusion: does width of laminectomy matter?. Spine Journal: Official Journal of the North American Spine Society 16(4): 462-467

Radcliff, K. 2016: C5 palsy and cervical laminectomy width: what is the right answer?. Spine Journal: Official Journal of the North American Spine Society 16(4): 468-469

Du, X.; Hinklin, R.J.; Xiong, Y.; Dransfield, P.; Park, J.; Kohn, T.J.; Pattaropong, V.; Lai, S.; Fu, Z.; Jiao, X.; Chow, D.; Jin, L.; Davda, J.; Veniant, M.M.; Anderson, D.A.; Baer, B.R.; Bencsik, J.R.; Boyd, S.A.; Chicarelli, M.J.; Mohr, P.J.; Wang, B.; Condroski, K.R.; DeWolf, W.E.; Conn, M.; Tran, T.; Yang, J.; Aicher, T.D.; Medina, J.C.; Coward, P.; Houze, J.B. 2014: C5-Alkyl-2-methylurea-Substituted Pyridines as a new Class of Glucokinase Activators. Acs Medicinal Chemistry Letters 5(12): 1284-1289

Morihiro, K.; Hasegawa, O.; Mori, S.; Tsunoda, S.; Obika, S. 2015: C5-azobenzene-functionalized locked nucleic acid uridine: isomerization properties, hybridization ability, and enzymatic stability. Organic and Biomolecular Chemistry 13(18): 5209-5214

Préchoux, A.él.; Halimi, C.él.; Simorre, J.-P.; Lortat-Jacob, H.; Laguri, C.éd. 2015: C5-epimerase and 2-O-sulfotransferase associate in vitro to generate contiguous epimerized and 2-O-sulfated heparan sulfate domains. Acs Chemical Biology 10(4): 1064-1071

Umadia, O.Chantelle.; Vinayagam, D.; Henares, J.Gutierrez.; Khalil, A. 2016: C5. Preeclampsia in twin pregnancies. Journal of Maternal-Fetal and Neonatal Medicine 29(Sup 2): 15-15

Kawada-Matsuo, M.; Shammi, F.; Oogai, Y.; Nakamura, N.; Sugai, M.; Komatsuzawa, H. 2016: C55 bacteriocin produced by ETB-plasmid positive Staphylococcus aureus strains is a key factor for competition with S. aureus strains. Microbiology and Immunology 60(3): 139-147

Bavia, L.; de Castro, Ír.A.; Isaac, L. 2015: C57BL/6 and A/J Mice have Different Inflammatory Response and Liver Lipid Profile in Experimental Alcoholic Liver Disease. Mediators of Inflammation 2015: 491641

Graber, T.G.; Kim, J.-H.; Grange, R.W.; McLoon, L.K.; Thompson, L.V. 2015: C57BL/6 life span study: age-related declines in muscle power production and contractile velocity. Age 37(3): 9773

Kerr, G.J.; McCann, M.R.; Branch, J.K.; Ratneswaran, A.; Pest, M.A.; Holdsworth, D.W.; Beier, F.; Dixon, S.J.; Séguin, C.A. 2017: C57BL/6 mice are resistant to joint degeneration induced by whole-body vibration. Osteoarthritis and Cartilage 25(3): 421-425

Baumgart, J.; Grebe, N. 2015: C57BL/6-specific conditions for efficient in utero electroporation of the central nervous system. Journal of Neuroscience Methods 240: 116-124

Schwartzer, J.J.; Onore, C.E.; Rose, D.; Ashwood, P. 2017: C57BL/6J bone marrow transplant increases sociability in BTBR T+ Itpr3tf/J mice. Brain Behavior and Immunity 59: 55-61

Gillombardo, C.B.; Darrah, R.; Dick, T.E.; Moore, M.; Kong, N.; Decker, M.J.; Han, F.; Yamauchi, M.; Dutschmann, M.; Azzam, S.; Strohl, K.P. 2017: C57BL/6J mouse apolipoprotein A2 gene is deterministic for apnea. Respiratory Physiology and Neurobiology 235: 88-94

Kalish, S.; Lyamina, S.; Chausova, S.; Kochetova, L.; Malyshev, Y.; Manukhina, E.; Malyshev, I. 2015: C57BL/6N Mice Are more Resistant to Ehrlich Ascites Tumors than C57BL/6J Mice: the Role of Macrophage Nitric Oxide. Medical Science Monitor Basic Research 21: 235-240

Wang, F.; Li, B.; Lan, L.; Li, L. 2015: C596G mutation in FBN1 causes Marfan syndrome with exotropia in a Chinese family. Molecular Vision 21: 194-200

Veazey, R.S.; Chatterji, U.; Bobardt, M.; Russell-Lodrigue, K.E.; Li, J.; Wang, X.; Gallay, P.A. 2016: C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge. Antimicrobial Agents and ChemoTherapy 60(1): 693-698

Wang, R.; Lu, B.; Gerard, C.; Gerard, N.P. 2016: C5L2, the Second C5a Anaphylatoxin Receptor, Suppresses LPS-Induced Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology 55(5): 657-666

Ji, M.; Lu, Y.; Zhao, C.; Gao, W.; He, F.; Zhang, J.; Zhao, D.; Qiu, W.; Wang, Y. 2016: C5a Induces the Synthesis of IL-6 and TNF-α in Rat Glomerular Mesangial Cells through MAPK Signaling Pathways. Plos one 11(9): E0161867

Zhang, T.; Wu, K.Y.; Duan, Z.Y.; Lin, Y.; Gui, B.S.; Liu, D.; Li, K. 2014: C5a Receptor Antagonist Protects Mice from Uropathogenic Escherichia Coli-Induced Kidney Infection. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(7): A811

Mahajan, S.D.; Parikh, N.U.; Woodruff, T.M.; Jarvis, J.N.; Lopez, M.; Hennon, T.; Cunningham, P.; Quigg, R.J.; Schwartz, S.A.; Alexander, J.J. 2015: C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology 146(1): 130-143

Quadros, A.U.; Cunha, T.M. 2016: C5a and pain development: An old molecule, a new target. Pharmacological Research 112: 58-67

Zhu, Y.; Dai, B.; Li, Y.; Peng, H. 2015: C5a and toll-like receptor 4 crosstalk in retinal pigment epithelial cells. Molecular Vision 21: 1122-1129

Mahajan, S.D.; Tutino, V.M.; Redae, Y.; Meng, H.; Siddiqui, A.; Woodruff, T.M.; Jarvis, J.N.; Hennon, T.; Schwartz, S.; Quigg, R.J.; Alexander, J.J. 2016: C5a induces caspase-dependent apoptosis in brain vascular endothelial cells in experimental lupus. Immunology 148(4): 407-419

Tuboly, E.; Futakuchi, M.; Varga, G.; Érces, D.; Tőkés, T.ün.; Mészáros, A.; Kaszaki, J.óz.; Suzui, M.; Imai, M.; Okada, A.; Okada, N.; Boros, M.ál.; Okada, H. 2016: C5a inhibitor protects against ischemia/reperfusion injury in rat small intestine. Microbiology and Immunology 60(1): 35-46

Li, M.-f.; Hu, Y.-h. 2016: C5a of Cynoglossus semilaevis has anaphylatoxin-like properties and promotes antibacterial and antiviral defense. Developmental and Comparative Immunology 60: 139-148

Kaida, T.; Nitta, H.; Kitano, Y.; Yamamura, K.; Arima, K.; Izumi, D.; Higashi, T.; Kurashige, J.; Imai, K.; Hayashi, H.; Iwatsuki, M.; Ishimoto, T.; Hashimoto, D.; Yamashita, Y.; Chikamoto, A.; Imanura, T.; Ishiko, T.; Beppu, T.; Baba, H. 2016: C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA. Oncotarget 7(51): 84798-84809

Hu, W.-H.; Hu, Z.; Shen, X.; Dong, L.-Y.; Zhou, W.-Z.; Yu, X.-X. 2016: C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition. Experimental and Molecular Pathology 100(1): 101-108

Wada, Y.; Maeda, Y.; Kubo, T.; Kikuchi, K.; Eto, M.; Imamura, T. 2016: C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy. Oncology Letters 12(5): 3995-4000

Yuan, B.; Fu, F.; Huang, S.; Lin, C.; Yang, G.; Ma, K.; Shi, H.; Yang, Z. 2017: C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage. Molecular Neurobiology 54(8): 6187-6197

Ehrnthaller, C.; Huber-Lang, M.; Kovtun, A.; Rapp, A.Elise.; Kemmler, J.; Gebhard, F.; Ignatius, A. 2016: C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healing. European Journal of Medical Research 21(1): 42

Maeda, Y.; Kawano, Y.; Wada, Y.; Yatsuda, J.; Motoshima, T.; Murakami, Y.; Kikuchi, K.; Imamura, T.; Eto, M. 2015: C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways. Oncology Reports 33(4): 1844-1850

Chen, J.; Yang, W.-J.; Sun, H.-J.; Yang, X.; Wu, Y.-Z. 2016: C5b-9 Staining Correlates with Clinical and Tumor Stage in Gastric Adenocarcinoma. Applied Immunohistochemistry and Molecular Morphology: Aimm 24(7): 470-475

Braczynski, A.K.; Harter, P.N.; Zeiner, P.S.; Drott, U.; Tews, D.-S.; Preusse, C.; Penski, C.; Dunst, M.; Weis, J.; Stenzel, W.; Mittelbronn, M. 2016: C5b-9 deposits on endomysial capillaries in non-dermatomyositis cases. Neuromuscular Disorders: Nmd 26(4-5): 283-291

Rangan, G.K. 2016: C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria. World Journal of Nephrology 5(3): 288-299

Huang, Q.; Wen, S.; Wang, B.; Wang, Q.; Guo, C.; Wu, X.; Zhang, R.; Yang, R.; Chen, F.; Xiao, W. 2015: C5b-9-targeted molecular MR imaging in rats with Heymann nephritis: a new approach in the evaluation of nephrotic syndrome. Plos one 10(3): E0121244

Muthana, M.; Hawtree, S.; Wilshaw, A.; Linehan, E.; Roberts, H.; Khetan, S.; Adeleke, G.; Wright, F.; Akil, M.; Fearon, U.; Veale, D.; Ciani, B.; Wilson, A.G. 2015: C5orf30 is a negative regulator of tissue damage in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America 112(37): 11618-11623

Gould, T.; Bučko, T.áš 2016: C6 Coefficients and Dipole Polarizabilities for all Atoms and many Ions in Rows 1-6 of the Periodic Table. Journal of Chemical Theory and Computation 12(8): 3603-3613

Xie, H.; Xiao, Z.; Huang, J. 2016: C6 Glioma-Secreted NGF and FGF2 Regulate Neuronal APP Processing Through Up-Regulation of ADAM10 and Down-Regulation of BACE1, Respectively. Journal of Molecular Neuroscience: Mn 59(3): 334-342

Pomelova, V.G.; Korenberg, E.I.; Kuznetsova, T.I.; Bychenkova, T.A.; Bekman, N.I.; Osin, N.S. 2015: C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis. Plos one 10(7): E0130048

Yang, L.; Zheng, L.-Y.; Tian, Y.; Zhang, Z.-Q.; Dong, W.-L.; Wang, X.-F.; Zhang, X.-Y.; Cao, C. 2015: C6 ceramide dramatically enhances docetaxel-induced growth inhibition and apoptosis in cultured breast cancer cells: a mechanism study. Experimental Cell Research 332(1): 47-59

Chen, M.-B.; Jiang, Q.; Liu, Y.-y.; Zhang, Y.; He, B.-s.; Wei, M.-X.; Lu, J.-W.; Ji, Y.; Lu, P.-H. 2015: C6 ceramide dramatically increases vincristine sensitivity both in vivo and in vitro, involving AMP-activated protein kinase-p53 signaling. Carcinogenesis 36(9): 1061-1070

Liu, M.; Gu, P.; Guo, W.; Fan, X. 2016: C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(8): 11039-11048

Ruei, J.-H.; Venukumar, P.; Ingle, A.B.; Mong, K.-K.T. 2015: C6 picoloyl protection: a remote stereodirecting group for 2-deoxy-β-glycoside formation. Chemical Communications 51(25): 5394-5397

Koshiji, K.; Nonaka, Y.; Iwamura, M.; Dai, F.; Matsuoka, R.; Hasegawa, T. 2016: C6-Modifications on chitosan to develop chitosan-based glycopolymers and their lectin-affinities with sigmoidal binding profiles. Carbohydrate Polymers 137: 277-286

Rice, P.A. 2015: C6-Perfluorinated Compounds: the new Greaseproofing Agents in Food Packaging. Current Environmental Health Reports 2(1): 33-40

Das, D.; Biswas, A.; Karmakar, U.; Chand, S.; Samanta, R. 2016: C6-Selective Direct Alkylation of Pyridones with Diazo Compounds under Rh(III)-Catalyzed Mild Conditions. Journal of Organic Chemistry 81(3): 842-848

Boppana, N.B.; Stochaj, U.; Kodiha, M.; Bielawska, A.; Bielawski, J.; Pierce, J.S.; Korbelik, M.; Separovic, D. 2015: C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy. Journal of Photochemistry and Photobiology. B Biology 143: 163-168

Samal, M.; Acharya, S.; Yi, D.K.; Lee, J.-S.; Samal, S. 2015: C60 Cheese Sticks: Supramolecular Architecture of an Amphiphilic Fullerene Pentapod. Journal of Nanoscience and Nanotechnology 15(9): 6847-6851

Wojciechowski, K.; Leijtens, T.; Siprova, S.; Schlueter, C.; Hörantner, M.T.; Wang, J.T.-W.; Li, C.-Z.; Jen, A.K.-Y.; Lee, T.-L.; Snaith, H.J. 2015: C60 as an Efficient n-Type Compact Layer in Perovskite Solar Cells. Journal of Physical Chemistry Letters 6(12): 2399-2405

Mulpur, P.; Podila, R.; Ramamurthy, S.S.; Kamisetti, V.; Rao, A.M. 2015: C60 as an active smart spacer material on silver thin film substrates for enhanced surface plasmon coupled emission. Physical Chemistry Chemical Physics: Pccp 17(15): 10022-10027

Jin, W.; Liu, Q.; Dougherty, D.B.; Cullen, W.G.; Reutt-Robey, J.E.; Weeks, J.; Robey, S.W. 2015: C60 chain phases on ZnPc/Ag(111) surfaces: Supramolecular organization driven by competing interactions. Journal of Chemical Physics 142(10): 101910

Skorkina, M.Y.; Sladkova, E.A.; Shamray, E.A.; Cherkashina, O.V.; Evstigneev, M.P.; Buchelnikov, A.S.; Prylutskyy, Y.I.; Ritter, U. 2015: C60 fullerene affects elastic properties and osmoregulation reactions of human lymphocytes. European Biophysics Journal: Ebj 44(6): 493-498

Prylutska, S.; Grynyuk, I.; Matyshevska, O.; Prylutskyy, Y.; Evstigneev, M.; Scharff, P.; Ritter, U. 2014: C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment. Drugs in R&d 14(4): 333-340

Russ, K.A.; Elvati, P.; Parsonage, T.L.; Dews, A.; Jarvis, J.A.; Ray, M.; Schneider, B.; Smith, P.J.S.; Williamson, P.T.F.; Violi, A.; Philbert, M.A. 2016: C60 fullerene localization and membrane interactions in RAW 264.7 immortalized mouse macrophages. Nanoscale 8(7): 4134-4144

Afanasieva, K.S.; Prylutska, S.V.; Lozovik, A.V.; Bogutska, K.I.; Sivolob, A.V.; Prylutskyy, Y.I.; Ritter, U.; Scharff, P. 2015: C60 fullerene prevents genotoxic effects of doxorubicin in human lymphocytes in vitro. Ukrainian Biochemical Journal 87(1): 91-98

Tiwari, A.J.; Ashraf-Khorassani, M.; Marr, L.C. 2016: C60 fullerenes from combustion of common fuels. Science of the Total Environment 547: 254-260

Bloom, A.N.; Tian, H.; Winograd, N. 2015: C60-SIMS imaging of nanoparticles within mammalian cells. Biointerphases 11(2): 02a306

Lian, Z.; Xu, P.; Wang, W.; Zhang, D.; Xiao, S.; Li, X.; Li, G. 2015: C60-decorated CdS/TiO2 mesoporous architectures with enhanced photostability and photocatalytic activity for H2 evolution. Acs Applied Materials and Interfaces 7(8): 4533-4540

Raza, K.; Thotakura, N.; Kumar, P.; Joshi, M.; Bhushan, S.; Bhatia, A.; Kumar, V.; Malik, R.; Sharma, G.; Guru, S.K.; Katare, O.P. 2015: C60-fullerenes for delivery of docetaxel to breast cancer cells: a promising approach for enhanced efficacy and better pharmacokinetic profile. International Journal of Pharmaceutics 495(1): 551-559

Zhao, D.; Fukuyama, S.; Sakai-Tagawa, Y.; Takashita, E.; Shoemaker, J.E.; Kawaoka, Y. 2015: C646, a Novel p300/CREB-Binding Protein-Specific Inhibitor of Histone Acetyltransferase, Attenuates Influenza a Virus Infection. Antimicrobial Agents and ChemoTherapy 60(3): 1902-1906

Wu, H.; Kong, L.; Tan, Y.; Epstein, P.N.; Zeng, J.; Gu, J.; Liang, G.; Kong, M.; Chen, X.; Miao, L.; Cai, L. 2016: C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21. Diabetologia 59(7): 1558-1568

Alizadeh, S.; Djafarian, K.; Moradi, S.; Shab-Bidar, S. 2016: C667T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene and susceptibility to myocardial infarction: a systematic review and meta-analysis. International Journal of Cardiology 217: 99-108

Romero-Sánchez, C.; Gómez-Gutierrez, A.; Gómez, P.E.; Casas-Gomez, M.C.; Briceño, I. 2015: C677T (RS1801133 ) MTHFR gene polymorphism frequency in a colombian population. Colombia Medica 46(2): 75-79

Di Renzo, L.; Marsella, L.T.; Sarlo, F.; Soldati, L.; Gratteri, S.; Abenavoli, L.; De Lorenzo, A. 2014: C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention. Journal of Translational Medicine 12: 329

Morales de Machín, A.; Méndez, K.; Solís, E.; Borjas de Borjas, L.; Bracho, A.; Hernández, M.ía.L.; Negrón, A.; Delgado, W.; Sánchez, Y. 2015: C677T polymorphism of the methylentetrahydrofolate reductase gene in mothers of children affected with neural tube defects. Investigacion Clinica 56(3): 284-295

Orlovskiy, V.; Kuchma, N.; Murenets, N.; Orlovskiy, A. 2015: C677t and A1298c Allele Polymorphism Gene of Methylenetetrahydrafolatereductase in Patients with Nonalcoholic Fatty Liver Disease and type 2 Diabetes. Georgian Medical News 247: 38-43

Ventura, E.; Cordazzo, C.; Quarto, R.; Zardi, L.; Rosano, C. 2016: C6: a Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8. Plos one 11(2): E0148103

Zhang, X.; Miao, Y.; Yu, X.; Zhang, Y.; Jiang, G.; Liu, Y.; Yu, J.; Han, Q.; Zhao, H.; Wang, E. 2015: C6orf106 enhances NSCLC cell invasion by upregulating vimentin, and downregulating E-cadherin and P120ctn. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 36(8): 5979-5985

Matsubayashi, Y.; Chikuda, H.; Oshima, Y.; Taniguchi, Y.; Fujimoto, Y.; Shimizu, T.; Tanaka, S. 2017: C7 sagittal vertical axis is the determinant of the C5-C7 angle in cervical sagittal alignment. Spine Journal: Official Journal of the North American Spine Society 17(5): 622-626

Kumar, R.; Gleissner, E.H.; Tiu, E.G.V.; Yamakoshi, Y. 2016: C70 as a Photocatalyst for Oxidation of Secondary Benzylamines to Imines. Organic Letters 18(2): 184-187

Rorbach, J.; Gammage, P.A.; Minczuk, M. 2016: C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial ribosome. Nucleic Acids Research 44(2): 992

Cueva, J.Pablo.; Roche, C.; Ostovar, M.; Kumar, V.; Clark, M.J.; Hillhouse, T.M.; Lewis, J.W.; Traynor, J.R.; Husbands, S.M. 2015: C7β-methyl analogues of the orvinols: the discovery of kappa opioid antagonists with nociceptin/orphanin FQ peptide (NOP) receptor partial agonism and low, or zero, efficacy at mu opioid receptors. Journal of Medicinal Chemistry 58(10): 4242-4249

Shi, R.; Lu, L.; Xie, H.; Yan, J.; Xu, T.; Zhang, H.; Qi, X.; Lan, Y.; Lei, A. 2016: C8-H bond activation vs. C2-H bond activation: from naphthyl amines to lactams. Chemical Communications 52(90): 13307-13310

Chen, X.; Cui, X.; Wu, Y. 2016: C8-Selective Acylation of Quinoline N-Oxides with α-Oxocarboxylic Acids via Palladium-Catalyzed Regioselective C-H Bond Activation. Organic Letters 18(15): 3722-3725

Cabezas-Camarero, S.; Sastre, J.; Polidura, Mía.Carmen.; Gómez-Ruíz, Mía.Natividad.; Subhi-Issa, I.; Alonso Lera, P.; Paredes, B.García.; Díaz-Rubio, E. 2016: C8-T1 Radiculopathy Due to an Intradural Extramedullary Metastasis of a Pancreatic Neuroendocrine Tumor: Case Report and Review of the Literature. Pancreas 45(5): 772-779

Cordeiro Pedrosa, L.íl.R.; van Cappellen, W.A.; Steurer, B.; Ciceri, D.; ten Hagen, T.L.M.; Eggermont, A.M.M.; Verheij, M.; Goñi, F.M.ía.; Koning, G.A.; Contreras, F.-X. 2015: C8-glycosphingolipids preferentially insert into tumor cell membranes and promote chemotherapeutic drug uptake. Biochimica et Biophysica Acta 1848(8): 1656-1670

Khan, A.O.; Decker, E.; Bachmann, N.; Bolz, H.J.; Bergmann, C. 2016: C8orf37 is mutated in Bardet-Biedl syndrome and constitutes a locus allelic to non-syndromic retinal dystrophies. Ophthalmic Genetics 37(3): 290-293

Wentrup, C.; Winter, H.-W.; Kvaskoff, D. 2015: C9H8 Pyrolysis. o-Tolylacetylene, Indene, 1-Indenyl, and Biindenyls and the Mechanism of Indene Pyrolysis. Journal of Physical Chemistry. a 119(24): 6370-6376

Fernández Suarez, M.; Surace, E.; Harris, P.; Tapajoz, F.; Sevlever, G.; Allegri, R.; Russo, G.N. 2016: C9ORF72 G4C2-repeat expansion and frontotemporal dementia first reported case in Argentina. Neurocase 22(3): 281-284

Cooper-Knock, J.; Bury, J.J.; Heath, P.R.; Wyles, M.; Higginbottom, A.; Gelsthorpe, C.; Highley, J.R.; Hautbergue, G.; Rattray, M.; Kirby, J.; Shaw, P.J. 2015: C9ORF72 GGGGCC Expanded Repeats Produce Splicing Dysregulation which Correlates with Disease Severity in Amyotrophic Lateral Sclerosis. Plos one 10(5): E0127376

Maharjan, N.; Künzli, C.; Buthey, K.; Saxena, S. 2017: C9ORF72 Regulates Stress Granule Formation and its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress. Molecular Neurobiology 54(4): 3062-3077

Scotter, E.L.; Smyth, L.; Bailey, J.A.W.T.; Wong, C.-H.; de Majo, M.; Vance, C.A.; Synek, B.J.; Turner, C.; Pereira, J.; Charleston, A.; Waldvogel, H.J.; Curtis, M.A.; Dragunow, M.; Shaw, C.E.; Smith, B.N.; Faull, R.L.M. 2017: C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in new Zealand: a genetic and pathologic study using banked human brain tissue. Neurobiology of Aging 49: 214.E1-214.E5

Atkinson, R.A.K.; Fernandez-Martos, C.M.; Atkin, J.D.; Vickers, J.C.; King, A.E. 2015: C9ORF72 expression and cellular localization over mouse development. Acta Neuropathologica Communications 3: 59

Pati, A.R.; Battisti, C.; Battistini, S.; Ricci, C.; Trapassi, A.; Marconi, R.; Mignarri, A.; Federico, A.; Dotti, M.T. 2017: C9ORF72 gene expansion in a patient with intellectual disability and psychiatric disease. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 38(1): 207-208

Abramycheva, N.Y.; Lysogorskaia, E.V.; Stepanova, M.S.; Zakharova, M.N.; Kovrazhkina, E.A.; Razinskaya, O.D.; Smirnov, A.P.; Maltsev, A.V.; Ustyugov, A.A.; Kukharsky, M.S.; Khritankova, I.V.; Bachurin, S.O.; Cooper-Knock, J.; Buchman, V.L.; Illarioshkin, S.N.; Skvortsova, V.I.; Ninkina, N. 2015: C9ORF72 hexanucleotide repeat expansion in ALS patients from the Central European Russia population. Neurobiology of Aging 36(10): 2908.E5-9

Benussi, L.; Rossi, G.; Glionna, M.; Tonoli, E.; Piccoli, E.; Fostinelli, S.; Paterlini, A.; Flocco, R.; Albani, D.; Pantieri, R.; Cereda, C.; Forloni, G.; Tagliavini, F.; Binetti, G.; Ghidoni, R. 2015: C9ORF72 hexanucleotide repeat number in frontotemporal lobar degeneration: a genotype-phenotype correlation study. Journal of Alzheimer's Disease: Jad 45(1): 319

Cannas, A.; Solla, P.; Borghero, G.; Floris, G.L.; Chio, A.; Mascia, M.M.; Modugno, N.; Muroni, A.; Orofino, G.; Di Stefano, F.; Calvo, A.; Moglia, C.; Restagno, G.; Meloni, M.; Farris, R.; Ciaccio, D.; Puddu, R.; Vacca, M.I.; Melis, R.; Murru, M.R.; Tranquilli, S.; Corongiu, D.; Rolesu, M.; Cuccu, S.; Marrosu, M.G.; Marrosu, F. 2015: C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population. Journal of Neurology 262(11): 2498-2503

Corbier, C.; Sellier, C. 2017: C9ORF72 is a GDP/GTP exchange factor for Rab8 and Rab39 and regulates autophagy. Small Gtpases 8(3): 181-186

Hsiao, C.-T.; Tsai, P.-C.; Liao, Y.-C.; Lee, Y.-C.; Soong, B.-W. 2014: C9ORF72 repeat expansion is not a significant cause of late onset cerebellar ataxia syndrome. Journal of the Neurological Sciences 347(1-2): 322-324

He, M.; Yan, W.-Q.; Zeng, S.; Liu, Z.; Zhou, Y.; Zeng, X.-F.; Zeng, J.-S.; Jiang, H.; Shen, L.; Tang, B.-S.; Wang, J.-L. 2016: C9ORF72 repeat expansion is not detected in sporadic ataxia patients in mainland China. Journal of the Neurological Sciences 361: 181-183

Chen, X.; Chen, Y.; Wei, Q.; Ou, R.; Cao, B.; Zhao, B.; Shang, H.-F. 2016: C9ORF72 repeat expansions in Chinese patients with Parkinson's disease and multiple system atrophy. Journal of Neural Transmission 123(11): 1341-1345

Hayes, L.R.; Rothstein, J.D. 2016: C9ORF72-ALS/FTD: Transgenic Mice make a Come-BAC. Neuron 90(3): 427-431

Venkitachalam, A.; Hume, S.; Suchowersky, O. 2014: C9orf 72 Repeat Expansions in Rapid Eye Movement Sleep Disorder. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 41(6): 681-682

Liu, Y.; Pattamatta, A.; Zu, T.; Reid, T.; Bardhi, O.; Borchelt, D.R.; Yachnis, A.T.; Ranum, L.P.W. 2016: C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD. Neuron 90(3): 521-534

O'Rourke, J.G.; Bogdanik, L.; Muhammad, A.K.M.G.; Gendron, T.F.; Kim, K.J.; Austin, A.; Cady, J.; Liu, E.Y.; Zarrow, J.; Grant, S.; Ho, R.; Bell, S.; Carmona, S.; Simpkinson, M.; Lall, D.; Wu, K.; Daughrity, L.; Dickson, D.W.; Harms, M.B.; Petrucelli, L.; Lee, E.B.; Lutz, C.M.; Baloh, R.H. 2015: C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD. Neuron 88(5): 892-901

Lee, K.-H.; Zhang, P.; Kim, H.J.; Mitrea, D.M.; Sarkar, M.; Freibaum, B.D.; Cika, J.; Coughlin, M.; Messing, J.; Molliex, A.; Maxwell, B.A.; Kim, N.C.; Temirov, J.; Moore, J.; Kolaitis, R.-M.; Shaw, T.I.; Bai, B.; Peng, J.; Kriwacki, R.W.; Taylor, J.P. 2016: C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell 167(3): 774-788.E17

Dafinca, R.; Scaber, J.; Ababneh, N.'a.; Lalic, T.; Weir, G.; Christian, H.; Vowles, J.; Douglas, A.G.L.; Fletcher-Jones, A.; Browne, C.; Nakanishi, M.; Turner, M.R.; Wade-Martins, R.; Cowley, S.A.; Talbot, K. 2016: C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Stem Cells 34(8): 2063-2078

Geiger, J.T.; Arthur, K.C.; Dawson, T.M.; Rosenthal, L.S.; Pantelyat, A.; Albert, M.; Hillis, A.E.; Crain, B.; Pletnikova, O.; Troncoso, J.C.; Scholz, S.W. 2016: C9orf72 Hexanucleotide Repeat Analysis in Cases with Pathologically Confirmed Dementia with Lewy Bodies. Neuro-Degenerative Diseases 16(5-6): 370-372

Koppers, M.; Blokhuis, A.M.; Westeneng, H.-J.; Terpstra, M.L.; Zundel, C.A.C.; Vieira de Sá, R.; Schellevis, R.D.; Waite, A.J.; Blake, D.J.; Veldink, J.H.; van den Berg, L.H.; Pasterkamp, R.J. 2015: C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Annals of Neurology 78(3): 426-438

Amick, J.; Roczniak-Ferguson, A.; Ferguson, S.M. 2016: C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling. Molecular Biology of the Cell 27(20): 3040-3051

Rooney, J.; Fogh, I.; Westeneng, H.-J.; Vajda, A.; McLaughlin, R.; Heverin, M.; Jones, A.; van Eijk, R.; Calvo, A.; Mazzini, L.; Shaw, C.; Morrison, K.; Shaw, P.J.; Robberecht, W.; Van Damme, P.; Al-Chalabi, A.; van den Berg, L.; Chiò, A.; Veldink, J.; Hardiman, O. 2017: C9orf72 expansion differentially affects males with spinal onset amyotrophic lateral sclerosis. Journal of Neurology Neurosurgery and Psychiatry 88(4): 281

Sanders, P.; Ewing, I.; Ahmad, K. 2016: C9orf72 expansion presenting as an eating disorder. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 25: 157-159

Rohrer, J.D.; Isaacs, A.M.; Mizielinska, S.; Mead, S.; Lashley, T.; Wray, S.; Sidle, K.; Fratta, P.; Orrell, R.W.; Hardy, J.; Holton, J.; Revesz, T.; Rossor, M.N.; Warren, J.D. 2015: C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. LANCET. Neurology 14(3): 291-301

Sun, Z.; Jiang, H.; Jiao, B.; Hou, X.; Shen, L.; Xia, K.; Tang, B. 2015: C9orf72 hexanucleotide expansion analysis in Chinese patients with multiple system atrophy. Parkinsonism and Related Disorders 21(7): 811-812

He, J.; Tang, L.; Benyamin, B.; Shah, S.; Hemani, G.; Liu, R.; Ye, S.; Liu, X.; Ma, Y.; Zhang, H.; Cremin, K.; Leo, P.; Wray, N.R.; Visscher, P.M.; Xu, H.; Brown, M.A.; Bartlett, P.F.; Mangelsdorf, M.; Fan, D. 2015: C9orf72 hexanucleotide repeat expansions in Chinese sporadic amyotrophic lateral sclerosis. Neurobiology of Aging 36(9): 2660.E1-8

Rizzu, P.; Blauwendraat, C.; Heetveld, S.; Lynes, E.M.; Castillo-Lizardo, M.; Dhingra, A.; Pyz, E.; Hobert, M.; Synofzik, M.; Simón-Sánchez, J.; Francescatto, M.; Heutink, P. 2016: C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers. Acta Neuropathologica Communications 4(1): 37

O'Rourke, J.G.; Bogdanik, L.; Yáñez, A.; Lall, D.; Wolf, A.J.; Muhammad, A.K.M.G.; Ho, R.; Carmona, S.; Vit, J.P.; Zarrow, J.; Kim, K.J.; Bell, S.; Harms, M.B.; Miller, T.M.; Dangler, C.A.; Underhill, D.M.; Goodridge, H.S.; Lutz, C.M.; Baloh, R.H. 2016: C9orf72 is required for proper macrophage and microglial function in mice. Science 351(6279): 1324-1329

Xiao, S.; MacNair, L.; McLean, J.; McGoldrick, P.; McKeever, P.; Soleimani, S.; Keith, J.; Zinman, L.; Rogaeva, E.; Robertson, J. 2016: C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration. Brain Research 1647: 43-49

Marshall, C.R.; Bocchetta, M.; Rohrer, J.D.; Warren, J.D. 2016: C9orf72 mutations and the puzzle of cerebro-cerebellar network degeneration. Brain: a Journal of Neurology 139(Pt 8): E44

Mukherjee, O.; Das, G.; Sen, S.; Dutt, A.; Alladi, S.; Ghosh, A. 2015: C9orf72 mutations may be rare in frontotemporal lobar degeneration patients in India. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17(1-2): 151-153

Webster, C.P.; Smith, E.F.; Grierson, A.J.; De Vos, K.J. 2018: C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy. Small Gtpases 9(5): 399-408

McMillan, C.T.; Russ, J.; Wood, E.M.; Irwin, D.J.; Grossman, M.; McCluskey, L.; Elman, L.; Van Deerlin, V.; Lee, E.B. 2015: C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence. Neurology 84(16): 1622-1630

Esanov, R.; Belle, K.C.; van Blitterswijk, M.; Belzil, V.V.; Rademakers, R.; Dickson, D.W.; Petrucelli, L.; Boylan, K.B.; Dykxhoorn, D.M.; Wuu, J.; Benatar, M.; Wahlestedt, C.; Zeier, Z. 2016: C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells. Experimental Neurology 277: 171-177

Watson, A.; Pribadi, M.; Chowdari, K.; Clifton, S.; Joel Wood; Miller, B.L.; Coppola, G.; Nimgaonkar, V. 2016: C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis. Psychiatry Research 235: 200-202

Tang, B.L. 2016: C9orf72's Interaction with Rab GTPases-Modulation of Membrane Traffic and Autophagy. Frontiers in Cellular Neuroscience 10: 228

Souza, P.V.S.d.; Pinto, W.B.V.d.R.; Oliveira, A.S.B. 2015: C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases. Arquivos de Neuro-Psiquiatria 73(3): 246-256

De la Lanza Espino, G.; Soto, L.A. 2015: C:N:P Molar Ratios, Sources and 14C Dating of Surficial Sediments from the NW Slope of Cuba. Plos one 10(6): E0125562

Wang, L.; Zhao, G.; Li, M.; Zhang, M.; Zhang, L.; Zhang, X.; An, L.; Xu, S. 2015: C:N:P stoichiometry and leaf traits of halophytes in an arid saline environment, northwest China. Plos one 10(3): E0119935

Kucherenko, A.S.; Lisnyak, V.G.; Kostenko, A.A.; Kochetkov, S.V.; Zlotin, S.G. 2016: C2-Symmetric pyrrolidine-derived squaramides as recyclable organocatalysts for asymmetric Michael reactions. Organic and Biomolecular Chemistry 14(41): 9751-9759

Wang, S.; Tholen, D.; Zhu, X.-G. 2017: C4 photosynthesis in C3 rice: a theoretical analysis of biochemical and anatomical factors. Plant Cell and Environment 40(1): 80-94

Bastien, G.; Dron, P.I.; Vincent, M.; Canevet, D.; Allain, M.; Goeb, S.éb.; Sallé, M. 2016: C60 Recognition from Extended Tetrathiafulvalene Bis-acetylide Platinum(II) Complexes. Organic Letters 18(22): 5856-5859

Sun, C.; Wang, L.; Gao, D.; Pan, Y.; Zhao, Y.; Chen, C.; Guo, M. 2016: C60(OH)22: a potential histone deacetylase inhibitor with anti-angiogenic activity. Nanoscale 8(36): 16332-16339

Yuan, B.; Sun, X.; Yan, J.; Xie, Z.; Chen, P.; Zhou, S. 2016: C96H30 tailored single-layer and single-crystalline graphene quantum dots. Physical Chemistry Chemical Physics: Pccp 18(36): 25002-25009

Stiksma, J.; Grootendorst, D.C.; van der Linden, P.W.G. 2014: CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. Clinical Colorectal Cancer 13(4): 239-244

Patel, B.; Heilburn, L.; Khanna, A.; Venkatramanamoorthy, R.; Shields, A.; Philip, P.; Zalupski, M.; El-Rayes, B. 2016: CA 19-9 as a predictor of response and survival in patients with pancreatic cancer treated with gemcitabine and cisplatin based chemotherapy. Journal of Clinical Oncology 23(16_Suppl): 4189-4189

Sagi-Dain, L.; Lavie, O.; Auslander, R.; Sagi, S. 2015: CA 19-9 in evaluation of adnexal mass: retrospective cohort analysis and review of the literature. International Journal of Biological Markers 30(3): E333-E340

Gibor, U.; Perry, Z.H.; Netz, U.; Glazer, Y.; Laufer, L.; Kirshtein, B. 2015: CA 19-9 in the presence of obstructive jaundice due to Mirizzi syndrome. Israel Medical Association Journal: Imaj 17(1): 60-61

Fogelman, D.R.; Schreibman, S.M.; Fine, R.L. 2016: CA 19-9 level predicts response to GTX chemotherapy in pancreatic cancer. Journal of Clinical Oncology 23(16_Suppl): 4206-4206

Scarà, S.; Bottoni, P.; Scatena, R. 2015: CA 19-9: Biochemical and Clinical Aspects. Advances in Experimental Medicine and Biology 867: 247-260

Chu, C.-Y.; Jin, Y.-T.; Zhang, W.; Yu, J.; Yang, H.-P.; Wang, H.-Y.; Zhang, Z.-J.; Liu, X.-P.; Zou, Q. 2016: CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer. International Journal of Oncology 48(1): 271-280

Supuran, C.T. 2016: CA IX stratification based on cancer treatment: a patent evaluation of US2016/0002350. Expert Opinion on Therapeutic Patents 26(10): 1105-1109

Vasington, F.D.; Greenawalt, J.W. 1964: Ca++ and P(I) Uptake by Non-Phosphorylating Mitochondrial Preparations. Biochemical and Biophysical Research Communications 15(2): 133-138

Patel, N.; Nizami, S.; Song, L.; Mikami, M.; Hsu, A.; Hickernell, T.; Chandhanayingyong, C.; Rho, S.; Compton, J.T.; Caldwell, J.-M.; Kaiser, P.B.; Bai, H.; Lee, H.G.; Fischer, C.R.; Lee, F.Y. 2015: CA-074Me compound inhibits osteoclastogenesis via suppression of the NFATc1 and c-FOS signaling pathways. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 33(10): 1474-1486

Sarkar, R.; Paul, R.; Pandey, R.; Thakur, I.; Mondal, J.; Sau, T.J. 2016: CA-125 Testing in Females with Ascites: a Red Herring. Journal of the Association of Physicians of India 64(8): 105

Burki, T.K. 2015: CA-125 blood test in early detection of ovarian cancer. LANCET. Oncology 16(6): E269

Boota, M.; Schinke, C.; Ledoux, S.; Alapat, D.; Khan, R.; Barlogie, B. 2016: CA-125 secreting IgG kappa multiple myeloma. American Journal of Hematology 91(10): E457-E458

Coppin, L.; Benomar, K.; Corfiotti, Fçois.; Cattan, Séphane.; Renaud, F.; Lapere, C.; Leteurtre, E.; Vantyghem, M-Christine.; Truant, Séphanie.; Pigny, P. 2016: CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases. Pancreatology: Official Journal of the International Association of Pancreatology . 16(1): 115-120

Han, F.; Wang, P.; Zhang, W.; Li, J.; Zhang, Q.; Qi, X.; Liu, M. 2016: CA-1H, a novel oxazole bearing analogue of combretastatin A-4, disrupts the tumor vasculatures and inhibits the tumor growth via inhibiting tubulin polymerization. Biomedicine and PharmacoTherapy 80: 151-161

Tidwell, J.; Kirk, L.; Luttrell, T.; Pike, C.A. 2016: CA-MRSA Decolonization Strategies: Do They Reduce Recurrence Rate?. Journal of Wound Ostomy and Continence Nursing: Official Publication of Wound Ostomy and Continence Nurses Society 43(6): 577-582

Braun, T.; Kahanov, L.; Dannelly, K.; Lauber, C. 2016: CA-MRSA Infection Incidence and Care in High School and Intercollegiate Athletics. Medicine and Science in Sports and Exercise 48(8): 1530-1538

Jarząbek, T.; Rucińska, M.; Rogowski, W.; Lewandowska, M.; Tujakowski, J.; Habib, M.; Kowalczyk, A.; Byszek, A.; Dziadziuszko, R.ł; Nawrocki, S. 2015: CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors who Develop Acneiform Rash Associated with the use of Cetuximab. Molecular Diagnosis and Therapy 19(2): 79-89

Zheng, Y.; Xu, B.; Zhao, Y.; Gu, H.; Li, C.; Wang, Y.; Chang, X. 2015: CA1 contributes to microcalcification and tumourigenesis in breast cancer. Bmc Cancer 15: 679

Hirsch, S.J.; Regmi, N.L.; Birnbaum, S.G.; Greene, R.W. 2015: CA1-specific deletion of NMDA receptors induces abnormal renewal of a learned fear response. Hippocampus 25(11): 1374-1379

Kanaan, Z.; Antaki, F. 2016: CA11-19: a promising marker for the detection of colorectal cancer. Gastrointestinal Endoscopy 84(4): 753-754

Overholt, B.F.; Wheeler, D.J.; Jordan, T.; Fritsche, H.A. 2016: CA11-19: a tumor marker for the detection of colorectal cancer. Gastrointestinal Endoscopy 83(3): 545-551

Zhao, T.; Hu, W. 2016: CA125 and HE4: Measurement Tools for Ovarian Cancer. Gynecologic and Obstetric Investigation 81(5): 430-435

Menczer, J.; Schreiber, L.; Berger, E.; Ben-Shem, E.; Golan, A.; Levy, T. 2014: CA125 expression in the tissue of uterine leiomyosarcoma. Israel Medical Association Journal: Imaj 16(11): 697-699

Tanabe, H.; Katsumata, N.; Matsumoto, K.; Nishio, S.; Kato, Y.; Yonemori, K.; Kouno, T.; Shimizu, C.; Ando, M.; Fujiwara, Y. 2016: CA125 nadir as a prognostic factor in advanced ovarian carcinoma: A retrospective study of 84 patients achieving clinical CR. Journal of Clinical Oncology 24(18_Suppl): 5060-5060

Colloca, G.; Venturino, A.; Governato, I. 2016: CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 18(8): 813-824

Tang, S.; Wei, L.; Sun, Y.; Zhou, F.; Zhu, S.; Yang, R.; Huang, Y.; Zhang, H.; Xu, H.; Yang, J. 2016: CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: a Meta Analysis. Plos one 11(9): E0163030

Williams, J.L.; Kadera, B.E.; Nguyen, A.H.; Muthusamy, V.R.; Wainberg, Z.A.; Hines, O.J.; Reber, H.A.; Donahue, T.R. 2016: CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 20(7): 1331-1342

Chiorean, E.G.; Von Hoff, D.D.; Reni, M.; Arena, F.P.; Infante, J.R.; Bathini, V.G.; Wood, T.E.; Mainwaring, P.N.; Muldoon, R.T.; Clingan, P.R.; Kunzmann, V.; Ramanathan, R.K.; Tabernero, J.; Goldstein, D.; McGovern, D.; Lu, B.; Ko, A. 2016: CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase IIi trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 27(4): 654-660

Jagric, T.; Potrc, S.; Mis, K.; Plankl, M.; Mars, T. 2016: CA19-9 serum levels predict micrometastases in patients with gastric cancer. Radiology and Oncology 50(2): 204-211

Luo, G.; Liu, C.; Guo, M.; Long, J.; Liu, Z.; Xiao, Z.; Jin, K.; Cheng, H.; Lu, Y.; Ni, Q.; Yu, X. 2017: CA19-9-Low&Lewis (+) pancreatic cancer: a unique subtype. Cancer Letters 385: 46-50

Colloca, G.; Venturino, A.; Guarneri, D. 2016: CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience. Medical Oncology 33(9): 103

Rack, B.; Jückstock, J.; Trapp, E.; Weissenbacher, T.; Alunni-Fabbroni, M.; Schramm, A.; Widschwendter, P.; Lato, K.; Zwingers, T.; Lorenz, R.; Tesch, H.; Schneeweiss, A.; Fasching, P.; Mahner, S.; Beckmann, M.W.; Lichtenegger, W.; Janni, W. 2016: CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(10): 13769-13775

Navratilova, Z.; Battaglia, F.P. 2015: CA2: it's about time-and episodes. Neuron 85(1): 8-10

Yu, L.M.Y.; Polygalov, D.; Wintzer, M.E.; Chiang, M.-C.; McHugh, T.J. 2016: CA3 Synaptic Silencing Attenuates Kainic Acid-Induced Seizures and Hippocampal Network Oscillations. Eneuro 3(1)

Liu, P.; Zhu, Y.; Liu, L. 2015: CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma. International Journal of Clinical and Experimental Pathology 8(11): 15112-15117

Li, G.; Feng, G.; Zhao, A.; Péoc'h, M.; Cottier, Mèle.; Mottet, N. 2017: CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma. Biomarkers: Biochemical Indicators of Exposure Response and Susceptibility to Chemicals 22(2): 123-126

Gu, M. 2015: CA9 overexpression is an independent favorable prognostic marker in intrahepatic cholangiocarcinoma. International Journal of Clinical and Experimental Pathology 8(1): 862-866

Voith, V.L. 2015: CAABs lend helping hand. Journal of the American Veterinary Medical Association 247(10): 1093

Terashi, G.; Takeda-Shitaka, M. 2015: CAB-Align: a Flexible Protein Structure Alignment Method Based on the Residue-Residue Contact Area. Plos one 10(10): E0141440

Kawashima, A.; Kigoshi, T.; Katoh, Y.; Ishikawa, Y.; Shawki, H.H.; Inoue, N.; Tamba, M.; Matsuda, M.; Okamura, N. 2016: CABCOCO1, a novel coiled-coil protein with calcium-binding activity, is localized in the sperm flagellum. Molecular Reproduction and Development 83(10): 912-926

Philip, F.; Southard, J.A. 2016: CABG Versus PCI: Are all Revascularization Strategies Created Equal?. Journal of the American College of Cardiology 67(12): 1503-1504

Habib, R.H.; Dimitrova, K.R.; Badour, S.A.; Yammine, M.B.; El-Hage-Sleiman, A.-K.M.; Hoffman, D.M.; Geller, C.M.; Schwann, T.A.; Tranbaugh, R.F. 2015: CABG Versus PCI: Greater Benefit in Long-Term Outcomes with Multiple Arterial Bypass Grafting. Journal of the American College of Cardiology 66(13): 1417-1427

Boden, W.E.; Mancini, G.B.J. 2016: CABG for Complex CAD: when will Evidence-Based Practice Align with Evidence-Based Medicine?. Journal of the American College of Cardiology 67(1): 56-58

Yuzaki, M.; Okamura, Y. 2016: CABG for patients with COPD. Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl 4 Pt 1: 506-510

Motomura, N.; Saito, A. 2016: CABG in NCD/JACVSD. Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl 4 Pt 1: 446-451

Rigatto, C.; Komenda, P.; Tangri, N. 2016: CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?. Kidney International 90(2): 257-259

Kappetein, A.P.; Head, S.J. 2015: CABG, stents, or hybrid procedures for left main disease?. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 11 Suppl V: V111-V114

Mier, P.; Andrade-Navarro, M.A. 2016: CABRA: Cluster and Annotate Blast Results Algorithm. Bmc Research Notes 9: 253

Kurcinski, M.; Jamroz, M.; Blaszczyk, M.; Kolinski, A.; Kmiecik, S. 2015: CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Research 43(W1): W419-W424

Young, S.A.M.; Miyata, H.; Satouh, Y.; Aitken, R.J.; Baker, M.A.; Ikawa, M. 2016: CABYR is essential for fibrous sheath integrity and progressive motility in mouse spermatozoa. Journal of Cell Science 129(23): 4379-4387

Paroni, A.; Graudenzi, A.; Caravagna, G.; Damiani, C.; Mauri, G.; Antoniotti, M. 2016: CABeRNET: a Cytoscape app for augmented Boolean models of gene regulatory NETworks. Bmc Bioinformatics 17: 64

Mahabadi, A.A.; Möhlenkamp, S.; Lehmann, N.; Kälsch, H.; Dykun, I.; Pundt, N.; Moebus, S.; Jöckel, K-Heinz.; Erbel, R. 2017: CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines. JACC. Cardiovascular imaging 10(2): 143-153

Darabian, S.; Luo, Y.; Homat, A.; Khosraviani, K.; Wong, N.; Zeb, I.; Nasir, K.; Budoff, M.J. 2015: CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis. Coronary Artery Disease 26(8): 678-685

Cecchetelli, A.D.; Hugunin, J.; Tannoury, H.; Cram, E.J. 2016: CACN-1 is required in the Caenorhabditis elegans somatic gonad for proper oocyte development. Developmental Biology 414(1): 58-71

Uemura, T.; Green, M.; Warsh, J.J. 2016: CACNA1C SNP rs1006737 associates with bipolar i disorder independent of the Bcl-2 SNP rs956572 variant and its associated effect on intracellular calcium homeostasis. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 17(7): 525-534

Porcelli, S.; Lee, S.-J.; Han, C.; Patkar, A.A.; Serretti, A.; Pae, C.-U. 2015: CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study. Psychiatric Genetics 25(4): 163-167

Jakobsson, J.; Pålsson, E.; Sellgren, C.; Rydberg, F.; Ekman, A.; Zetterberg, H.; Blennow, K.; Landén, M. 2016: CACNA1C polymorphism and altered phosphorylation of tau in bipolar disorder. British Journal of Psychiatry: the Journal of Mental Science 208(2): 195-196

Lancaster, T.M.; Foley, S.; Tansey, K.E.; Linden, D.E.J.; Caseras, X. 2016: CACNA1C risk variant is associated with increased amygdala volume. European Archives of Psychiatry and Clinical Neuroscience 266(3): 269-275

Ou, X.; Crane, D.E.; MacIntosh, B.J.; Young, L.T.; Arnold, P.; Ameis, S.; Goldstein, B.I. 2015: CACNA1C rs1006737 genotype and bipolar disorder: Focus on intermediate phenotypes and cardiovascular comorbidity. Neuroscience and Biobehavioral Reviews 55: 198-210

Pinggera, A.; Lieb, A.; Benedetti, B.; Lampert, M.; Monteleone, S.; Liedl, K.R.; Tuluc, P.; Striessnig, J.ör. 2015: CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biological Psychiatry 77(9): 816-822

Daniil, G.; Fernandes-Rosa, F.L.; Chemin, J.; Blesneac, I.; Beltrand, J.; Polak, M.; Jeunemaitre, X.; Boulkroun, S.; Amar, L.; Strom, T.M.; Lory, P.; Zennaro, M.-C. 2016: CACNA1H Mutations Are Associated with Different Forms of Primary Aldosteronism. Ebiomedicine 13: 225-236

Rzhepetskyy, Y.; Lazniewska, J.; Blesneac, I.; Pamphlett, R.; Weiss, N. 2016: CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing. Channels 10(6): 466-477

Reimer, E.N.; Walenda, G.; Seidel, E.; Scholl, U.I. 2016: CACNA1H(M1549V) Mutant Calcium Channel Causes Autonomous Aldosterone Production in HAC15 Cells and Is Inhibited by Mibefradil. Endocrinology 157(8): 3016-3022

Hasan, N.; Ray, T.A.; Gregg, R.G. 2016: CACNA1S expression in mouse retina: Novel isoforms and antibody cross-reactivity with GPR179. Visual Neuroscience 33: E009

Jin, Y.; Cui, D.; Ren, J.; Wang, K.; Zeng, T.; Gao, L. 2017: CACNA2D3 is downregulated in gliomas and functions as a tumor suppressor. Molecular Carcinogenesis 56(3): 945-959

Aadil, F.; Bajwa, K.B.; Khan, S.; Chaudary, N.M.; Akram, A. 2016: CACONET: Ant Colony Optimization (ACO) Based Clustering Algorithm for VANET. Plos one 11(5): E0154080

Bavishi, C.; Argulian, E.; Chatterjee, S.; Rozanski, A. 2016: CACS and the Frequency of Stress-Induced Myocardial Ischemia During MPI: a Meta-Analysis. JACC. Cardiovascular Imaging 9(5): 580-589

Yan, F.; Di, S.; Takahashi, R. 2015: CACTA-superfamily transposable element is inserted in MYB transcription factor gene of soybean line producing variegated seeds. Genome 58(8): 365-374

Choi, H.; Lee, S.H.; Um, S.-J.; Kim, E.-J. 2016: CACUL1 functions as a negative regulator of androgen receptor in prostate cancer cells. Cancer Letters 376(2): 360-366

Fukuda, T.; Kigoshi-Tansho, Y.; Naganuma, T.; Kazaana, A.; Okajima, T.; Tsuruta, F.; Chiba, T. 2017: CACUL1/CAC1 attenuates p53 activity through PML post-translational modification. Biochemical and Biophysical Research Communications 482(4): 863-869

Luo, X.; Yang, B.; Sheng, L.; Chen, J.; Li, H.; Xie, L.; Chen, G.; Yu, M.; Guo, W.; Tian, W. 2015: CAD based design sensitivity analysis and shape optimization of scaffolds for bio-root regeneration in swine. Biomaterials 57: 59-72

Stefanini, G.G.; Panico, C. 2015: CAD in TAVi patients: relevance of disease complexity. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 11(4): 373-375

AlHelal, A.; AlBader, B.; Kattadiyil, M.T.; Garbacea, A.; Proussaefs, P. 2017: CAD-CAM implant-supported fixed complete dental prosthesis with titanium milled molars: A clinical report. Journal of Prosthetic Dentistry 117(4): 463-469

Wu, W.; Zhao, Z.; Shen, B.; Zhai, J.; Song, S.; Song, Z. 2018: Crystallization characteristic and scaling behavior of germanium antimony thin films for phase change memory. Nanoscale 10(15): 7228-7237

Chandrashekhar, Y.; Min, J.K.; Hecht, H.; Narula, J. 2016: CAD-RADS: a Giant first Step Toward a Common Lexicon?. JACC. Cardiovascular Imaging 9(9): 1125-1129

Liu, P.; Lv, S.; Chen, X.; Tang, J.; Li, J.; Zhou, S. 2018: Crystallization control toward colorless cerium-doped scintillating glass. Optics Express 26(16): 20582-20589

Antonaya-Martin, J.L.; Del Rio-Highsmith, J.; Moreno-Hay, I.; Lillo-Rodríguez, J.C.; Gomez-Polo, M.A.; Celemin-Viñuela, A. 2016: CAD/CAM Conic Crowns for Predictable Retention in Implant-Supported Prostheses. International Journal of Prosthodontics 29(3): 230-232

Bilgin, M.Selim.; Erdem, A.; Tanrıver, M. 2016: CAD/CAM Endocrown Fabrication from a Polymer-Infiltrated Ceramic Network Block for Primary Molar: A Case Report. Journal of Clinical Pediatric Dentistry 40(4): 264-268

Baumgarten, H.S.; Wunsche, A. 2015: CAD/CAM Fabrication of Definitive Implant Prostheses: a Digital Workflow from Planning to Implant Placement to Final Restoration. Compendium of Continuing Education in Dentistry 36(10): 746-755

Güth, J.-F.; Edelhoff, D.; Goldberg, J.; Magne, P. 2016: CAD/CAM Polymer vs Direct Composite Resin Core Buildups for Endodontically Treated Molars Without Ferrule. Operative Dentistry 41(1): 53-63

Guess Gierthmuehlen, P.C.; Steger, E. 2016: CAD/CAM Solutions for Minimally Invasive All-Ceramic Rehabilitation of Extended Erosive Lesions. Compendium of Continuing Education in Dentistry 37(5): 340-345

Srinivasan, M.; Cantin, Y.; Mehl, A.; Gjengedal, H.; Müller, F.; Schimmel, M. 2017: CAD/CAM milled removable complete dentures: an in vitro evaluation of trueness. Clinical Oral Investigations 21(6): 2007-2019

Vailati, F.; Carciofo, S. 2016: CAD/CAM monolithic restorations and full-mouth adhesive rehabilitation to restore a patient with a past history of bulimia: the modified three-step technique. International Journal of Esthetic Dentistry 11(1): 36-56

Zheng, Y.; Lu, B.; Zhang, J.; Wu, G. 2015: CAD/CAM silicone simulator for teaching cheiloplasty: description of the technique. British Journal of Oral and Maxillofacial Surgery 53(2): 194-196

Tominaga, K.; Habu, M.; Tsurushima, H.; Takahashi, O.; Yoshioka, I. 2016: CAD/CAM splint based on soft tissue 3D simulation for treatment of facial asymmetry. Maxillofacial Plastic and Reconstructive Surgery 38(1): 4

Chervin, C.N.; Parker, J.F.; Nelson, E.S.; Rolison, D.R.; Long, J.W. 2016: CAD/CAM-designed 3D-printed electroanalytical cell for the evaluation of nanostructured gas-diffusion electrodes. Nanotechnology 27(17): 174002

Patzelt, S.B.M.; Spies, B.C.; Kohal, R.J. 2015: CAD/CAM-fabricated implant-supported restorations: a systematic review. Clinical Oral Implants Research 26(Suppl 11): 77-85

Lee, D.-H. 2015: CAD/CAM-fabricated template for locating implant abutment screws in cement-retained anatomic zirconia restorations. Journal of Prosthetic Dentistry 114(3): 343-345

Augimeri, A.; Cherubini, A.; Cascini, G.L.; Galea, D.; Caligiuri, M.E.; Barbagallo, G.; Arabia, G.; Quattrone, A. 2016: CADA-computer-aided DaTSCAN analysis. Ejnmmi Physics 3(1): 4

Ando, T.; Goto, Y.; Mano, K.; Ueda, A.; Ando, Y.; Mizuta, I.; Mizuno, T. 2016: CADASIL Presenting as Acute Bilateral Multiple Subcortical Infarcts without a Characteristic Temporal Pole or Any External Capsule Lesions. Internal Medicine 55(19): 2873-2876

Carone, D.A. 2017: CADASIL and multiple sclerosis: A case report of prolonged misdiagnosis. Applied Neuropsychology. Adult 24(3): 294-297

Joshi, S.; Yau, W.; Kermode, A. 2017: CADASIL mimicking multiple sclerosis: the importance of clinical and MRi red flags. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 35: 75-77

Ho, C.S.H.; Mondry, A. 2015: CADASIL presenting as schizophreniform organic psychosis. General Hospital Psychiatry 37(3): 273.E11-13

Koutroulou, I.; Karapanayiotides, T.; Grigoriadis, N.; Karacostas, D. 2016: CADASIL presenting with spontaneous intracerebral hemorrhage: report of a case and description of the first family in Northern Greece. Hippokratia 20(1): 76-79

Williams, D.S. 2014: CADASIL syndrome. Journal of Insurance Medicine 44(2): 127-129

Sangle, N.; Baringer, J.Richard.; Majersik, J.; DeWitt, L.Dana. 2016: CADASIL with Multiorgan Involvement: a Complete Autopsy Examination Report. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 43(1): 202-205

Ozaki, K.; Irioka, T.; Ishikawa, K.; Mizusawa, H. 2015: CADASIL with a novel NOTCH3 mutation (Cys478Tyr). Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association 24(3): E61-E62

Haffner, C.; Vinters, H.V. 2016: CADASIL, CARASIL, CARASAL: the linguistic subtleties of cerebral small vessel disease. Neurology 87(17): 1752-1753

Zhu, S.; Nahas, S.J. 2016: CADASIL: Imaging Characteristics and Clinical Correlation. Current Pain and Headache Reports 20(10): 57

Samões, R.; Alves, Jé.Eduardo.; Taipa, R.; Silva, Jão.; Melo Pires, M.; Pereira-Monteiro, Jé.Maria. 2016: CADASIL: MRI may be normal in the fourth decade of life - a case report. Cephalalgia: An International Journal of Headache 36(11): 1082-1085

Tan, R.Y.Y.; Markus, H.S. 2016: CADASIL: Migraine, Encephalopathy, Stroke and their Inter-Relationships. Plos one 11(6): E0157613

Bhhatarai, B.; Teetz, W.; Liu, T.; Öberg, T.; Jeliazkova, N.; Kochev, N.; Pukalov, O.; Tetko, I.V.; Kovarich, S.; Papa, E.; Gramatica, P. 2011: CADASTER QSPR Models for Predictions of Melting and Boiling Points of Perfluorinated Chemicals. Molecular Informatics 30(2-3): 189-204

Aslantas, A.; Dandil, E.; Saǧlam, S.; Çakiroǧlu, M. 2016: CADBOSS: a computer-aided diagnosis system for whole-body bone scintigraphy scans. Journal of Cancer Research and Therapeutics 12(2): 787-792

Ambure, P.; Roy, K. 2017: CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease. Current Drug Targets 18(5): 522-533

Gilbert, F.J.; Astley, S.M.; Gillan, M.G.; Agbaje, O.F.; Wallis, M.G.; James, J.; Boggis, C.R.; Duffy, S.W. 2016: CADET II: A prospective trial of computer-aided detection (CAD) in the UK Breast Screening Programme. Journal of Clinical Oncology 26(15_Suppl): 508-508

Kasner, S.E. 2015: CADISS: a feasibility trial that answered its question. Lancet. Neurology 14(4): 342-343

Van Baars, R.; van der Marel, J.; Snijders, P.J.F.; Rodriquez-Manfredi, A.; ter Harmsel, B.; van den Munckhof, H.A.M.; Ordi, J.; del Pino, M.; van de Sandt, M.M.; Wentzensen, N.; Meijer, C.J.L.M.; Quint, W.G.V. 2016: CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies. International Journal of Cancer 138(2): 463-471

Zhang, W.; Xie, H.-Y.; Ding, S.-M.; Xing, C.-Y.; Chen, A.; Lai, M.-C.; Zhou, L.; Zheng, S.-S. 2016: CADM1 regulates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 15(3): 289-296

Manivannan, K.; Rowan, A.G.; Tanaka, Y.; Taylor, G.P.; Bangham, C.R.M. 2016: CADM1/TSLC1 Identifies HTLV-1-Infected Cells and Determines their Susceptibility to CTL-Mediated Lysis. Plos Pathogens 12(4): E1005560

Kostal, J.; Voutchkova-Kostal, A. 2016: CADRE-SS, an in Silico Tool for Predicting Skin Sensitization Potential Based on Modeling of Molecular Interactions. Chemical Research in Toxicology 29(1): 58-64

Malhotra, R.; Ziahosseini, K.; Litwin, A.; Nduka, C.; El-Shammah, N. 2016: CADS grading scale: towards better grading of ophthalmic involvement in facial nerve paralysis. British Journal of Ophthalmology 100(6): 866-870

Calder, L.A.; Abu-Laban, R.B.; Artz, J.D.; McLeod, S.; Blackie, B.; Das, B.; Woods, R.; Perry, J.J.; Vaillancourt, C.; Stiell, I.G.; Frank, J.R. 2015: CAEP 2014 Academic Symposium: "How to make research succeed in your department: Promoting excellence in Canadian emergency medicine resident research". CJEM 17(5): 591-599

Perry, J.J.; Snider, C.E.; Artz, J.D.; Stiell, I.G.; Shaeri, S.; McLeod, S.; Le Sage, N.; Hohl, C.; Calder, L.A.; Vaillancourt, C.; Holroyd, B.; Hollander, J.E.; Morrison, L.J. 2015: CAEP 2014 Academic Symposium: "How to make research succeed in your emergency department: How to develop and train career researchers in emergency medicine". Cjem 17(3): 334-343

Vaillancourt, C.; Rowe, B.H.; Artz, J.D.; Green, R.; Émond, M.; Thiruganasambandamoorthy, V.; Innes, G.; Perry, J.J.; Calder, L.A.; Stiell, I.G. 2015: CAEP 2014 Academic symposium: "How to make research succeed in your department: How to fund your research program". Cjem 17(4): 453-461

Lang, E.S.; Artz, J.D.; Wilkie, R.D.; Stiell, I.G.; Topping, C.; Belanger, Fçois.P.; Afilalo, M.; Renouf, T.; Crocco, A.; Wyatt, K.; Christenson, J. 2016: CAEP 2015 Academic Symposium: Current State and Recommendations to Achieve Adequate and Sustainable Funding for Emergency Medicine Academic Units. Cjem 18 Suppl. 1: S10-S17

Sinclair, D.; Worthington, J.R.; Joubert, G.; Holroyd, B.R.; Stempien, J.; Letovsky, E.; Rutledge, T.; LeBlanc, C.; Pitters, C.; McCallum, A.; Carr, B.; Gerace, R.; Stiell, I.G.; Artz, J.D.; Christenson, J. 2016: CAEP 2015 Academic Symposium: Leadership within the emergency medicine academic community and beyond. Cjem 18 Suppl. 1: S1-S9

Petrie, D.; Chopra, A.; Chochinov, A.; Artz, J.D.; Schull, M.; Tallon, J.; Jones, G.; MacPhee, S.; Ackerman, M.; Stiell, I.G.; Christenson, J. 2016: CAEP 2015 Academic Symposium: Recommendations for University Governance and Administration for Emergency Medicine. Cjem 2016: 1-8

Botnaru, T.; Bova, C.; Artz, J.D.; Kuuskne, M. 2016: CAEP Residents' Section: A Unified Voice for Canadian Emergency Medicine Trainees. CJEM 18(2): 146-148

Kentish-Barnes, N.; Seegers, V.ér.; Legriel, S.ép.; Cariou, A.; Jaber, S.; Lefrant, J.-Y.; Floccard, B.; Renault, A.; Vinatier, I.; Mathonnet, A.; Reuter, D.; Guisset, O.; Cracco, C.; Seguin, A.él.; Durand-Gasselin, J.; Éon, B.éa.; Thirion, M.; Rigaud, J.-P.; Philippon-Jouve, B.én.éd.; Argaud, L.; Chouquer, R.; Adda, M.él.; Papazian, L.; Dedrie, C.él.; Georges, H.; Lebas, E.; Rolin, N.; Bollaert, P.-E.; Lecuyer, L.; Viquesnel, G.ér.; Léone, M.; Chalumeau-Lemoine, L.; Cohen-Solal, Z.é; Garrouste-Orgeas, M.é; Tamion, F.; Falissard, B.; Chevret, S.; Azoulay, E. 2016: CAESAR: a new tool to assess relatives' experience of dying and death in the ICU. Intensive Care Medicine 42(6): 995-1002

Fernández-Jiménez, R.; Ibanez, B. 2015: CAESAR: one step beyond in the construction of a translational bridge for cardioprotection. Circulation Research 116(4): 554-556

Roy, A.; Bera, S. 2016: CAF cellular glycolysis: linking cancer cells with the microenvironment. Tumour Biology: the Journal of the International Society for Oncodevelopmental Biology and Medicine 37(7): 8503-8514

Yeung, T-Lun.; Leung, C.S.; Mok, S.C. 2014: CAF reprogramming inhibits ovarian cancer progression. Cell Cycle 13(24): 3783-3784

Etzold, A.; Galetzka, D.; Weis, E.; Bartsch, O.; Haaf, T.; Spix, C.; Itzel, T.; Schweiger, S.; Strand, D.; Strand, S.; Zechner, U. 2016: CAF-like state in primary skin fibroblasts with constitutional BRCA1 epimutation sheds new light on tumor suppressor deficiency-related changes in healthy tissue. Epigenetics 11(2): 120-131

Busch, S.; Landberg, G.ör. 2015: CAF-specific markers: role of the TGFβ pathway. Oncoscience 2(10): 835-836

Shi, J.-X.; Li, J.-S.; Hu, R.; Li, X.-M.; Wang, H. 2016: CAF1-knockout mice are more susceptive to lipopolysaccharide-induced acute lung injury. Journal of Inflammation Research 9: 115-121

Komohara, Y.; Takeya, M. 2017: CAFs and TAMs: maestros of the tumour microenvironment. Journal of Pathology 241(3): 313-315

Minhas, F.U.A.A.; Asif, A.; Arif, M. 2016: CAFÉ-Map: Context Aware Feature Mapping for mining high dimensional biomedical data. Computers in Biology and Medicine 79: 68-79

Yoong, S.Lin.; Nathan, N.; Wolfenden, L.; Wiggers, J.; Reilly, K.; Oldmeadow, C.; Wyse, R.; Sutherland, R.; Delaney, T.; Butler, P.; Janssen, L.; Preece, S.; Williams, C.M. 2016: CAFÉ: a multicomponent audit and feedback intervention to improve implementation of healthy food policy in primary school canteens: a randomised controlled trial. International Journal of Behavioral Nutrition and Physical Activity 13(1): 126

Williams, C.M.; Nathan, N.; Delaney, T.; Yoong, S.Lin.; Wiggers, J.; Preece, S.; Lubans, N.; Sutherland, R.; Pinfold, J.; Smith, K.; Small, T.; Reilly, K.L.; Butler, P.; Wyse, R.J.; Wolfenden, L. 2015: CAFÉ: a multicomponent audit and feedback intervention to improve implementation of healthy food policy in primary school canteens: protocol of a randomised controlled trial. Bmj Open 5(6): E006969

Zurawel, A.A.; Kabeche, R.; DiGregorio, S.E.; Deng, L.; Menon, K.M.; Opalko, H.; Duennwald, M.L.; Moseley, J.B.; Supattapone, S. 2016: CAG Expansions Are Genetically Stable and Form Nontoxic Aggregates in Cells Lacking Endogenous Polyglutamine Proteins. Mbio 7(5)

Huang, S.-R.; Wu, Y.-T.; Jao, C.-W.; Soong, B.-W.; Lirng, J.-F.; Wu, H.-M.; Wang, P.-S. 2017: CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3. NEUROIMAGE. Clinical 13: 97-105

Mao, Q.; Qiu, M.; Dong, G.; Xia, W.; Zhang, S.; Xu, Y.; Wang, J.; Rong, Y.; Xu, L.; Jiang, F. 2015: CAG repeat polymorphisms in the androgen receptor and breast cancer risk in women: a meta-analysis of 17 studies. Oncotargets and Therapy 8: 2111-2120

Zhang, J.; Jiang, W.; Zhou, Q.; Ni, M.; Liu, S.; Zhu, P.; Wu, Q.; Li, W.; Zhang, M.; Xia, X. 2016: CAG-repeat polymorphisms in the polymerase γ gene and male infertility: a meta-analysis. Andrologia 48(9): 882-889

Hashimoto, K.; Suzuki, A.M.; Dos Santos, A.; Desterke, C.; Collino, A.; Ghisletti, S.; Braun, E.; Bonetti, A.; Fort, A.; Qin, X.-Y.; Radaelli, E.; Kaczkowski, B.; Forrest, A.R.R.; Kojima, S.; Samuel, D.; Natoli, G.; Buendia, M.A.; Faivre, J.; Carninci, P. 2015: CAGE profiling of nc RNAs in hepatocellular carcinoma reveals widespread activation of retroviral LTR promoters in virus-induced tumors. Genome Research 25(12): 1812-1824

Vitezic, M.; Bertin, N.; Andersson, R.; Lipovich, L.; Kawaji, H.; Lassmann, T.; Sandelin, A.; Heutink, P.; Goldowitz, D.; Ha, T.; Zhang, P.; Patrizi, A.; Fagiolini, M.; Forrest, A.R.R.; Carninci, P.; Saxena, A. 2014: CAGE-defined promoter regions of the genes implicated in Rett Syndrome. Bmc Genomics 15: 1177

Arenillas, D.J.; Forrest, A.R.R.; Kawaji, H.; Lassmann, T.; Wasserman, W.W.; Mathelier, A. 2016: CAGEd-oPOSSUM: motif enrichment analysis from CAGE-derived TSSs. Bioinformatics 32(18): 2858-2860

Haberle, V.; Forrest, A.R.R.; Hayashizaki, Y.; Carninci, P.; Lenhard, B. 2015: CAGEr: precise TSS data retrieval and high-resolution promoterome mining for integrative analyses. Nucleic Acids Research 43(8): E51

Hou, Y.; Liu, Z.; Zhao, Y.; Chen, S.; Zheng, Y.; Chen, F. 2016: CAH1 and CAH2 as key enzymes required for high bicarbonate tolerance of a novel microalga Dunaliella salina HTBS. Enzyme and Microbial Technology 87-88: 17-23

Lehrman, W.G.; Friedberg, M.W. 2015: CAHPS Surveys: Valid and Valuable Measures of Patient Experience. Hastings Center Report 45(6): 3-4

Enache, D.; Solomon, A.; Cavallin, L.; Kåreholt, I.; Kramberger, M.Gregoric.; Aarsland, D.; Kivipelto, M.; Eriksdotter, M.; Winblad, B.; Jelic, V. 2016: CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia. Neurobiology of aging 42: 124-131

Morani, A.C.; Vicens, R.A.; Wei, W.; Gupta, S.; Vikram, R.; Balachandran, A.; Reed, B.J.; Ma, J.; Qayyum, A.; Szklaruk, J. 2015: CAIPIRINHA-VIBE and GRAPPA-VIBE for liver MRi at 1.5 T: a comparative in vivo patient study. Journal of Computer Assisted Tomography 39(2): 263-269

Li, M.; Dick, A.; Hassold, N.; Pabst, T.; Bley, T.; Köstler, H.; Neubauer, H. 2016: CAIPIRINHA-accelerated T1w 3D-FLASH for small-bowel MR imaging in pediatric patients with Crohn's disease: assessment of image quality and diagnostic performance. World Journal of Pediatrics: Wjp 12(4): 455-462

Nomani, L.; Bodo, J.; Zhao, X.; Durkin, L.; Loghavi, S.; Hsi, E.D. 2016: CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms. American Journal of Clinical Pathology 146(4): 431-438

Battistelli, E.S.; Bellini, F.; Bucci, C.; Calvo, M.; Cardani, L.; Casali, N.; Castellano, M.G.; Colantoni, I.; Coppolecchia, A.; Cosmelli, C.; Cruciani, A.; de Bernardis, P.; Di Domizio, S.; D'Addabbo, A.; Martinez, M.; Masi, S.; Pagnanini, L.; Tomei, C.; Vignati, M. 2015: CALDER: neutrinoless double-beta decay identification in TeO[Formula: see text] bolometers with kinetic inductance detectors. European Physical Journal. C Particles and Fields 75(8): 353

Rudin, C.M.; Salgia, R.; Wang, X.F.; Green, M.R.; Vokes, E.E. 2016: CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC). Journal of Clinical Oncology 23(16_Suppl): 7168-7168

Partridge, A.H.; Archer, L.E.; Kornblith, A.B.; Gralow, J.R.; Grenier, D.; Perez, E.A.; Wolff, A.C.; Hudis, C.A.; Winer, E.P.; Muss, H. 2016: CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907. Journal of Clinical Oncology 26(15_Suppl): 6542-6542

Enzinger, P.C.; Burtness, B.A.; Niedzwiecki, D.; Ye, X.; Douglas, K.; Ilson, D.H.; Villaflor, V.M.; Cohen, S.J.; Mayer, R.J.; Venook, A.; Benson, A.B.; Goldberg, R.M. 2016: CALGB 80403 (Alliance)/E1206: a Randomized Phase Ii Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34(23): 2736-2742

Rosenberg, J.E.; Halabi, S.; Sanford, B.L.; Himelstein, A.L.; Atkins, J.N.; Hohl, R.; Seagren, S.L.; Bajorin, D.F.; Small, E.J. 2016: CALGB 90207: Phase II trial of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma (TCC). Journal of Clinical Oncology 24(18_Suppl): 4582-4582

Maddaus, M.A.; Wang, X.; Vollmer, R.T.; Abraham, N.Z.; D'Cunha, J.; Herzan, D.L.; Patterson, A.; Kohman, L.J.; Green, M.R.; Kratzke, R.A. 2016: CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC. Journal of Clinical Oncology 24(18_Suppl): 7030-7030

Hellekant, G.ör.; Schmolling, J.; Marambaud, P.; Rose-Hellekant, T.A. 2015: CALHM1 Deletion in Mice Affects Glossopharyngeal Taste Responses, Food Intake, Body Weight, and Life Span. Chemical Senses 40(6): 373-379

Moreno-Ortega, A.J.é; Buendia, I.; Mouhid, L.; Egea, J.; Lucea, S.; Ruiz-Nuño, A.; López, M.G.; Cano-Abad, M.ía.F. 2015: CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β. Aging Cell 14(6): 1094-1102

Vingtdeux, V.ér.; Chandakkar, P.; Zhao, H.; Blanc, L.; Ruiz, S.; Marambaud, P. 2015: CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain. Journal of Cell Science 128(13): 2330-2338

Pázmándi, T.; Andrási, A.; Fehér, I.; Kocsonya, A.; Pántya, A.; Szántó, P.; Zagyvai, P. 2016: Calibration of a Whole Body Counter for 241am with the Llnl Chest Phantom. Radiation Protection Dosimetry 170(1-4): 225-230

Labyntseva, R.D.; Bevza, A.A.; Lul'ko, A.O.; Cherenok, S.O.; Kalchenko, V.I.; Kosterin, S.O. 2015: Calix[4]arene C-99 Inhibits Myosin Atpase Activity and Changes the Organization of Contractile Filaments of Myometrium. Ukrainian Biochemical Journal 87(6): 95-103

Miller, S.E.; Mathiasen, S.; Bright, N.A.; Pierre, F.; Kelly, B.T.; Kladt, N.; Schauss, A.; Merrifield, C.J.; Stamou, D.; Höning, S.; Owen, D.J. 2015: CALM regulates clathrin-coated vesicle size and maturation by directly sensing and driving membrane curvature. Developmental Cell 33(2): 163-175

Reed, G.J.; Boczek, N.J.; Etheridge, S.P.; Ackerman, M.J. 2015: CALM3 mutation associated with long QT syndrome. Heart Rhythm 12(2): 419-422

Sun, B.K.; Boxer, L.D.; Ransohoff, J.D.; Siprashvili, Z.; Qu, K.; Lopez-Pajares, V.; Hollmig, S.T.; Khavari, P.A. 2015: CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation. Genes and Development 29(21): 2225-2230

Shlykov, S.G.; Babich, L.G.; Yevtushenko, M.E.; Karakhim, S.O.; Kosterin, S.O. 2015: Calmodulin Antagonists effect on Ca2+ Level in the Mitochondria and Cytoplasm of Myometrium cells. Ukrainian Biochemical Journal 87(5): 54-60

Doig, G.S.; Simpson, F. 2015: CALORIES trial offers confirmatory evidence that parenteral nutrition does not cause infectious complications in critically ill patients. Evidence-Based Medicine 20(2): 60

Zhang, X.; Zhou, M.; Chao, H.; Lu, X.; Cen, L. 2015: CALR gene mutation detection and clinical observation of 150 essential thrombocythemia patients. Zhonghua Xue Ye Xue Za Zhi 36(5): 378-382

Bilbao-Sieyro, C.; Florido, Y.; Gómez-Casares, M.ía.T. 2016: CALR mutation characterization in myeloproliferative neoplasms. Oncotarget 7(33): 52614-52617

Haslam, K.; Conneally, E.; Flynn, C.M.; Cahill, M.R.; Gilligan, O.; O'Shea, D.; Langabeer, S.E. 2016: CALR mutation profile in Irish patients with myeloproliferative neoplasms. Hematology/Oncology and Stem Cell Therapy 9(3): 112-115

Zhang, P.; Ma, H.; Min, Q.; Zu, M.; Lu, Z. 2016: CALR mutations in Chinese Budd-Chiari syndrome patients. European Journal of Gastroenterology and Hepatology 28(3): 361-362

Nunes, D.P.T.; Lima, L.T.d.; Chauffaille, M.d.L.; Mitne-Neto, M.; Santos, M.T.d.; Cliquet, M.G.; Guerra-Shinohara, E.M. 2015: CALR mutations screening in wild type JAK2(V617F) and MPL(W515K/L) Brazilian myeloproliferative neoplasm patients. Blood Cells Molecules and Diseases 55(3): 236-240

Castro, N.; Rapado, I.; Ayala, R.; Martinez-Lopez, J. 2015: CALR mutations screening should not be studied in splanchnic vein thrombosis. British Journal of Haematology 170(4): 588-589

Kim, S.Y.; Im, K.; Park, S.N.; Kwon, J.; Kim, J.-A.; Lee, D.S. 2015: CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable. American Journal of Clinical Pathology 143(5): 635-644

Bonzheim, I.; Mankel, B.; Klapthor, P.; Schmidt, J.; Hinrichsen, T.; Wachter, O.; Fend, F.; Quintanilla-Martinez, L. 2015: CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation. Blood 125(14): 2309-2311

Diamond, J.M.S.; de Almeida, A.ón.M.; Belo, H.él.J.é L.ço.M.én.R.; da Costa, M.P.G.P.G.; Cabeçadas, J.é M.V.S.; Abecasis, M.M.d.S.F. 2016: CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene. Annals of Hematology 95(12): 2101-2104

Jover, E.; Marín, F.; Quintana, M.ír.; Pérez-Andreu, J.ín.; Hurtado, J.é A.; Rodríguez, C.; Martínez-González, J.é; González-Conejero, R.ío.; Valdés, M.; Hernández-Romero, D. 2015: CALU polymorphism A29809G affects calumenin availability involving vascular calcification. Journal of Molecular and Cellular Cardiology 82: 218-227

Sakthivel, S.; Balasubramanian, P.; Nakamura, M.; Ko, S.; Chakraborty, P. 2016: CALUX bioassay: a cost-effective rapid screening technique for screening dioxins like compounds. Reviews on Environmental Health 31(1): 149-152

Daskalopoulos, E.P. 2015: CALibrating the CALumenin gene: new insights in overcoming the vascular CALcification CALamity?. Journal of Molecular and Cellular Cardiology 84: 81-83

Neofytou, K.; Giakoustidis, A.; Mudan, S. 2015: CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases. Journal of BUON: Official Journal of the Balkan Union of Oncology 20(3): 746-755

Schöne-Seifert, B.; Friedrich, D.R.; Reichardt, J.-O. 2015: CAM products as therapeutic placebos: theoretical and bioethical reflections. Zeitschrift für Evidenz Fortbildung und Qualitat Im Gesundheitswesen 109(3): 245-254

Park, C.L.; Finkelstein-Fox, L.; Barnes, D.M.; Mazure, C.M.; Hoff, R. 2016: CAM use in recently-returned OEF/OIF/OND US veterans: Demographic and psychosocial predictors. Complementary Therapies in Medicine 28: 50-56

Almeida, J.; Gabe, J. 2016: CAM within a field force of countervailing powers: the case of Portugal. Social Science and Medicine 155: 73-81

Abbas, N.; Chattopadhyay, S. 2014: CAM7 and HY5 genetically interact to regulate root growth and abscisic acid responses. Plant Signaling and Behavior 9(9): E29763

Sudhir, K.M.; Kanupuru, K.K.; Fareed, N.; Mahesh, P.; Vandana, K.; Chaitra, N.T. 2016: CAMBRA as a Tool for Caries Risk Prediction Among 12- to 13-year-old Institutionalised Children - A Longitudinal Follow-up Study. Oral Health and Preventive Dentistry 14(4): 355-362

Groitl, F.; Graf, D.; Birk, J.O.; Markó, M.ár.; Bartkowiak, M.; Filges, U.; Niedermayer, C.; Rüegg, C.; Rønnow, H.M. 2016: CAMEA--A novel multiplexing analyzer for neutron spectroscopy. Review of Scientific Instruments 87(3): 035109

Ruff, K.M.; Harmon, T.S.; Pappu, R.V. 2015: CAMELOT: a machine learning approach for coarse-grained simulations of aggregation of block-copolymeric protein sequences. Journal of Chemical Physics 143(24): 243123

Tong, S.Y.C.; Nelson, J.; Paterson, D.L.; Fowler, V.G.; Howden, B.P.; Cheng, A.C.; Chatfield, M.; Lipman, J.; Van Hal, S.; O'Sullivan, M.; Robinson, J.O.; Yahav, D.; Lye, D.; Davis, J.S. 2016: CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials 17: 170

Förster, S.; Reimer, T.; Rimbach, S.; Louwen, F.; Volk, T.; Bürkle, H.; Benecke, C.; Carus, T.; Türler, A.; Wullstein, C.; Ludwig, K. 2016: CAMIC Recommendations for Surgical Laparoscopy in Non-Obstetric Indications during Pregnancy. Zentralblatt für Chirurgie 141(5): 538-544

Pina, D.; Baar, K. 2016: CAMK in Skeletal Muscle Stimulated by Caffeine to Promote Endurance Adaptation: 2077 Board #229 June 2, 2: 00 PM - 3: 30 PM. Medicine and Science in Sports and Exercise 48(5 Suppl 1): 583-583

Chen, S.Z.; Wang, Z.; Zhang, L.N.; Lu, G.L.; Zhou, C.M.; Wang, D.W.; Tang, Z.M.; Wang, L.; Qin, L.; Zhai, Z.H. 2016: CAMK4 gene variation is associated with hypertension in a Uygur population. Genetics and Molecular Research: Gmr 15(1)

Liu, D-Ming.; Wang, H-Jun.; Han, B.; Meng, X-Qi.; Chen, M-Hui.; Yang, D-Bo.; Sun, Y.; Li, Y-Li.; Jiang, C-Lu. 2016: CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas. Cns Neuroscience and Therapeutics 22(6): 518-524

Waghu, F.H.; Barai, R.S.; Gurung, P.; Idicula-Thomas, S. 2016: CAMPR3: a database on sequences, structures and signatures of antimicrobial peptides. Nucleic Acids Research 44(D1): D1094-D1097

Saeed, F.; Hoffert, J.D.; Knepper, M.A. 2014: CAMS-RS: Clustering Algorithm for Large-Scale Mass Spectrometry Data Using Restricted Search Space and Intelligent Random Sampling. Ieee/Acm Transactions on Computational Biology and Bioinformatics 11(1): 128-141

Toya, M.; Kobayashi, S.; Kawasaki, M.; Shioi, G.; Kaneko, M.; Ishiuchi, T.; Misaki, K.; Meng, W.; Takeichi, M. 2016: CAMSAP3 orients the apical-to-basal polarity of microtubule arrays in epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 113(2): 332-337

Wiwanitkit, V. 2015: CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers. Turk Patoloji Dergisi 31(1): 80

Shibuya, R.; Matsuyama, A.; Shiba, E.; Harada, H.; Yabuki, K.; Hisaoka, M. 2015: CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma. Histopathology 67(6): 827-835

Cestarelli, V.; Fiscon, G.; Felici, G.; Bertolazzi, P.; Weitschek, E. 2016: CAMUR: Knowledge extraction from RNA-seq cancer data through equivalent classification rules. Bioinformatics 32(5): 697-704

Lakizadeh, A.; Jalili, S.; Marashi, S.-A. 2015: CAMWI: Detecting protein complexes using weighted clustering coefficient and weighted density. Computational Biology and Chemistry 58: 231-240

Morrissey, J. 2016: CAN EHRs KEEP PACE? New demands lead to system innovations. Health Data Management 24(3): 35-37

Reynolds, A. 2014: CAN HEPATITIS C BE SEXUALLY TRANSMITTED? Yes. No. Maybe. It's complicated. All of the above. Positively aware: the monthly journal of the Test Positive Aware Network 26(7): 27-31

Barr, P. 2015: CAN i QUOTE YOU? Making headlines. Hospitals and Health Networks 89(8): 14

Singh, L.; Pua, T.; Tedjarati, S.; Song, C.; LeCompte, L.; Pradhan, T. 2015: Can we Improve Detection of Borderline Ovarian Tumors?: Igcs-0065 Ovarian Cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 25(Suppl 1): 60-61

Cook, O.; Frost, G.; Twose, D.; Wallman, L.; Falk, B.; Galea, V.; Adkin, A.; Klentrou, P. 2015: CAN-flip: A Pilot Gymnastics Program for Children With Cerebral Palsy. Adapted Physical Activity Quarterly: Apaq 32(4): 349-370

Hiew, S. 2016: CAN.recall. LANCET. Oncology 17(5): 564

Blank, C.U.; Haanen, J.B.; Ribas, A.; Schumacher, T.N. 2016: CANCER IMMUNOLOGY. the "cancer immunogram". Science 352(6286): 658-660

Couzin-Frankel, J. 2015: CANCER IMMUNOTHERAPY. Baby's leukemia recedes after novel cell therapy. Science 350(6262): 731

Escobar, H. 2016: CANCER RESEARCH. Brazil bill would legalize renegade cancer pill. Science 352(6281): 18

Fanini, F.; Fabbri, M. 2017: Cancer-derived exosomic micro RNAs shape the immune system within the tumor microenvironment: State of the art. Seminars in Cell and Developmental Biology 67: 23-28

Zitvogel, L.; Kroemer, G. 2015: CANCER. a p53-regulated immune checkpoint relevant to cancer. Science 349(6247): 476-477

Nanus, D.M.; Giannakakou, P. 2015: CANCER. Cancer therapies that are gone with the Wnt. Science 349(6254): 1283-1284

Tüting, T.; de Visser, K.E. 2016: CANCER. how neutrophils promote metastasis. Science 352(6282): 145-146

Reczek, C.R.; Chandel, N.S. 2015: CANCER. Revisiting vitamin C and cancer. Science 350(6266): 1317-1318

Malkin, D.; Garber, J.E.; Strong, L.C.; Friend, S.H. 2016: CANCER. the cancer predisposition revolution. Science 352(6289): 1052-1053

Gubin, M.M.; Schreiber, R.D. 2015: CANCER. the odds of immunotherapy success. Science 350(6257): 158-159

Wala, J.; Beroukhim, R. 2016: CANCER. the oncogene makes its escape. Science 351(6280): 1398-1399

Boumahdi, S.; Blanpain, C.éd. 2016: CANCER. Tracking the origins of tumorigenesis. Science 351(6272): 453-454

Rivera, L.B.; Bergers, G. 2015: CANCER. Tumor angiogenesis, from foe to friend. Science 349(6249): 694-695

Prigitano, A.; Cavanna, C.; Passera, M.; Ossi, C.; Sala, E.; Lombardi, G.; Grancini, A.; De Luca, C.; Bramati, S.; Gelmi, M.; Tejada, M.; Grande, R.; Farina, C.; Lallitto, F.; Tortorano, A.M. 2016: CAND-LO 2014-15 study: changing epidemiology of candidemia in Lombardy (Italy). Infection 44(6): 765-780

Dubiel, D.; Ordemann, J.ür.; Pratschke, J.; Dubiel, W.; Naumann, M. 2015: CAND1 exchange factor promotes Keap1 integration into cullin 3-RING ubiquitin ligase during adipogenesis. International Journal of Biochemistry and Cell Biology 66: 95-100

Roberts, T.; Stephen, L.; Scott, C.; di Pasquale, T.; Naser-Eldin, A.; Chetty, M.; Shaik, S.; Lewandowski, L.; Beighton, P. 2015: CANDLE Syndrome: orodfacial manifestations and dental implications. Head and Face Medicine 11: 38

Cavalcante, M.P.V.; Brunelli, J.B.; Miranda, C.C.; Novak, G.V.; Malle, L.; Aikawa, N.E.; Jesus, A.A.; Silva, C.A. 2016: CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature-a rare case with a novel mutation. European Journal of Pediatrics 175(5): 735-740

Boothman, R.C. 2016: CANDOR: the Antidote to Deny and Defend?. Health Services Research 51(Suppl 3): 2487-2490

Indulkar, A.S.; Gao, Y.; Raina, S.A.; Zhang, G.G.Z.; Taylor, L.S. 2018: Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid. Pharmaceutical Research 35(8): 158

Velmeshev, D.; Lally, P.; Magistri, M.; Faghihi, M.A. 2016: CANEapp: a user-friendly application for automated next generation transcriptomic data analysis. Bmc Genomics 17: 49

Cameron, C.; Craig, C.L.; Bauman, A.; Tudor-Locke, C. 2016: CANPLAY study: Secular trends in steps/day amongst 5-19year-old Canadians between 2005 and 2014. Preventive Medicine 86: 28-33

Coci, E.G.; Koehler, U.; Liehr, T.; Stelzner, A.; Fink, C.; Langen, H.; Riedel, J. 2016: CANPMR syndrome and chromosome 1p32-p31 deletion syndrome coexist in two related individuals affected by simultaneous haplo-insufficiency of CAMTA1 and NIFA genes. Molecular Cytogenetics 9: 10

Soares, F.C.; de Oliveira, T.ís.C.G.; de Macedo, L.D.e.D.; Tomás, A.M.ça.; Picanço-Diniz, D.L.W.; Bento-Torres, J.ão.; Bento-Torres, N.ál.V.O.; Picanço-Diniz, C.W. 2015: CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study. Clinical Interventions in Aging 10: 37-48

Szcześniak, M.ł W.; Rosikiewicz, W.; Makałowska, I. 2016: CANTATAdb: a Collection of Plant Long Non-Coding RNAs. Plant and Cell Physiology 57(1): E8

Szmulewicz, D.J.; McLean, C.A.; MacDougall, H.G.; Roberts, L.; Storey, E.; Halmagyi, G.Michael. 2014: CANVAS an update: clinical presentation, investigation and management. Journal of Vestibular Research: Equilibrium and Orientation 24(5-6): 465-474

Riza, N.A.; La Torre, J.P.; Amin, M.J. 2016: CAOS-CMOS camera. Optics Express 24(12): 13444-13458

Heimer, G.; Sadaka, Y.; Israelian, L.; Feiglin, A.; Ruggieri, A.; Marshall, C.R.; Scherer, S.W.; Ganelin-Cohen, E.; Marek-Yagel, D.; Tzadok, M.; Nissenkorn, A.; Anikster, Y.; Minassian, B.A.; Zeev, B.B. 2015: CAOS-Episodic Cerebellar Ataxia, Areflexia, Optic Atrophy, and Sensorineural Hearing Loss: a Third Allelic Disorder of the ATP1A3 Gene. Journal of Child Neurology 30(13): 1749-1756

Wunderink, R.G. 2015: CAP death: what goes wrong when everything is right?. LANCET. Infectious Diseases 15(9): 995-996

Stroehlein, A.J.; Young, N.D.; Hall, R.S.; Korhonen, P.K.; Hofmann, A.; Sternberg, P.W.; Jabbar, A.; Gasser, R.B. 2016: CAP protein superfamily members in Toxocara canis. Parasites and Vectors 9(1): 360

Krivoshei, A.; Uuetoa, H.; Min, M.; Annus, P.; Uuetoa, T.; Lamp, J. 2015: CAP waveform estimation from the measured electrical bioimpedance values: Patient's heart rate variability analysis. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2015: 2788-2791

Weiss, B.; Curran, J.A. 2015: CAP(+) selection: A combined chemical-enzymatic strategy for efficient eukaryotic messenger RNA enrichment via the 5' cap. Analytical Biochemistry 484: 72-74

Hua, M.; Yan, S.; Deng, Y.; Xi, Q.; Liu, R.; Yang, S.; Liu, J.; Tang, C.; Wang, Y.; Zhong, J. 2015: CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation. International Journal of Molecular Medicine 35(4): 941-949

Kosmas, K.; Eskandarnaz, A.; Khorsandi, A.B.; Kumar, A.; Ranjan, R.; Eming, S.A.; Noegel, A.A.; Peche, V.S. 2015: CAP2 is a regulator of the actin cytoskeleton and its absence changes infiltration of inflammatory cells and contraction of wounds. European Journal of Cell Biology 94(1): 32-45

Mueller, S. 2015: CAP: a novel era to better quantitate fatty liver?. Journal of Gastrointestinal and Liver Diseases: Jgld 24(1): 11-13

Dara, R.C.; Tiwari, A.K.; Arora, D.; Rawat, G.; Raina, V. 2015: CAPA analysis of clotted red cell unit detected during leukodepletion process: Importance of quality check on blood collection monitors. Asian Journal of Transfusion Science 9(2): 217-218

Gulcan, E.; Gulcan, A.; Ozkaya, D.P.ın.; Celik, Y. 2015: CAPD Peritonitis Due to Acinetobacter baumannii Bacteremia after Coronary By-Pass Surgery. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 35(7): 762-763

Sug Kim, J.; Won Lee, T.; Gyoo Ihm, C.; Jin Kim, Y.; Mi Moon, S.; Joo Lee, H.; Hwan Jeong, K. 2015: CAPD peritonitis caused by co-infection with Cellulosimicrobium cellulans (Oerskovia xanthineolytica) and Enterobacter cloacae: a case report and literature review. Internal Medicine 54(6): 627-630

Beauregard, A.-P.; Harquail, J.; Lassalle-Claux, G.ég.; Belbraouet, M.; Jean-Francois, J.; Touaibia, M.; Robichaud, G.A. 2015: CAPE Analogs Induce Growth Arrest and Apoptosis in Breast Cancer Cells. Molecules 20(7): 12576-12589

Tseng, J.-C.; Lin, C.-Y.; Su, L.-C.; Fu, H.-H.; Yang, S.-D.; Chuu, C.-P. 2016: CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling. Oncotarget 7(25): 38010-38024

Personne, V.; Chevalier, J.; Buffel du Vaure, C.; Partouche, H.; Gilberg, S.; de Pouvourville, G. 2016: CAPECO: Cost evaluation of community acquired pneumonia managed in primary care. Vaccine 34(19): 2275-2280

Yang, S.; Zhang, X.; Diao, L.; Guo, F.; Wang, D.; Liu, Z.; Li, H.; Zheng, J.; Pan, J.; Nice, E.C.; Li, D.; He, F. 2015: CAPER 3.0: a Scalable Cloud-Based System for Data-Intensive Analysis of Chromosome-Centric Human Proteome Project Data Sets. Journal of Proteome Research 14(9): 3720-3728

Kang, Y.K.; Putluri, N.; Maity, S.; Tsimelzon, A.; Ilkayeva, O.; Mo, Q.; Lonard, D.; Michailidis, G.; Sreekumar, A.; Newgard, C.B.; Wang, M.; Tsai, S.Y.; Tsai, M.-J.; O'Malley, B.W. 2015: CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-α-Gabpa and stress-induced adaptive responses via NF-κB-cMYC. Plos Genetics 11(4): E1005116

Westbrook, J.A.; Cairns, D.A.; Peng, J.; Speirs, V.; Hanby, A.M.; Holen, I.; Wood, S.L.; Ottewell, P.D.; Marshall, H.; Banks, R.E.; Selby, P.J.; Coleman, R.E.; Brown, J.E. 2016: CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment. Journal of the National Cancer Institute 108(4)

Ziras, N.; Polyzos, A.; Kakolyris, S.; Xenidis, N.; Kentepozidis, N.; Athanasiadis, A.; Stergiou, I.; Androulakis, N.; Vamvakas, L.; Souglakos, J. 2016: CAPIRI (capecitabine, irinotecan) + bevacizumab vs FOLFIRI (folinic acid, 5 fluorouracil, irinotecan) + bevacizumab for the treatment of patients with metastatic colorectal cancer (mCRC): Interim analysis for safety of a randomized phase III trial. Journal of Clinical Oncology 26(15_Suppl): 15008-15008

Cai, G.; Zhu, J.; Palmer, J.D.; Xu, Y.; Hu, W.; Gu, W.; Cai, S.; Zhang, Z. 2015: CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Radiation Oncology 10: 57

Kelley, T. 2015: CAPITATION. the Once and Future King. Managed Care 24(8): 26-28

Charton, K.; Sarparanta, J.; Vihola, A.; Milic, A.; Jonson, P.H.; Suel, L.; Luque, H.; Boumela, I.èn.; Richard, I.; Udd, B. 2015: CAPN3-mediated processing of C-terminal titin replaced by pathological cleavage in titinopathy. Human Molecular Genetics 24(13): 3718-3731

Wert, K.J.; Bassuk, A.G.; Wu, W.-H.; Gakhar, L.; Coglan, D.; Mahajan, M.; Wu, S.; Yang, J.; Lin, C.-S.; Tsang, S.H.; Mahajan, V.B. 2015: CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model. Human Molecular Genetics 24(16): 4584-4598

Suttorp, N.; Welte, T.; Marre, R.; Stenger, S.; Pletz, M.; Rupp, J.; Schütte, H.; Rohde, G.; Dreher, M.; Cornelissen, C.; Knüppel, W.; Amari, I.; Stolz, D.; Suttorp, N.; Schütte, H.; Creutz, P.; Bauer, T.; Weiß, T.; Pankow, W.; Lies, A.; Thiemig, D.; Hauptmeier, B.; Ewig, S.; Wehde, D.; Suermann, M.; Prediger, M.; Zernia, G.; Höffken, G.; Kolditz, M.; Welte, T.; Barten, G.; Abrahamczik, M.; Naim, J.; Kröner, W.; Illig, T.; Klopp, N.; Kroegel, C.; Pletz, M.; Dalhoff, K.; Schütz, S.; Hörster, R.; von Plessen, C.; Ravn, P.; Rohde, G.; Buschmann, H.; Kröning, R.; Schaberg, T.; Hering, I.; Schumann, C.; Illmann, T.; Wallner, M. 2016: CAPNETZ. the competence network for community-acquired pneumonia (CAP). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 59(4): 475-481

Lu, C.-J.; Hao, G.; Nikiforova, N.; Larsen, H.E.; Liu, K.; Crabtree, M.J.; Li, D.; Herring, N.; Paterson, D.J. 2015: CAPON modulates neuronal calcium handling and cardiac sympathetic neurotransmission during dysautonomia in hypertension. Hypertension 65(6): 1288-1297

Potic, A.; Nmezi, B.; Padiath, Q.S. 2015: CAPOS syndrome and hemiplegic migraine in a novel pedigree with the specific ATP1A3 mutation. Journal of the Neurological Sciences 358(1-2): 453-456

Zimmermann, M.; Delouya, G.; Alenizi, A.M.; Rajih, E.; Zorn, K.C.; Taussky, D. 2016: CAPRA-S predicts outcome for adjuvant and salvage external beam radiotherapy after radical prostatectomy. Canadian Urological Association Journal 10(3-4): 132-136

Ramazzotti, D.; Caravagna, G.; Olde Loohuis, L.; Graudenzi, A.; Korsunsky, I.; Mauri, G.; Antoniotti, M.; Mishra, B. 2015: CAPRI: efficient inference of cancer progression models from cross-sectional data. Bioinformatics 31(18): 3016-3026

Wada, T.; Tominaga-Wada, R. 2015: CAPRICE family genes control flowering time through both promoting and repressing CONSTANS and FLOWERING LOCUS T expression. Plant Science: An International Journal of Experimental Plant Biology 241: 260-265

Kuemmerle-Deschner, J.B. 2015: CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease. Seminars in Immunopathology 37(4): 377-385

Farina, M.; van de Bospoort, R.; He, E.; Persoon, C.M.; van Weering, J.R.T.; Broeke, J.H.; Verhage, M.; Toonen, R.F. 2015: CAPS-1 promotes fusion competence of stationary dense-core vesicles in presynaptic terminals of mammalian neurons. Elife 4

Xue, R.; Tang, W.; Dong, P.; Weng, S.; Ma, L.; Chen, S.; Liu, T.; Shen, X.; Huang, X.; Zhang, S.; Dong, L. 2016: CAPS1 Negatively Regulates Hepatocellular Carcinoma Development through Alteration of Exocytosis-Associated Tumor Microenvironment. International Journal of Molecular Sciences 17(10)

Miyake, K.; Ohta, T.; Nakayama, H.; Doe, N.; Terao, Y.; Oiki, E.; Nagatomo, I.; Yamashita, Y.; Abe, T.; Nishikura, K.; Kumanogoh, A.; Hashimoto, K.; Kawahara, Y. 2016: CAPS1 RNA Editing Promotes Dense Core Vesicle Exocytosis. Cell Reports 17(8): 2004-2014

Eckenstaler, R.; Lessmann, V.; Brigadski, T. 2016: CAPS1 effects on intragranular pH and regulation of BDNF release from secretory granules in hippocampal neurons. Journal of Cell Science 129(7): 1378-1390

Parrigon, S.; Woo, S.Eun.; Tay, L.; Wang, T. 2017: CAPTION-ing the situation: A lexically-derived taxonomy of psychological situation characteristics. Journal of Personality and Social Psychology 112(4): 642-681

Inoue, T.; Rosin, D.L.; Okusa, M.D. 2016: CAPing inflammation and acute kidney injury. Kidney International 90(3): 462-465

Strongman, D.B.; Wang, J. 2015: New trichomycete species from China and additional information on Gauthieromyces. Mycologia 107(4): 874-888

Gao, J.; Yan, J.; Xu, M.; Ren, S.; Xie, W. 2015: CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α. Molecular Endocrinology 29(11): 1558-1570

Newick, K.; O'Brien, S.; Moon, E.; Albelda, S.M. 2017: CAR T Cell Therapy for Solid Tumors. Annual Review of Medicine 68: 139-152

Singh, N.; Frey, N.V.; Grupp, S.A.; Maude, S.L. 2016: CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia. Current Treatment Options in Oncology 17(6): 28

Almåsbak, H.; Aarvak, T.; Vemuri, M.C. 2016: CAR T Cell Therapy: a Game Changer in Cancer Treatment. Journal of Immunology Research 2016: 5474602

Shiina, S.; Ohno, M.; Ohka, F.; Kuramitsu, S.; Yamamichi, A.; Kato, A.; Motomura, K.; Tanahashi, K.; Yamamoto, T.; Watanabe, R.; Ito, I.; Senga, T.; Hamaguchi, M.; Wakabayashi, T.; Kaneko, M.K.; Kato, Y.; Chandramohan, V.; Bigner, D.D.; Natsume, A. 2016: CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains. Cancer Immunology Research 4(3): 259-268

Bankhead, C. 2016: CAR T-Cell Therapy Highly Active in Various Lymphomas. American Health and Drug Benefits 9(Spec Issue): 19

Enblad, G.; Karlsson, H.; Loskog, A.S.I. 2015: CAR T-Cell Therapy: the Role of Physical Barriers and Immunosuppression in Lymphoma. Human Gene Therapy 26(8): 498-505